<SEC-DOCUMENT>0001493152-26-035196.txt : 20260729
<SEC-HEADER>0001493152-26-035196.hdr.sgml : 20260729
<ACCEPTANCE-DATETIME>20260729162144
ACCESSION NUMBER:		0001493152-26-035196
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20260729
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260729
DATE AS OF CHANGE:		20260729

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanara MedTech Inc.
		CENTRAL INDEX KEY:			0000714256
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				592220004
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39678
		FILM NUMBER:		261217930

	BUSINESS ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		817-529-2300

	MAIL ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WOUND MANAGEMENT TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20080611

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MB SOFTWARE CORP
		DATE OF NAME CHANGE:	19960805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INAV TRAVEL CORPORATION
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:SMTI="http://sanaramedtech.com/20260729">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_SMTI_sanaramedtech.com_20260729 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20260729_20260729 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000714256 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000004" name="dei:EntityCentralIndexKey">0000714256</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="smti-20260729.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-07-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000714256</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-07-29</xbrli:startDate>
        <xbrli:endDate>2026-07-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 50%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_901_edei--DocumentType_c20260729__20260729_z3SJJDtsBIjg"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 50%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
REPORT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported)<b>: <span id="xdx_90B_edei--DocumentPeriodEndDate_c20260729__20260729_zTPyzVbkPvMc"><ix:nonNumeric contextRef="AsOf2026-07-29" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">July 29, 2026</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 50%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_909_edei--EntityRegistrantName_c20260729__20260729_zirHgAriEqKa"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000011" name="dei:EntityRegistrantName">SANARA
MEDTECH INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 50%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20260729__20260729_zgcb7yqvnbJ6"><ix:nonNumeric contextRef="AsOf2026-07-29" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Texas</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityFileNumber_c20260729__20260729_zXEw3HqqvCn9"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000013" name="dei:EntityFileNumber">001-39678</ix:nonNumeric></span>
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20260729__20260729_z3jf0Mhbclc6"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000014" name="dei:EntityTaxIdentificationNumber">59-2219994</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                            incorporation)</span></p></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
                                            Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
                                            No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20260729__20260729_zaoScaIzNw0a"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000015" name="dei:EntityAddressAddressLine1">1200
    Summit Avenue</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20260729__20260729_zOHLRLUMvjVj"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 414</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt; width: 32%"/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressCityOrTown_c20260729__20260729_z5Lm1YoVi4T8"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000017" name="dei:EntityAddressCityOrTown">Fort
    Worth</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20260729__20260729_ztu34BjdD5Hj"><ix:nonNumeric contextRef="AsOf2026-07-29" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_905_edei--EntityAddressPostalZipCode_c20260729__20260729_zean0rD8qTA3"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000019" name="dei:EntityAddressPostalZipCode">76102</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_90D_edei--CityAreaCode_c20260729__20260729_zsumdR4v3aRl"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000020" name="dei:CityAreaCode">(817)</ix:nonNumeric></span> <span id="xdx_900_edei--LocalPhoneNumber_c20260729__20260729_zA7njhMhkDia"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000021" name="dei:LocalPhoneNumber">529-2300</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
Name or Former Address, if Changed Since Last Report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20260729__20260729_z5ReFQRyxap7"><ix:nonNumeric contextRef="AsOf2026-07-29" format="ixt:booleantrue" id="Fact000022" name="dei:WrittenCommunications">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SolicitingMaterial_c20260729__20260729_zjJ8N97Z30yi"><ix:nonNumeric contextRef="AsOf2026-07-29" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementTenderOffer_c20260729__20260729_ztLwfLdjuTQ4"><ix:nonNumeric contextRef="AsOf2026-07-29" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20260729__20260729_zEYhZZRJXaU9"><ix:nonNumeric contextRef="AsOf2026-07-29" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--Security12bTitle_c20260729__20260729_zmDyEGULg3Hb"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, $0.001 Par Value</ix:nonNumeric></span></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--TradingSymbol_c20260729__20260729_zafB4Ksa0g1d"><ix:nonNumeric contextRef="AsOf2026-07-29" id="Fact000027" name="dei:TradingSymbol">SMTI</ix:nonNumeric></span></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>The
    <span id="xdx_90E_edei--SecurityExchangeName_c20260729__20260729_zfujlE5ziTbb"><ix:nonNumeric contextRef="AsOf2026-07-29" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_906_edei--EntityEmergingGrowthCompany_c20260729__20260729_zVpUMADBVFf8"><ix:nonNumeric contextRef="AsOf2026-07-29" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Agreement
and Plan of Merger</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 29, 2026, Sanara MedTech Inc. (the &#8220;Company&#8221;) entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;)
by and among the Company, MiMedx Group, Inc., a Florida corporation (&#8220;Parent&#8221;) and Mustang Merger Sub, Inc., a Texas corporation
and a wholly-owned subsidiary of Parent (&#8220;Merger Subsidiary&#8221;). Upon the terms and conditions set forth in the Merger Agreement,
Merger Subsidiary will be merged with and into the Company (the &#8220;Merger&#8221;), with the Company surviving the Merger as a wholly-owned
subsidiary of Parent. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Merger
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors of the Company (the &#8220;Board&#8221;) unanimously (i) determined that the Merger Agreement and the transactions
contemplated by the Merger Agreement, including the Merger, are advisable, fair to and in the best interests of the Company and its stockholders,
(ii) approved the execution, delivery and performance by the Company of the Merger Agreement and the consummation of the transactions
contemplated thereby, including the Merger, (iii) declared advisable the Merger Agreement and the transactions contemplated thereby,
(iv) resolved to recommend that the Company&#8217;s stockholders vote to approve and adopt the Merger Agreement and the transactions
contemplated thereby (the &#8220;Company Board Recommendation&#8221;) and (v) directed that the Merger Agreement be submitted to the
Company&#8217;s stockholders for their approval and adoption. The Board of Directors of Parent unanimously approved the Merger Agreement
and the Transactions, including, the Merger and the issuance by Parent of common stock, par value $0.001 per share of Parent (the &#8220;Parent
Common Stock&#8221;)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Merger
Consideration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, and upon the terms and subject to the conditions described therein, at the effective time of the Merger (the
&#8220;Effective Time&#8221;), each share of Common Stock, par value $0.001 per share of the Company (&#8220;Company Stock&#8221;) issued
and outstanding immediately prior to the Effective Time (other than (i) shares held by a holder who is entitled to demand and properly
demands appraisal of such shares in accordance with Chapter 10, Subchapter H of the Texas Business Organizations Code and (ii) shares
held by the Company, Parent or any of their respective subsidiaries (each, an &#8220;Excluded Company Share&#8221;)), will be cancelled
and converted into the right to receive $33.00 per share in cash, without interest (the &#8220;Per Share Cash Consideration&#8221;) and
0.4735 shares of Parent Common Stock (the &#8220;Per Share Stock Consideration,&#8221; and together with the Per Share Cash Consideration,
the &#8220;Merger Consideration&#8221;). The Per Share Stock Consideration represents a value of $2.00 per share, calculated based on
the average closing price of Parent Common Stock for the five consecutive trading days immediately prior to July 29, 2026. At the Effective
Time, each Excluded Company Share will automatically be cancelled and extinguished without any consideration paid for such Excluded Company
Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Parent Common Stock to be issued in connection with the Merger will be listed on the Nasdaq Stock Market. In connection with
the issuance of Parent Common Stock as Merger Consideration, Parent will file with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;)
a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;), which will include the proxy statement of the Company
for its stockholder meeting relating to the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Treatment
of Equity Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, immediately prior to the Effective Time, (a) each share of restricted Company Stock, granted pursuant to the
Company&#8217;s Restated 2014 Omnibus Long-Term Incentive Plan, the Company&#8217;s 2024 Omnibus Long-Term Incentive Plan, or otherwise,
whether vested or unvested, which is outstanding as of immediately prior to the Effective Time and which is subject to restrictions on
transfer and/or forfeiture (the &#8220;Company Restricted Stock&#8221;), will automatically be canceled and converted automatically into
the right to receive from the Company, at or promptly after the Effective Time, an amount (i) in cash (less applicable tax withholdings)
equal to the Per Share Cash Consideration and (ii) a number of shares of Parent common stock equal to the Per Share Stock Consideration
(the &#8220;Restricted Stock Consideration&#8221;); and (b) immediately prior to the Effective Time, each option that represents the
right to acquire Company Stock, which is outstanding as of immediately prior to the Effective Time (each, a &#8220;Company Option&#8221;)
shall, by virtue of the Merger and without any action on the part of the Company, Parent or the holder of such Company Option, automatically
be cancelled and converted automatically into the right to receive from the Company, at or promptly after the Effective Time, an amount
in cash (less applicable taxes) equal to the Merger Consideration (with the Per Share Stock Consideration based on the closing price
of the shares of Parent common stock on the last trading day prior to the Closing Date) less the exercise price payable in respect of
such Company Option (the &#8220;Option Consideration&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Representations,
Warranties and Covenants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement contains customary representations, warranties and covenants, including, among others, <span style="background-color: white">covenants
relating to the Company&#8217;s conduct of its business between the date of the Merger Agreement and the earlier of the Effective Time
and the termination of the Merger Agreement,</span> and the Company&#8217;s obligation to convene a meeting of the Company&#8217;s stockholders
to consider and vote upon the adoption and approval of the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the Company is bound by a covenant not to solicit, initiate, or knowingly take any action to facilitate or encourage any competing acquisition
proposals. However, at any time before receiving the Company Stockholder Approval (as defined below), if the Board determines in good
faith, after consultation with its financial advisors and outside legal counsel, that an unsolicited competing acquisition proposal is
or would reasonably be expected to lead to a Superior Proposal and the Board&#8217;s failure to engage would be reasonably likely to
be inconsistent with its fiduciary duties, then the Company is permitted to engage in discussions or negotiations with the third party,
subject to certain requirements set forth in the Merger Agreement. If, at any time before receiving the Company Stockholder Approval,
the Company has received an unsolicited Superior Proposal, then the Board may make an Adverse Recommendation Change and/or cause the
Company to terminate the Merger Agreement, subject to certain requirements set forth in the Merger Agreement, including first providing
Parent with customary match rights. In addition, subject to certain conditions and requirements, including first providing Parent customary
match rights, the Board may effect an Adverse Recommendation Change (but not terminate the Merger Agreement) in response to an &#8220;Intervening
Event&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conditions
to the Transactions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
stockholders of the Company will be asked to vote on the adoption of the Merger Agreement and the approval of the Merger and the other
transactions contemplated thereby at a meeting of the Company&#8217;s stockholders. The Merger is not subject to a financing condition,
but is subject to the satisfaction or waiver (where permitted by applicable law) of certain closing conditions, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>



<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt">the
adoption and approval of the Merger Agreement by the affirmative vote of the holders of a majority of the outstanding shares of Common
Stock entitled to vote thereon (the &#8220;Company Stockholder Approval&#8221;);</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt">the
absence of any law, ruling, injunction or order that restrains, enjoins, renders illegal or otherwise prohibits the consummation of the
Merger;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt">the
expiration or earlier termination of all applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act, and receipt
of certain other applicable approvals, clearances or expirations of waiting periods under the antitrust laws and foreign direct investment
laws of other jurisdictions;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                            customary closing conditions, including the accuracy of each party&#8217;s representations
                                            and warranties and each party&#8217;s compliance with its covenants and agreements contained
                                            in the Merger Agreement (subject to certain qualifications as to materiality);</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    registration statement on Form S-4, pursuant to which the shares of Parent common stock issuable in connection with the Merger being
    registered with the SEC and declared effective by the SEC, and the absence of a stop order suspending such registration statement,
    and the shares of Parent common stock to be issued in connection with the Merger being approved for listing on Nasdaq;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt">the
absence of a Material Adverse Effect since the date of the Merger Agreement.</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Termination</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement may be terminated by mutual written agreement of the Company and Parent. In addition, either party may terminate the
Merger Agreement if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Merger has not been consummated on or before July 29, 2027 (the &#8220;End Date&#8221;), provided that either Company or Parent may
    extend the End Date to January 29, 2028 in the event that the requisite antitrust approvals have not been obtained by the End Date;
    </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    court or other governmental authority issues a final, non-appealable order permanently restraining, enjoining or otherwise prohibiting
    the consummation of the Merger;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company Stockholder Approval is not obtained at a meeting of the Company&#8217;s stockholders (or any adjournment or postponement
    thereof taken in accordance with the Merger Agreement); or</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the other party breaches any of its representations, warranties or covenants, the breach would cause certain closing conditions not
    to be satisfied, and the breach is not curable or, if curable, is not cured within the time period set forth in the Merger Agreement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Merger Agreement may be terminated (i) by the Company, prior to obtaining the Company Stockholder Approval, to enter into
a definitive agreement with respect to a Superior Proposal, subject to compliance with the applicable provisions of the Merger Agreement
and payment of the Termination Fee described below, and (ii) by Parent if at any time prior to obtaining the Company Stockholder Approval
the Board effects an Adverse Recommendation Change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Merger Agreement is terminated under certain circumstances, the Company would be obligated to pay Parent a termination fee of $22,540,785.00
in cash (the &#8220;Parent Termination Fee&#8221;). The Parent Termination Fee would be payable, among other circumstances, if: (i) the
Merger Agreement is terminated by Parent following the Board&#8217;s Adverse Recommendation Change; (ii) the Company terminates the Merger
Agreement to enter into a definitive agreement with respect to a Superior Proposal; or (iii) following the public disclosure of an alternative
acquisition proposal with respect to the Company, the Merger Agreement is terminated for failure to obtain the Company Stockholder Approval
and, within 12 months after such termination, the Company enters into a definitive agreement for, or consummates, certain alternative
acquisition transactions. Furthermore, Parent will be required to pay to the Company a termination fee of $9,660,336.00 if the Company
terminates the Merger Agreement because of a failure of Parent to consummate the Merger when required to do so by the Merger Agreement.
In no event will either party be required to pay its applicable termination fee on more than one occasion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Merger Agreement is consummated, the Company Stock will be delisted from the Nasdaq Capital Market and deregistered under the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the Merger Agreement is attached hereto as Exhibit 2.1 and is incorporated herein by reference. The foregoing description of
the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the full texts of the Merger Agreement.
The Merger Agreement has been filed to provide information to investors regarding its terms. It is not intended to provide any other
factual information about the Company, Parent, or Merger Subsidiary during the period prior to the consummation of the Merger. The Merger
Agreement and the summary should not be relied upon as disclosure about the Company, Parent, or Merger Subsidiary. None of the Company&#8217;s
stockholders or any other third parties should rely on the representations, warranties and covenants in the Merger Agreement or any descriptions
thereof as characterizations of the actual state of facts or conditions of the Company, Parent, or Merger Subsidiary, or any of their
respective subsidiaries or affiliates. The representations and warranties contained in the Merger Agreement are the product of negotiations
among the parties thereto and that the parties made to, and solely for the benefit of, each other as of specified dates. The assertions
embodied in those representations and warranties are subject to qualifications and limitations agreed to by the respective parties and
are also qualified in important part by confidential disclosure schedules delivered in connection with the Merger Agreement. The representations
and warranties may have been made for the purpose of allocating contractual risk between the parties to the agreements instead of establishing
these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable
to investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently
with the execution of the Merger Agreement, on July 29, 2026, Parent entered into a voting agreement (the &#8220;Voting Agreement&#8221;)
with the Company and certain stockholders of the Company (the &#8220;Specified Stockholders&#8221;). Pursuant to the Voting Agreement,
each of the Specified Stockholders has agreed, among other things, to vote, or cause to be voted, all of the shares beneficially owned
by such Specified Stockholder (the &#8220;Shares&#8221;) in favor of the adoption of the Merger Agreement and against any alternative
acquisition proposal, in each case, subject to certain conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of the Merger Agreement, the Specified Stockholders collectively held approximately 38.9% of the total voting power of the
Shares. The Voting Agreement also contains restrictions on, among other things, the transfer of the Shares held by the Specified Stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Voting Agreement will terminate upon the earliest of (a) the termination of the Merger Agreement in accordance with its terms, (b) the
Effective Time, (c) the termination of the Voting Agreement by written agreement of the parties thereto, (d) the date on which the Board
makes an Adverse Recommendation Change, or (e) such date and time as the Merger Agreement shall have been, without the prior written
consent of the Company&#8217;s stockholders, amended or supplemented, or any provision thereof waived, in a manner that changes the form
of the consideration or reduces the amount of the Merger Consideration payable (or issuable) in respect of the Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summary of the Voting Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full
text of such agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01 Regulation FD Disclosure.</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 29, 2026, the Company issued a press release announcing its entry into the Merger Agreement. A copy of the press release is attached
as Exhibit 99.1 and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221;
for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject
to the liabilities under that section. Further, the information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1,
shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or
the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing. Item
7.01 of this Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in this Current Report
on Form 8-K that is required to be disclosed solely by Regulation FD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Forward-Looking
Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
communication relates to a proposed business combination transaction between MiMedx Group, Inc. (&#8220;MiMedx&#8221;) and Sanara MedTech
Inc. (&#8220;Sanara&#8221;). This communication contains certain forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, which include all statements that do not relate solely to historical or current facts, such as statements regarding
the timing of the proposed transaction and the anticipated benefits of the proposed transaction. These forward-looking statements are
and will be, subject to many risks, uncertainties and factors which may cause future events to be materially different from these forward-looking
statements or anything implied therein. These risks and uncertainties include, but are not limited to: uncertainties as to the timing
of the proposed transaction; the timing, receipt and terms and conditions of any required governmental or regulatory approvals of the
proposed transaction that could reduce the anticipated benefits of or cause the parties to abandon the proposed transaction; risks related
to the satisfaction of the conditions to closing the proposed transaction (including the failure to obtain necessary regulatory approvals
or the approval of Sanara&#8217;s stockholders) in the anticipated timeframe or at all; the risk that any announcements relating to the
proposed transaction could have adverse effects on the market price of Sanara&#8217;s or MiMedx&#8217;s stock; disruption from the proposed
transaction making it more difficult to maintain business and operational relationships, including retaining and hiring key personnel;
the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement, including
in certain circumstances requiring Sanara to pay a termination fee; risks related to disruption of management&#8217;s attention from
Sanara&#8217;s ongoing business operations due to the proposed transaction; significant transaction costs; the risk of litigation and/or
regulatory actions related to the proposed transaction; global economic conditions; adverse industry and market conditions; the ability
to retain management and other personnel; risks associated with the development and process for obtaining regulatory approval for new
products, the extent of product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, uncertainties
associated with the development and process for obtaining regulatory approval for new products, the ability to consummate and integrate
acquisitions, and other risks, contingencies and uncertainties detailed in Sanara&#8217;s most recent annual report on Form 10-K and
subsequent reports filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;). While the list of risks and uncertainties
presented here is, and the discussion of risks and uncertainties to be presented in the proxy statement that will be filed by Sanara
with the SEC in connection with the proposed transaction will be, considered representative, no such list or discussion should be considered
a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization
of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking
statements could include, among other things, business disruption, operational problems, financial loss, and legal liability to third
parties and similar risks, any of which could have a material adverse effect on the completion of the proposed transaction and/or Sanara&#8217;s
consolidated financial condition, results of operations, credit rating or liquidity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of the significant uncertainties in these forward-looking statements, Sanara cannot assure you that the forward-looking statements
in this communication will prove to be accurate, and you should not regard these statements as a representation or warranty by Sanara,
its directors, officers or employees or any other person that Sanara will achieve its objectives and plans in any specified time frame,
or at all. Any forward-looking statements in this communication are based upon information available to Sanara on the date of this communication.
Subject to applicable law, Sanara does not undertake to publicly update or revise its forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Important
Additional Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the proposed transaction, MiMedx intends to file with the SEC a registration statement on Form S-4 that will include
a proxy statement of Sanara and that also constitutes a prospectus of MiMedx. Each of MiMedx and Sanara may also file other relevant
documents with the SEC regarding the proposed transaction. This communication is not a substitute for the proxy statement/prospectus
or registration statement or any other document that MiMedx or Sanara may file with the SEC. The definitive proxy statement/prospectus
(if and when available) will be mailed to stockholders of Sanara. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT,
PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS
TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT
INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain free copies of the registration statement
and proxy statement/prospectus (if and when available) and other documents containing important information about MiMedx, Sanara and
the proposed transaction, once such documents are filed with the SEC through the website maintained by the SEC at http://www.sec.gov.
Copies of the documents filed with the SEC by MiMedx will be available free of charge on MiMedx&#8217;s website at https://investors.mimedx.com/.
Copies will also be available at no charge at the Investors Relations section of Sanara&#8217;s website at <span style="text-decoration: underline">https://ir.sanaramedtech.com/</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Participants
in the Solicitation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara,
MiMedx and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies
in respect of the proposed transaction. Information about the directors and executive officers of Sanara, including a description of
their direct or indirect interests, by security holdings or otherwise, is set forth in Sanara&#8217;s proxy statement for its 2026 Annual
Meeting of Stockholders, which was filed with the SEC on April 17, 2026. Information about the directors and executive officers of MiMedx,
including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in MiMedx&#8217;s proxy
statement for its 2026 Annual Meeting of Stockholders, which was filed with the SEC on April 29, 2026. Other information regarding the
participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise,
will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed transaction
when such materials become available. Investors should read the proxy statement/prospectus carefully when it becomes available before
making any voting or investment decisions. You may obtain free copies of these documents from Sanara and MiMedx using the sources indicated
above<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No
Offer or Solicitation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
communication does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy any securities or a solicitation
of any vote or approval with respect to the proposed transactions or otherwise, nor shall there be any sale, issuance or transfer of
securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of such jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>(d)
Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibits are included with this report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    No.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; vertical-align: bottom; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex2-1.htm">Agreement and Plan of Merger, dated as of July 29, 2026, by and among Sanara MedTech Inc., MiMedx Group, Inc., and Mustang Merger Sub, Inc.*</a>    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; vertical-align: bottom; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Voting Agreement, dated as of July 29, 2026, by and among MiMedx Group, Inc., Sanara MedTech Inc., and certain stockholders identified in an exhibit thereto*</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release issued by Sanara MedTech Inc. on July 29, 2026.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
<span style="background-color: white">Schedules (or similar attachments) have been omitted pursuant to Item 601(a)(5) of Regulation S-K.
The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules upon request by the SEC.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sanara
    MedTech Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 5%; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 45%; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 3%; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 47%; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    29, 2026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; padding-right: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Elizabeth B. Taylor</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; vertical-align: bottom; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; vertical-align: bottom; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; vertical-align: bottom; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0pt; padding-left: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elizabeth
                                            B. Taylor</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; vertical-align: bottom; padding-left: 0pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; vertical-align: bottom; padding-left: 0pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; vertical-align: bottom; padding-left: 0pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdsKgkAQhp/Adxj2OjxBRd6VmEQWIRHdLjnGku7I7HZ6pN6yVYmGgTn93/xCTEROa9Ugw3lVFnDEtmukRSixRkZ9QadIN9sEXC3xqoxlqe0w/sCUHIOOmflT6faD8qEMVgmE8yBeBPHMNUk4h+VOeP09JV2rCrVVsgGpKzgwdazQSn6PH47yRZra9+B0QjaKdAKRH47nD8RhFMOeHvJJfDNQFKnwJkN4Ime6d06VvSzqnoSswdbZmZH+p/cFzMtKXQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex2-1.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
2.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Execution
Version</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREEMENT
AND PLAN OF MERGER</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dated
as of</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
29, 2026</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">among</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SANARA
MEDTECH INC.,</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MIMEDX
GROUP, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MUSTANG
MERGER SUB, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 1</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">2</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Definitional and Interpretative Provisions</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">11</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 2</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Merger</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Merger</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">12</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
    of Shares</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">12</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surrender
    and Payment</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">13</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing
    of Transfer Books</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">14</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenting
    Shares</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment
    of Equity Awards</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    Adjustments</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">16</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Awards; Withholding Rights</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 3</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Surviving Corporation</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">17</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Incorporation</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    and Officers</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">17</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 4</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations and Warranties of the Company</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Existence and Power</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">17</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Authorization</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">18</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental
    Authorization</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">18</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-contravention</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">19</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">20</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
    Filings and the Sarbanes-Oxley Act</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">21</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">22</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
    Documents</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">22</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence
    of Certain Changes</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Undisclosed Material Liabilities</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">23</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance
    with Laws and Court Orders</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">23</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
    Matters</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">24</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.14</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.15</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permits</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">26</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.16</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Properties</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">27</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.17</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    Property</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.18</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">30</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.19</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    Benefit Plans and Labor and Employment Matters</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.20</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
    Matters</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">35</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.21</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
    Contracts</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">35</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.22</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
    Party Transactions</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">37</TD></TR>
</TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.23</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.24</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    of the Company&rsquo;s Financial Advisor</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">38</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.25</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeover
    Laws</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">38</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.26</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">38</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.27</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Other Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">38</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.28</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusivity
    of Parent Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">38</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.29</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Reliance</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 5</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations and Warranties of Parent</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">39</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Existence and Power</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Authorization</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">39</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental
    Authorization</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">40</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-contravention</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">40</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
    Documents</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">40</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
    Filings and the Sarbanes-Oxley Act</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">41</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">41</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">41</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solvency</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">43</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    of Company Stock</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">43<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
    and Management Arrangements</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">43</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusivity
    of Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">44</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 6</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covenants of the Company</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">44</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
    of the Company</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">44</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Stockholder Meeting</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">48</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Solicitation; Other Offers</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access
    to Information</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignations</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">53</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payoff
    Letters; Lien Releases; Transaction Expenses.</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">53</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
    Cooperation</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">53</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 7</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covenants of Parent</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">54</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
    of Parent</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations
    of Merger Subsidiary</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
    of Shares</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">55</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and Officer Liability</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">55</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    Matters</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">58</TD></TR>
</TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 8</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covenants of Parent and the Company</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">59</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
    Authorizations and Consents</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">59</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
    Statement and Registration Statement</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">61</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    Announcements</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">62</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
    Assurances</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices
    of Certain Events</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    16 Matters</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">63</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    Litigation</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">63</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeover
    Laws</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">64</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Exchange Listing; Delisting and Deregistration</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">64</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 9</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to the Merger</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">64</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    9.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions
    to the Obligations of Each Party</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">64</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    9.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions
    to the Obligations of Parent and Merger Subsidiary</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">65</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    9.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions
    to the Obligations of the Company</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">66</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 10</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">66</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of Termination</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article 11</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">69</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Survival of Representations, Warranties and Agreements</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments
    and Waivers</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">70</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses
    and Termination Fee</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Binding
    Effect; Benefit; Assignment</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing
    Law</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">73</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">73</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WAIVER
    OF JURY TRIAL</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts;
    Effectiveness</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">74<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire
    Agreement</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">74</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific
    Performance</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Recourse</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.14</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt
    Financing Sources</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">76</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREEMENT
AND PLAN OF MERGER</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREEMENT
AND PLAN OF MERGER (this &ldquo;<B>Agreement</B>&rdquo;) dated as of July <B>29,</B> 2026 among <B>Sanara MedTech Inc.</B>, a Texas corporation
(the &ldquo;<B>Company</B>&rdquo;), <B>MiMedx Group, Inc.</B>, a <B>Florida</B> corporation (&ldquo;<B>Parent</B>&rdquo;), and <B>Mustang
Merger Sub, Inc.</B>, a Texas corporation and a wholly-owned subsidiary of Parent (&ldquo;<B>Merger Subsidiary</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">W
I T N E S S E T H:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
upon the terms and subject to the conditions set forth in this Agreement, Merger Subsidiary will be merged with and into the Company,
with the Company continuing as the Surviving Corporation, and each issued and outstanding share of Company Stock immediately prior to
the Effective Time (other than shares to be canceled in accordance with <U>Section 2.2</U> and Dissenting Shares) will be converted into
the right to receive the Merger Consideration;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company Board has unanimously (i) determined that this Agreement and the Transactions, including the Merger, are advisable, fair
to and in the best interests of the Company and its stockholders; (ii) approved the execution, delivery and performance by the Company
of this Agreement and the consummation of the transactions contemplated hereby, including the Merger (the &ldquo;<B>Transactions</B>&rdquo;);
(iii) declared advisable this Agreement and the Transactions on the terms and subject to the conditions set forth herein; (iv) recommended
that the Company&rsquo;s stockholders vote to approve and adopt this Agreement; and (v) directed that this Agreement be submitted to
the Company&rsquo;s stockholders for their approval and adoption;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Board of Directors of Parent has approved and declared advisable this Agreement and the Transactions, including the Merger and the
issuance of Parent Common Stock in connection with the Merger;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Board of Directors of Merger Subsidiary has approved and declared advisable this Agreement and the Transactions, including the Merger;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
in order to induce Parent to enter into this Agreement and cause the Transactions to be consummated, certain stockholders of the Company
are executing voting and support agreements in favor of Parent concurrently with the execution and delivery of this Agreement (the &ldquo;<B>Voting
Agreements</B>&rdquo;), providing among other things, that each such person shall vote in favor of and support the Merger and the other
Transactions contemplated hereby; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
each of the parties hereto desires to make certain representations, warranties, covenants and agreements in connection with the Merger
and the Transactions and also to prescribe certain conditions to the Merger as specified herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and agreements contained herein, the parties
hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Definitions</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
1.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) As
used herein, the following terms have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>1933
Act</B>&rdquo; means the Securities Act of 1933.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>1934
Act</B>&rdquo; means the Securities Exchange Act of 1934.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Acquisition
Proposal</B>&rdquo; means, other than the Transactions, any offer or proposal from a Third Party relating to any transaction or series
of related transactions involving (i) any acquisition or purchase, directly or indirectly, of 20% or more of the consolidated assets
of the Company and its Subsidiaries or 20% or more of any class of equity or voting securities of the Company or any of its Subsidiaries
whose net revenues, net income or assets, individually or in the aggregate, constitute 20% or more of the consolidated net revenues,
net income or assets of the Company and its Subsidiaries; (ii) any tender offer (including a self-tender offer) or exchange offer that,
if consummated, would result in a Third Party beneficially owning 20% or more of any class of equity or voting securities of the Company
or any of its Subsidiaries whose net revenues, net income or assets, individually or in the aggregate, constitute 20% or more of the
consolidated net revenues, net income or assets of the Company and its Subsidiaries; (iii) a merger, consolidation, share exchange, business
combination, reorganization, recapitalization, liquidation, dissolution or other similar transaction involving the Company or any of
its Subsidiaries whose net revenues, net income or assets, individually or in the aggregate, constitute 20% or more of the consolidated
net revenues, net income or assets of the Company and its Subsidiaries and that would have any of the effects specified in clause (i);
or (iv) any combination of any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under common control with such
Person. For purposes of this definition, the term &ldquo;control&rdquo; (including the correlative meanings of the terms &ldquo;controlled
by&rdquo; and &ldquo;under common control with&rdquo;), as used with respect to any Person, means the possession, direct or indirect,
of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting
securities, by Contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Antitrust
Laws</B>&rdquo; means, collectively, the Sherman Act of 1890, 15 U.S.C. &sect;&sect; 1 et seq., the Clayton Act, 15 U.S.C. &sect;&sect;
12-27 (including the HSR Act), the Federal Trade Commission Act, 15 U.S.C. &sect;&sect; 41 et seq and any other Applicable Law that is
designed or intended to preserve or protect competition, prohibit and restrict agreements in restraint of trade or monopolization, attempted
monopolization, restraints of trade and abuse of a dominant position, or to regulate, prohibit or prevent acquisitions, mergers or other
business combinations and similar transactions, the effect of which may be to lessen or impede competition or to tend to create or strengthen
a dominant position or to create a monopoly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable
Date</B>&rdquo; means January 1, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable
Law</B>&rdquo; means, with respect to any Person, any domestic or foreign federal, state or local law (statutory, common or otherwise),
constitution, treaty, convention, ordinance, code, rule, regulation, order, injunction, judgment, decree, ruling or other similar requirement
enacted, adopted, promulgated or applied by a Governmental Authority that is binding upon or applicable to such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
Day</B>&rdquo; means a day, other than Saturday, Sunday or other day on which commercial banks in Dallas, Texas and New York, New York
are authorized or required by Applicable Law to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>CARES
Act</B>&rdquo; means the Coronavirus Aid, Relief and Economic Security Act and any similar or conforming legislation in any U.S. jurisdiction,
and any subsequent legislation relating to the COVID-19 pandemic, including the Health and Economic Recovery Omnibus Emergency Solutions
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Code</B>&rdquo;
means the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Balance Sheet</B>&rdquo; means the consolidated balance sheet of the Company as of the Company Balance Sheet Date and the footnotes thereto
set forth in the Company 10-Q.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Balance Sheet Date</B>&rdquo; means March 31, 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Board</B>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Disclosure Schedule</B>&rdquo; means the disclosure schedule dated the date hereof regarding this Agreement that has been provided by
the Company to Parent and Merger Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Employee</B>&rdquo; means an employee of the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Equity Plans</B>&rdquo; means the Company&rsquo;s Restated 2014 Omnibus Long-Term Incentive Plan, the Company&rsquo;s 2024 Omnibus Long-Term
Incentive Plan and the Precision Healing, Inc. 2020 Stock Option and Grant Plan, in each case, as amended, modified or restated from
time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
IT Systems</B>&rdquo; means all software, computer hardware, servers, networks, platforms, peripherals, and similar or related items
of automated, computerized, or other information technology networks and systems (including telecommunications networks and systems for
voice, data, and video) owned, leased, licensed, or used (including through cloud-based or other Third Party service providers) by the
Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Company
Option&rdquo;</B> means each option that represents the right to purchase Company Stock, granted pursuant to the Company Equity Plan
or otherwise, whether vested or unvested, which is outstanding as of immediately prior to the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Restricted Stock</B>&rdquo; means each restricted stock award with respect to a share of Company Stock, granted pursuant to the Company
Equity Plan or otherwise, whether vested or unvested, which is outstanding as of immediately prior to the Effective Time and which is
subject to Restrictions on transfer and/or forfeiture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Stock</B>&rdquo; means the Common Stock, par value $0.001 per share, of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
10-Q</B>&rdquo; means the Company&rsquo;s quarterly report on Form 10-Q for the fiscal period ended March 31, 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Confidentiality
Agreement</B>&rdquo; means the confidentiality agreement dated December 15, 2025 between the Company and Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Contract</B>&rdquo;
means any contract, agreement, lease, sublease, license, note, mortgage, bond, indenture or other legally binding obligation, commitment
or undertaking, written or oral (but excluding for purposes of this Agreement any statements of work, purchase orders, service orders
or other similar documents entered into in the ordinary course of business).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Data
Privacy and Security Requirements</B>&rdquo; means to the extent relating to data privacy, protection, or security, or any consumer protection
laws, or telemarketing-related laws concerning email, telephone calls and text messages, and applying to the conduct of the business
of the Company or any of its Subsidiaries: (i) all Applicable Laws including any related security breach notification requirements; (ii)
the external past and present policies that are or were adopted by the Company or any of its Subsidiaries during such time period in
which the Company or its Subsidiaries were or are bound thereby; and (iii) Contracts to which the Company or any its Subsidiaries are
parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Debt
Financing Sources</B>&rdquo; means, in its capacity as such, any lender or similar debt financing sources providing the Debt Financing
(including the parties to any joinder agreements, credit agreements or other definitive agreements relating thereto) and their respective
Affiliates, and such lender&rsquo;s or other debt financing source&rsquo;s (and their respective Affiliates&rsquo;) former, current and
future equity holders, members, partners, employees, officers, directors, managers, controlling persons, attorneys, agents, advisors
or other representatives or the heirs, executors, successors, or assigns of any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Employee
Plan</B>&rdquo; means any (i) &ldquo;employee benefit plan&rdquo; as defined in Section 3(3) of ERISA or (ii) any profit sharing, bonus,
incentive, commission, individual consulting agreement, employment agreement, equity or equity-based compensation, phantom equity, pension,
retirement, severance, deferred compensation, change in control, retention, stay bonus, excess benefit, supplemental unemployment, post-retirement
medical or life insurance, welfare or incentive plan, or sick leave, long-term disability, medical, hospitalization, life insurance,
other insurance plan, or other employee benefit plan, programs, agreements, understandings or arrangements, in each case that is sponsored,
maintained or contributed to by the Company or any of its Subsidiaries, or under which the Company and/or its Subsidiaries could have
any obligation or liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Environmental
Laws</B>&rdquo; means any and all statutes, laws, regulations or rules that have as their principal purpose the protection of the environment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>ERISA</B>&rdquo;
means the Employee Retirement Income Security Act of 1974.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>ERISA
Affiliate</B>&rdquo; means, with respect to the Company or any of its Subsidiaries, any other entity, trade or business that is a member
of a group described in Section 414(b),(c), (m) or (o) of the Code or Section 4001(b)(l) of ERISA that includes the Company or any Subsidiary,
or that is a member of the same &ldquo;controlled group&rdquo; as the Company or any of its Subsidiaries pursuant to Section 4001(a)(14)
of ERISA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>FDA</B>&rdquo;
means the United States Food and Drug Administration (21 U.S.C. &sect;301 <I>et seq.</I>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>FDCA</B>&rdquo;
means the Food, Drug, and Cosmetic Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>GAAP</B>&rdquo;
means generally accepted accounting principles in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Government
Official</B>&rdquo; means (i) any officer or employee of any Governmental Authority, (ii) any person acting in an official capacity on
behalf of a Governmental Authority, (iii) any officer or employee of a political party or any person acting in an official capacity on
behalf of a political party, or (iv) any candidate for political office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Governmental
Authority</B>&rdquo; means any transnational, domestic or foreign federal, state or local governmental, regulatory, self-regulatory or
administrative authority, department, court, agency or official, including any political subdivision or instrumentality thereof or any
arbitral body (whether public or private).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Hazardous
Substances</B>&rdquo; means any pollutants, contaminants, wastes, or other materials or substances that are regulated or for which liability
or standards of conduct may be imposed under any Environmental Law, and shall include oil, petroleum, petroleum-derived substances, radiation
and radioactive materials, polychlorinated biphenyls, urea formaldehyde, perfluoroalkyl and polyfluoroalkyl substances, silica, radon,
dust, noise, odors, mold, microbial matter, and asbestos or any materials containing asbestos.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Healthcare
Laws</B>&rdquo; means all healthcare Applicable Laws applicable to the Company and the operation of its business, including, without
limitation, all Applicable Laws applicable to the ownership, research, development, testing, manufacture, quality, safety, accreditation,
packaging, storage, use, distribution, labeling, sale, offer for sale, import, export or disposal of any product manufactured or distributed
by the Company, including in relation to the United States, the Federal FDCA, the Public Health Service Act (42 U.S.C. &sect; 201 <I>et
seq</I>.), the Federal Controlled Substances Act (21 U.S.C. &sect;801 <I>et seq</I>.), all Applicable Laws concerning fraud and abuse,
including the federal Anti-Kickback Statute (42 U.S.C. &sect; 1320a- 7b(b)), the federal False Claims Act (42 U.S.C. &sect; 1320a-7b(a)),
as amended, the federal Exclusion statute (42 U.S.C. &sect; 1320a- 7) and the federal Civil Monetary Penalties Law (42 U.S.C. &sect;
1320a-7a), and any state analogs, as well as applicable laws of any foreign Governmental Authority, and including in each case the applicable
implementing regulations, together with any rules, requirements and guidance promulgated or issued thereunder, Applicable Laws related
to the licensure, certification, accreditation, qualification or authority required to transact business relating to the operation of
the business, the so-called federal &ldquo;sunshine&rdquo; law or Open Payments law (42 U.S.C. &sect; 1320a-7h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>HSR
Act</B>&rdquo; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indebtedness</B>&rdquo;
means, with respect to the Company, (i) all indebtedness for borrowed money, (ii) all obligations evidenced by bonds, debentures, notes
or similar instruments (including any letter of credit, surety bond, banker&rsquo;s acceptance or similar reimbursement agreement or
obligation, in each case, solely to the extent drawn), (iii) all obligations to pay the deferred purchase price of property or services
(excluding trade accounts payable arising in the ordinary course of business of the Company), (iv) all obligations under leases required
to be capitalized in accordance with GAAP, (v) all obligations under any direct or indirect guaranties in respect of, or obligations
(contingent or otherwise) to purchase or otherwise acquire, or otherwise to assure a creditor against loss in respect of, indebtedness
for borrowed money or obligations of others of the kinds referred to in clauses (i) through (iv) above, (vi) all obligations of the Company
(including with respect to any ERISA Affiliate) for underfunded or unfunded pension, deferred compensation plans or similar plans and
any withdrawal liability or similar obligation arising under ERISA, and (vii) all obligations of the kinds referred to in clauses (i)
through (v) above of other Persons secured by any Lien on any property or asset of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Intellectual
Property</B>&rdquo; means all of the following, anywhere in the world: (i) patents, patent applications and inventions, designs and improvements
described and claimed therein, patentable inventions and other patent rights (including any divisions, continuations, continuations-in-part,
reissues, reexaminations, or interferences thereof, whether or not patents are issued on any such applications and whether or not any
such applications are modified, withdrawn, or resubmitted) (&ldquo;<B>Patents</B>&rdquo;); (ii) trademarks, service marks, trade dress,
trade names, brand names, designs, logos, or corporate names, whether registered or unregistered, and all registrations and applications
for registration thereof, and all goodwill related thereto (&ldquo;<B>Trademarks</B>&rdquo;); (iii) copyrights and mask works, including
all renewals and extensions thereof, copyright registrations and applications for registration thereof, and non-registered copyrights
(&ldquo;<B>Copyrights</B>&rdquo;); (iv) trade secrets, know-how, inventions, processes, procedures, databases, confidential business
information, concepts, ideas, designs, research or development information, techniques, technical information, specifications, operating
and maintenance manuals, engineering drawings, methods, technical data, discoveries, modifications, extensions, improvements, and other
proprietary information and rights (whether or not patentable or subject to copyright, mask work, or trade secret protection) (collectively,
&ldquo;<B>Trade Secrets</B>&rdquo;); (v) computer software programs, including all source code, object code, and documentation related
thereto; and (vi) domain names, Internet addresses and other computer identifiers, websites, web pages and similar rights and items.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Knowledge</B>&rdquo;
means (i) with respect to the Company, the actual knowledge of the individuals listed on <U>Section 1.1</U> of the Company Disclosure
Schedule after due inquiry of their direct reports and (ii) with respect to Parent, the actual knowledge of the individuals listed on
<U>Section 1.1</U> of the Parent Disclosure Schedule after due inquiry of their direct reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Lien</B>&rdquo;
means, with respect to any property or asset, any mortgage, lien, pledge, charge, security interest, encumbrance or other adverse claim
of any kind in respect of such property or asset. For purposes of this Agreement, a Person shall be deemed to own subject to a Lien any
property or asset that it has acquired or holds subject to the interest of a vendor or lessor under any conditional sale agreement, capital
lease or other title retention agreement relating to such property or asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Material
Adverse Effect</B>&rdquo; means, with respect to the Company, any fact, event, circumstance, occurrence or effect (an &ldquo;<B>Effect</B>&rdquo;)
that, individually or in the aggregate, (i) prevents or materially impairs or would reasonably be expected to prevent or materially impair
the ability of the Company to consummate the Merger on the terms and conditions of this Agreement by the End Date or (ii) has had, or
would reasonably be expected to have a material adverse effect on the financial condition, business, assets or results of operations
of the Company and its Subsidiaries, taken as a whole; <I>provided, however</I>, that none of the following, either alone or in combination,
shall be taken into account in determining whether there has been, is, or would reasonably be expected to be a Material Adverse Effect
for purposes of this clause (ii): (A) changes in GAAP, (B) changes in the financial or securities markets or in general economic or political
conditions, (C) changes in Applicable Law or the enforcement or interpretation thereof, (D) changes or proposed changes in reimbursement
rates or coverage limitations applicable to the products or services of the Company or its Subsidiaries, (E) changes generally affecting
the industry in which the Company or its Subsidiaries operate, (F) hostilities, acts of war, sabotage or terrorism, or any escalation
or worsening thereof, (G) the announcement, pendency or consummation of the Transactions, (H) any failure by the Company and its Subsidiaries
to meet any internal or published budgets, projections, forecasts or predictions of financial performance for any period (it being understood
that this clause (H) shall not prevent a party from asserting that any Effect not otherwise excluded that may have contributed to such
failure independently constitutes or contributes to a Material Adverse Effect), (I) any action taken (or omitted to be taken) by Parent
or Merger Subsidiary or their respective Affiliates, representatives or agents after the date of this Agreement, (J) any action taken
by the Company or any of its Subsidiaries after the date of this Agreement at the request of Parent or that is required, expressly contemplated
or expressly permitted pursuant to this Agreement, (K) changes in the market price or trading volume of the shares of Company Stock (it
being understood that this clause (K) shall not prevent a party from asserting that any Effect not otherwise excluded that may have contributed
to such change independently constitutes or contributes to a Material Adverse Effect), or (L) earthquakes, hurricanes, tsunamis, tornadoes,
floods, mudslides, wild fires or other natural disasters, weather conditions, epidemics, pandemics or disease outbreaks and other force
majeure events; <I>provided, further, however</I>, that, with respect to clauses (A),(B), (C), (F) and (L), such Effect shall be taken
into account in determining whether a &ldquo;Material Adverse Effect&rdquo; has occurred to the extent it has a disproportionate adverse
effect on the Company and its Subsidiaries, taken as a whole, relative to other participants in the industries in which the Company and
its Subsidiaries operate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Order</B>&rdquo;
means any orders, judgments, injunctions, awards, decrees or writs handed down, adopted or imposed by any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Parent
Common Stock</B>&rdquo; means the common stock, par value $0.001 per share, of Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Parent
Disclosure Schedule</B>&rdquo; means the disclosure schedule dated the date hereof regarding this Agreement that has been provided by
Parent to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Parent
Material Adverse Effect</B>&rdquo; means an Effect that, individually or in the aggregate, prevents or materially impairs, or would reasonably
be expected to prevent or materially impair, the ability of Parent or Merger Subsidiary to consummate the Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Permits</B>&rdquo;
means all permits, licenses, consents, approvals, franchises, authorizations, approvals, privileges, certificates, waivers, exemptions,
variances, exclusionary or inclusionary orders and other concessions, or similar rights issued by or filed with any Governmental Authority
or other authority possessing legal or contractual right to issue or grant any such rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Permitted
Liens</B>&rdquo; means (i) Liens disclosed on the Company Balance Sheet or notes thereto or securing liabilities reflected on the Company
Balance Sheet or notes thereto or any Liens securing liabilities incurred in the ordinary course of business following the Company Balance
Sheet Date, (ii) Liens for Taxes, assessments and similar charges that are not yet due or payable or are being contested in good faith
and for which adequate reserves have been established on the financial statements of the Company in accordance with GAAP, (iii) mechanic&rsquo;s,
materialman&rsquo;s, carrier&rsquo;s, repairer&rsquo;s and other similar Liens arising or incurred in the ordinary course of business
or that are not yet due and payable or are being contested in good faith, (iv) any matters of record, Liens and other imperfections of
title that do not, individually or in the aggregate, materially and adversely impair the continued use, occupancy and operation of the
property to which they relate in the business of the Company and its Subsidiaries as currently conducted, (v) any Liens on title affecting
a lessor&rsquo;s (or sublessor&rsquo;s) interest in any of the Leased Real Property or affecting the interest of a subtenant of Company
or its Subsidiaries therein, (vi) zoning, entitlement, building codes and other land use regulations, ordinances or other Applicable
Laws imposed by any Governmental Authorities having jurisdiction over the Real Property that, in each case, do not adversely affect in
any material respect the current use or value of the Real Property, (vii) non-exclusive licenses of Intellectual Property granted in
the ordinary course of business, and (viii) any state of facts that an accurate survey of the Real Property would disclose and that,
individually or in the aggregate, do not materially and adversely impair the continued use, occupancy and operation of the applicable
Real Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual, corporation, general or limited partnership, limited liability company, association, statutory or grantor trust
or other entity or organization, including any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Personal
Information</B>&rdquo; means (i) any information that can be used to identify, locate, or contact an individual, alone or when combined
with other personal or identifying information, (ii) any information that constitutes &ldquo;personal data,&rdquo; &ldquo;personal information,&rdquo;
&ldquo;protected health information&rdquo; or other similar terms as defined by Applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Privacy
Laws</B>&rdquo; means all Applicable Laws worldwide relating to data privacy, protection or security or the receipt, or processing of
Personal Information and all binding guidance thereunder issued by a Governmental Authority, including all Applicable Laws governing
cybercrime and breach notification, Section 5 of the Federal Trade Commission Act, California Consumer Privacy Act of 2018 as amended
by the California Privacy Rights Act of 2020, state data breach notification Laws, state data security Applicable Laws, state social
security number protection Laws, EU General Data Protection Regulation 2016/679, EU Privacy and Electronic Communications Directive 2002/58/EC,
any successor or implementing legislation or regulation to any of the foregoing and any Applicable Law concerning requirements for any
outbound communications and/or electronic marketing (including e-mail marketing, telemarketing and text messaging).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Proceeding</B>&rdquo;
means any cause of action, claim, demand, proceeding, arbitration, suit, hearing, litigation, audit, complaint, charge, examination,
indictment or investigation (whether civil, criminal, administrative, judicial or investigative) by or before any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Products</B>&rdquo;
means those products developed, tested, manufactured, stored, distributed, promoted, marketed, sold and otherwise commercialized by the
Company or its Subsidiaries, including those Products set forth on <U>Schedule 1.2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Registration
Statement</B>&rdquo; means the registration statement on Form S-4, as amended or supplemented from time to time, pursuant to which shares
of Parent Common Stock issuable in connection with the Merger will be registered with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Regulatory
Authority</B>&rdquo; means any local, state, federal, national, or multinational governmental health regulatory agency or authority within
a regulatory jurisdiction, with the authority to grant approvals, licenses, registrations or authorizations necessary for the development,
manufacture, use, and sale of a medical device product. For clarity, references in this Agreement to Regulatory Authority shall be deemed
to include the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Regulatory
Approval</B>&rdquo; means, with respect to a particular jurisdiction, such approvals, clearances, permits, licenses, registrations and/or
authorizations by any Regulatory Authority as are necessary for the development, manufacture, use or sale of any Product in such jurisdiction,
excluding any approval of pricing and/or reimbursement for such Product in such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sanctioned
Country</B>&rdquo; means a country, region, or territory which is the subject of country-wide or territory-wide economic sanctions, including,
as of the date of this Agreement, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, the so-called Donetsk People&rsquo;s
Republic of Ukraine and the so-called Luhansk People&rsquo;s Republic of Ukraine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sanctioned
Person</B>&rdquo; means any Person that (i) appears on the &ldquo;List of Specially Designated Nationals and Blocked Persons&rdquo; maintained
by the United States Department of the Treasury&rsquo;s Office of Foreign Assets Control (&ldquo;<B>OFAC</B>&rdquo;), the U.K. Sanctions
List, the E.U. Consolidated Financial Screening List, or is otherwise the target of any Sanctions, including U.S. Executive Order 14024
issued on April 15, 2021, U.S. Executive Order 13662 issued on March 20, 2014, and any directives or designations issued pursuant thereto;
(ii) is operating in, organized in, a national of, ordinarily resident in, or an agency or instrumentality of the government of Venezuela
or a Sanctioned Country; or (iii) is directly or indirectly owned 50% or more in the aggregate, or controlled by or acting for or on
behalf of one or more Persons described in clauses (i) and (ii), above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sanctions</B>&rdquo;
means all economic or financial sanctions or trade embargoes imposed, administered, or enforced by (i) the U.S. government, including
those administered by OFAC or the U.S. Department of State, or (ii) the United Nations Security Council, the European Union, any European
Union member state, His Majesty&rsquo;s Treasury of the United Kingdom, the Government of Canada or other relevant sanctions Governmental
Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sarbanes-Oxley
Act</B>&rdquo; means the Sarbanes-Oxley Act of 2002.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>SEC</B>&rdquo;
means the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Security
Incident</B>&rdquo; means an event (cyber or otherwise) that actually compromises, or is reasonably likely to compromise, the confidentiality,
integrity, or availability of, or any other cyber or other security incident with respect to, any Company IT System.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subsidiary</B>&rdquo;
means, with respect to any Person, of which such first Person directly or indirectly owns or has the power to vote or control securities
or other ownership interests (a) representing fifty percent (50%) or more of any class or series of capital stock or other securities
or equity interests of such Person or (b) having ordinary voting power to elect a majority of the board of directors (or other persons
performing similar functions) of such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Takeover
Laws</B>&rdquo; means any &ldquo;moratorium,&rdquo; &ldquo;control share acquisition,&rdquo; &ldquo;fair price,&rdquo; &ldquo;supermajority,&rdquo;
&ldquo;affiliate transactions,&rdquo; or &ldquo;business combination statute or regulation&rdquo; or other similar state anti-takeover
law, including TBOC &sect;&sect; 21.601&ndash;21.610.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Tax</B>&rdquo;
means any and all federal, state, local, or foreign income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation,
premium, windfall profits, environmental, customs, duties, capital stock, franchise, margin, gross margin, profits, withholding, social
security (or similar), unemployment, disability, real property, personal property, ad valorem, capital, documentary, goods and services,
intangible, inventory, recording, sales, use, transfer, registration, value added, alternative or add-on minimum, estimated, or other
tax of any kind whatsoever, including any interest, penalty, or addition thereto, whether disputed or not.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Tax
Return</B>&rdquo; means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including
any schedule or attachment thereto, and including any amendment thereof, supplied or required to be supplied to a Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>TBOC</B>&rdquo;
means the Texas Business Organizations Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third
Party</B>&rdquo; means any Person, including any &ldquo;group&rdquo; as defined in Section 13(d) of the 1934 Act, other than Parent or
any of its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Unless
otherwise defined in <U>Section 1.1(a)</U>, each of the following terms is defined on the page set forth opposite such term:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acceptable
    Confidentiality Agreement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adverse
    Recommendation Change</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternative
    Acquisition Agreement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternative
    Financing</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    Bonus</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bankruptcy
    and Equity Exception</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clearance
    Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing
    Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Board Recommendation</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Enforcement Expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Group</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Intellectual Property</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    SEC Documents</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Securities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Stockholder Approval</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Stockholder Meeting</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Subsidiary Securities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuation
    Period</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing
    Employee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Converted
    Share</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customary
    Payment Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D&amp;O
    Insurance</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt
    Commitment Letter</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt
    Financing</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenting
    Shares</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Divestiture
    Action</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    Time</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Electronic
    Delivery</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e-mail</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">End Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    Agent</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HIPAA</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnified
    Person</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance
    Policies</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internal
    Controls</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intervening
    Event</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Labor
    Agreement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leased
    Real Property</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
    Contract</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
    Consideration</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    Period</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OFAC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
    Consideration</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned
    Intellectual Property</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned
    Real Property</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent
    Enforcement Expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent
    SEC Documents</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent
    Termination Fee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per Share
    Cash Consideration</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per Share
    Stock Consideration</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHI</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prime
    Rate</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
    Statement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
    Property</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
    Property Lease</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representatives</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    Stock Consideration</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separation
    Agreement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Superior
    Proposal</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surviving
    Corporation</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surviving
    Corporation Plan</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    Fee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    Litigation</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
    Agreements</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARN
    Act</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Willful
    Breach</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
1.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Definitional and Interpretative Provisions.
<FONT STYLE="font-style: normal">The words &ldquo;hereof,&rdquo; &ldquo;herein&rdquo; and &ldquo;hereunder&rdquo; and words of like import
used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The captions herein
are included for convenience of reference only and shall be ignored in the construction or interpretation hereof. References to Articles,
Sections and Schedules are to Articles, Sections and Schedules of this Agreement unless otherwise specified. All Schedules annexed hereto
or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth in full herein. Any capitalized terms
used in any Schedule but not otherwise defined therein shall have the meaning as defined in this Agreement. Any singular term in this
Agreement shall be deemed to include the plural, and any plural term the singular. Whenever the words &ldquo;include,&rdquo; &ldquo;includes&rdquo;
or &ldquo;including&rdquo; are used in this Agreement, they shall be deemed to be followed by the words &ldquo;without limitation,&rdquo;
whether or not they are in fact followed by those words or words of like import. &ldquo;Writing,&rdquo; &ldquo;written&rdquo; and comparable
terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. References to any
statute or Applicable Law shall be deemed to refer to such statute or Applicable Law as amended or superseded from time to time and to
any rules or regulations promulgated thereunder. References to any Contract are to that Contract as amended, modified or supplemented
from time to time in accordance with the terms hereof and thereof. References to any Person include the successors and permitted assigns
of that Person. References from or through any date mean, unless otherwise specified, from and including or through and including, respectively.
References to &ldquo;law,&rdquo; &ldquo;laws&rdquo; or to a particular statute or law shall be deemed also to include any Applicable
Law promulgated under such statute or law. The word &ldquo;shall&rdquo; shall be construed to have the same meaning and effect of the
word &ldquo;will.&rdquo; The phrase &ldquo;to the extent&rdquo; shall mean the degree to which, and such phrase shall not mean simply
&ldquo;if.&rdquo; The phrases &ldquo;delivered&rdquo; or &ldquo;made available,&rdquo; when used in this Agreement, shall mean that the
information shall have been (i) posted in the virtual data room titled &ldquo;Project Spur&rdquo; established by the Company or its Representatives
at least one (1) Business Day prior to the date hereof, and remained accessible to Parent and its Representatives at all times through
the Closing or (ii) filed or furnished by the Company with the SEC and publicly available at least one (1) Business Day prior to the
date hereof. Unless the context otherwise requires, &ldquo;neither,&rdquo; &ldquo;nor,&rdquo; &ldquo;any,&rdquo; &ldquo;either&rdquo;
and &ldquo;or&rdquo; shall not be exclusive. References to any period of days shall be deemed to be the relevant number of calendar days,
unless otherwise specified.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
The Merger</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
2.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) On
the terms and subject to the conditions set forth in this Agreement, at the Effective Time, Merger Subsidiary shall be merged (the &ldquo;<B>Merger</B>&rdquo;)
with and into the Company in accordance with the TBOC, whereupon the separate existence of Merger Subsidiary shall cease, and the Company
shall be the surviving corporation in the Merger (the &ldquo;<B>Surviving Corporation</B>&rdquo;). The Merger shall have the effects
specified in this Agreement and the TBOC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Subject
to the provisions of &lrm;<U>Article 9</U>, the closing of the Merger (the &ldquo;<B>Closing</B>&rdquo;) shall take place via the electronic
exchange of documents and signature pages as soon as possible, but in any event no later than three (3) Business Days after the date
the conditions set forth in &lrm;<U>Article 9</U> have been satisfied or, to the extent permissible, waived by the party or parties entitled
to the benefit of such conditions (other than conditions that by their nature are to be satisfied at the Closing, but subject to the
satisfaction or, to the extent permissible, waiver of those conditions at the Closing), or at such other place, at such other time or
on such other date as Parent and the Company may mutually agree in writing (the date on which the Closing actually occurs, the &ldquo;<B>Closing
Date</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) At
the Closing, the Company shall file a certificate of merger with the Secretary of State of the State of Texas and make all other filings
required by the TBOC in connection with the Merger. The Merger shall become effective at the time the certificate of merger is duly filed
with and accepted by, the Secretary of State of the State of Texas or such later date and time as may be agreed to by the parties and
specified in the certificate of merger (the &ldquo;<B>Effective Time</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
2.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion of Shares. <FONT STYLE="font-style: normal">At
the Effective Time:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Except
as otherwise provided in <U>Section 2.2(b)</U> or <U>Section 2.5</U>, each share of Company Stock issued and outstanding immediately
prior to the Effective Time (except for Company Stock to be canceled under Section 2.2(b) and Dissenting Shares) (each, a &ldquo;<B>Converted
Share</B>&rdquo;) shall be converted into the right to receive (i) $33.00 in cash, without interest (the &ldquo;<B>Per Share Cash Consideration</B>&rdquo;),
and (ii) 0.4735 shares of Parent Common Stock (the &ldquo;<B>Per Share Stock Consideration</B>&rdquo;, and together with the Per Share
Cash Consideration, the &ldquo;<B>Merger Consideration</B>&rdquo;). As of the Effective Time, all such shares of Company Stock shall
no longer be outstanding and shall automatically be canceled and retired and shall cease to exist, and shall thereafter represent only
the right to receive the Merger Consideration to be paid in accordance with <U>Section 2.3</U>, without interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Each
share of Company Stock held by the Company as treasury stock or owned by any Subsidiary of the Company or Parent or any Subsidiary of
Parent immediately prior to the Effective Time shall be canceled, and no payment shall be made with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Each
share of common stock of Merger Subsidiary outstanding immediately prior to the Effective Time shall be converted into and become one
share of common stock of the Surviving Corporation and shall constitute the only outstanding shares of capital stock of the Surviving
Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
2.3 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surrender and Payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Prior
to the Effective Time, Parent shall appoint Broadridge Corporate Issuer Solutions, LLC (the &ldquo;<B>Exchange Agent</B>&rdquo;) for
the purpose of exchanging for the Merger Consideration uncertificated shares of Company Stock (the &ldquo;<B>Shares</B>&rdquo;). At or
prior to the Effective Time, Parent shall deposit with the Exchange Agent the aggregate (i) amount of cash payable in respect of the
Converted Shares under <U>Section 2.2(a)(i)</U> and <U>Section 2.3(b)</U>, and (ii) number of whole shares of Parent Common Stock, subject
to <U>Section 2.3(b)</U>, issuable under <U>Section 2.2(a)(ii)</U>. Promptly after the Effective Time (and after receipt by the Exchange
Agent from the Company&rsquo;s transfer agent of all information reasonably necessary to enable the Exchange Agent to effect the mailing
set forth in this <U>Section 2.3)</U> (<I>provided</I> that Parent and the Surviving Corporation shall use reasonable best efforts to
obtain such information to enable such mailing to occur not later than two (2) Business Days after the Effective Time), the Surviving
Corporation shall (and Parent shall cause the Surviving Corporation to) send, or cause the Exchange Agent to send, to each holder of
certificated shares of Company Stock at the Effective Time a letter of transmittal and instructions (which shall be in a form reasonably
acceptable to the Company and approved by the Company prior to Closing) for use in such exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) No
fraction of a share of Parent Common Stock shall be issued as a result of or in connection with the Merger. In lieu of the issuance of
any such fraction of a share to which a former holder of Converted Shares would otherwise be entitled, Parent shall pay to the Exchange
Agent an amount in cash, without interest, determined by multiplying such fraction by the closing price of a share of Parent Common Stock
on Nasdaq on the last trading day immediately preceding the Closing Date (rounded to the nearest cent). As soon as reasonably practicable
after the determination of the amount of cash, if any, to be paid to holders of Converted Shares in lieu of any fractional share interests
in Parent Common Stock, the Exchange Agent shall make available such amounts, without interest, to the holders of Converted Shares entitled
to receive such cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Each
holder of shares of Company Stock that have been converted into the right to receive the Merger Consideration shall be entitled to receive,
upon receipt of (i) an &ldquo;agent&rsquo;s message&rdquo; by the Exchange Agent (or such other evidence, if any, of transfer as the
Exchange Agent may reasonably request), in the case of uncertificated Shares, or (ii) a properly completed letter of transmittal (or
affidavit in lieu thereof pursuant to <U>Section 2.3(f)</U>), in the case of certificated Shares, the Merger Consideration in respect
of the Company Stock represented by a Share. Until so surrendered or transferred, as the case may be, each such Share shall represent
after the Effective Time for all purposes only the right to receive such Merger Consideration without interest thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) If
any portion of the Merger Consideration is to be paid to a Person other than the Person in whose name the transferred Share is registered,
it shall be a condition to such payment that (i) such Share shall be properly transferred and (ii) the Person requesting such payment
shall pay to the Exchange Agent any transfer or other Taxes required as a result of such payment to a Person other than the registered
holder of such Share or establish to the satisfaction of the Exchange Agent that such Tax has been paid or is not payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) After
the Effective Time, there shall be no further registration of transfers of shares of Company Stock. If, after the Effective Time, Shares
are presented to the Surviving Corporation or the Exchange Agent, they shall be canceled and exchanged for the Merger Consideration in
accordance with the procedures set forth in this <U>Article 2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) If
any certificate in respect of a certificated Share shall have been lost, stolen or destroyed, upon the making of an affidavit of that
fact by the Person claiming such certificate to be lost, stolen or destroyed and, if required by the Surviving Corporation, the posting
by such Person of a bond, in such reasonable amount as the Surviving Corporation may direct, as indemnity against any claim that may
be made against it with respect to such Certificate, the Exchange Agent will issue, in exchange for such lost, stolen or destroyed certificate,
the Merger Consideration to be paid in respect of the shares of Company Stock represented by such certificate, as contemplated by this
<U>&lrm;Article 2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Any
portion of the Merger Consideration made available to the Exchange Agent pursuant to &lrm;<U>Section 2.3(a)</U> that remains unclaimed
by the holders of shares of Company Stock twelve (12) months after the Effective Time shall be returned to Surviving Corporation, upon
demand, and any such holder who has not exchanged shares of Company Stock for the Merger Consideration in accordance with this <U>&lrm;Section
2.3</U> prior to that time shall thereafter look only to Surviving Corporation for payment of the Merger Consideration in respect of
such shares without any interest thereon. Notwithstanding the foregoing, Parent shall not be liable to any holder of shares of Company
Stock for any amounts paid to a public official pursuant to applicable abandoned property, escheat or similar Applicable Laws. To the
extent permitted by Applicable Law, any amounts remaining unclaimed by such holders of Company Stock five (5) years after the Effective
Time, or at such earlier date as is immediately prior to the time at which such amounts would otherwise escheat to or become property
of any Governmental Authority, shall become the property of the Surviving Corporation free and clear of any claims or interest of any
such holders (and their successors, assigns or personal representatives) previously entitled thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
2.4 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing of Transfer Books. <FONT STYLE="font-style: normal">At
the Effective Time, the stock transfer books of the Company shall be closed with respect to all shares of Company Stock outstanding immediately
prior to the Effective Time and no further transfer of any such shares of Company Stock shall be made on such stock transfer books after
the Effective Time.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
2.5 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenting Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Notwithstanding
anything to the contrary contained in this Agreement, shares of Company Stock held by a holder who is entitled to demand and properly
demands appraisal of such shares in accordance with Chapter 10, Subchapter H of the TBOC and does not vote such shares in favor of adoption
of this Agreement or consent in writing thereto (any such shares being referred to as &ldquo;<B>Dissenting Shares</B>&rdquo; until such
time as such holder effectively withdraws or fails to perfect or otherwise loses such holder&rsquo;s appraisal rights under Chapter 10,
Subchapter H of the TBOC with respect to such shares) shall not be converted into or represent the right to receive Merger Consideration
in accordance herewith, but shall be entitled only to such rights as are granted by the TBOC to a holder of Dissenting Shares. At the
Effective Time, Dissenting Shares shall no longer be outstanding and shall automatically be canceled and shall cease to exist, and each
holder of Dissenting Shares shall cease to have any rights with respect thereto, except the right to receive the fair value of such Dissenting
Shares in accordance with the provisions of Chapter 10, Subchapter H of the TBOC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) If
any Dissenting Shares shall lose their status as such (through failure to perfect appraisal rights under Chapter 10, Subchapter H of
the TBOC or otherwise), then such shares shall be deemed to have been converted as of the Effective Time into the right to receive the
Merger Consideration and shall represent only the right to receive the Merger Consideration in accordance herewith, without interest
thereon, and shall not thereafter be Dissenting Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
Company shall give Parent: (i) prompt notice of (A) any demand for appraisal received by the Company prior to the Effective Time pursuant
to the TBOC; and (B) any withdrawal or attempted withdrawal of any such demand; and (ii) the opportunity to direct all negotiations and
proceedings with respect to any such demand, notice or instrument. Prior to the Effective Time, the Company shall not, without the prior
written consent of Parent or as otherwise required by an order, decree, ruling or injunction of a court of competent jurisdiction, make
any payment with respect to, or settle or compromise or offer to settle or compromise, any such demand, or agree to do any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
2.6 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment of Equity Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <I>Restricted
Stock</I>. Immediately prior to the Effective Time, each share of Company Restricted Stock, whether or not vested, shall, by virtue of
the Merger and without any action on the part of the Company, Parent or the holder of such Company Restricted Stock, automatically be
canceled and converted automatically into the right to receive from the Company, at or promptly after the Effective Time, an amount (i)
in cash (less applicable Tax withholdings as provided in <U>Section 2.8</U> on the entire Restricted Stock Consideration) equal to the
Per Share Cash Consideration and (ii) a number of shares of Parent Common Stock equal to the Per Share Stock Consideration (the &ldquo;<B>Restricted
Stock Consideration</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <I>Options</I>.
Immediately prior to the Effective Time, each Company Option, whether or not vested, shall, by virtue of the Merger and without any action
on the part of the Company, Parent or the holder of such Company Option, automatically be canceled and converted automatically into the
right to receive from the Company, at or promptly after the Effective Time, an amount in cash (less applicable Tax withholdings as provided
in <U>Section 2.8</U>) equal to the difference between (i) the Merger Consideration (with the Per Share Stock Consideration value based
on the closing price of the Parent Common Stock on the last trading day prior to the Closing Date) and (ii) the exercise price payable
in respect of such Company Option (the &ldquo;<B>Option Consideration</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <I>Termination
at the Effective Time</I>. As of the Effective Time, the Company Equity Plans shall immediately terminate and no holder of Company Restricted
Stock or Company Options shall have any rights to acquire, or other rights in respect of, the capital stock of the Company, the Surviving
Corporation or any of their Subsidiaries, pursuant to the Company Equity Plans or otherwise, except the rights contemplated by this <U>Section
2.6</U>. Following the Effective Time, no Company Restricted Stock, Company Option or other equity interest in the Company or other right
with respect to shares of Company Stock that was outstanding immediately prior to the Effective Time shall remain outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <I>Further
Actions</I>. Prior to the Effective Time, the Company Board (or, if appropriate, any committee thereof administering any Company Equity
Plan) shall take such actions as are necessary or appropriate to approve and effectuate the foregoing provisions of this <U>Section 2.6</U>,
including making any determinations and/or resolutions of the Company Board or a committee thereof or any administrator of such Company
Equity Plan as may be necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
2.7 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain <I>Adjustments</I>. <FONT STYLE="font-style: normal">If,
during the period between the date of this Agreement and the Effective Time, any change in the outstanding shares of capital stock of
the Company or Parent shall occur, including by reason of any reclassification, recapitalization, stock split or combination, exchange
or readjustment of shares, or any stock dividend thereon with a record date during such period, but excluding any change that results
from any vesting, settlement or exercise of Company Restricted Stock or Company Options outstanding as of the date hereof, the Merger
Consideration and any other amounts payable pursuant to this Agreement shall be appropriately adjusted to provide Parent and the holders
of Company Stock (including holders of Company Restricted Stock and Company Options) the same economic effect as contemplated by <U>Sections
2.2</U> and <U>2.6</U>. For the avoidance of doubt, to the extent any adjustments may be required pursuant to this <U>&lrm;Section 2.7</U>
with respect to Company Restricted Stock or Company Options, such adjustments will be made in a manner consistent with the relevant adjustment
provisions of the Company Equity Plan to which such Company Restricted Stock or Company Options relate.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
2.8 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Awards; Withholding Rights. <FONT STYLE="font-style: normal">Parent
shall cause (i) the Surviving Corporation to pay through the payroll system of the Surviving Corporation or its Affiliate to each holder
of Company Restricted Stock or Company Options that is or was a Company employee, the cash component of the Restricted Stock Consideration,
including cash in lieu of fractional shares of Parent Common Stock, or the Option Consideration, as applicable, of such Company employee
less any required withholding Taxes and without interest, and (ii) the Exchange Agent to issue the Parent Common Stock portion of the
Restricted Stock Consideration to the holders of a Company Restricted Stock, in each case, within five (5) Business Days following the
Effective Time. Notwithstanding any provision contained herein to the contrary, each of the Exchange Agent, the Surviving Corporation
and Parent shall be entitled to deduct and withhold from the consideration otherwise payable to any Person pursuant to this &lrm;<U>Article
2</U> such amounts as it is required to deduct and withhold with respect to the making of such payment under any provision of federal,
state, local or foreign tax law. To the extent that amounts are so withheld and timely paid over to the appropriate Governmental Authority
by the Exchange Agent, the Surviving Corporation or Parent, as the case may be, such amounts shall be treated for all purposes of this
Agreement as having been paid to the Person in respect of whom the Exchange Agent, the Surviving Corporation or Parent, as the case may
be, made such deduction and withholding.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
The Surviving Corporation</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
3.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Incorporation. <FONT STYLE="font-style: normal">Subject
to <U>&lrm;Section 7.4(b)</U>, the certificate of incorporation of the Company shall, by virtue of the Merger, be amended at the Effective
Time in its entirety to read as the certificate of incorporation of Merger Subsidiary in effect immediately prior to the Effective Time,
except that <U>Article 1</U> thereof shall provide that the name of the Surviving Corporation shall be &ldquo;<B>Sanara MedTech Inc</B>.&rdquo;
Such certificate of incorporation, as so amended, shall be the certificate of incorporation of the Surviving Corporation until thereafter
amended in accordance with Applicable Law and such certificate of incorporation.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
3.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws. <FONT STYLE="font-style: normal">At the
Effective Time, the bylaws of Merger Subsidiary in effect as of immediately prior to the Effective Time shall be the bylaws of the Surviving
Corporation until amended in accordance with Applicable Law, the certificate of incorporation and such bylaws.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
3.3 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors and Officers. <FONT STYLE="font-style: normal">The
parties shall take all requisite actions so that, except as may be determined by Parent prior to the Closing, from and after the Effective
Time, until successors are duly elected or appointed and qualified or until their earlier, death, resignation or removal in accordance
with Applicable Law, the certificate of incorporation and the bylaws of the Surviving Corporation, (i) the directors of Merger Subsidiary
immediately prior to the Effective Time shall be the directors of the Surviving Corporation and (ii) the officers of Merger Subsidiary
immediately prior to the Effective Time shall be the officers of the Surviving Corporation.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Representations and Warranties of the Company</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth in (i) any Company SEC Document filed at least one (1) Business Day before the date hereof (but excluding any risk factor
disclosures contained under the heading &ldquo;Risk Factors&rdquo; (other than any factual information contained therein), any disclosure
of risks explicitly included in any &ldquo;forward-looking statements&rdquo; disclaimer, and any other disclosures contained or referenced
therein of information, factors or risks to the extent they are predictive, cautionary or forward-looking in nature (other than any factual
information contained therein)), <I>provided</I> that in no event shall any disclosure in any Company SEC Document apply to or qualify
any representation or warranty contained in <U>Section 4.5(a)</U> or <U>Section 4.5(b)</U>, or (ii) the Company Disclosure Schedule (each
section of which qualifies the correspondingly numbered representation and warranty or covenant to the extent specified therein, <I>provided</I>
that any disclosure set forth with respect to any particular section shall be deemed to be disclosed in reference to all other applicable
sections of this Agreement (other than <U>Section 4.5(a)</U> or <U>Section 4.5(b)</U>) if the relevance of such disclosure to such other
sections is reasonably apparent on its face), the Company hereby represents and warrants to Parent and Merger Subsidiary as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Existence and Power. <FONT STYLE="font-style: normal">The
Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Texas and has all corporate
powers and all governmental licenses, authorizations, permits, consents and approvals required to carry on its business as now conducted,
except for those licenses, authorizations, permits, consents and approvals the absence of which would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. The Company is duly qualified to do business as a foreign corporation and
is in good standing in each jurisdiction where such qualification is necessary, except for those jurisdictions where failure to be so
qualified would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Authorization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the Transactions are within
the Company&rsquo;s corporate powers and, except for the Company Stockholder Approval (as defined below), have been duly authorized by
all necessary corporate action on the part of the Company. The affirmative vote of the holders of a majority of the outstanding shares
of Company Stock is the only vote of the holders of the Company&rsquo;s capital stock necessary to approve and adopt this Agreement and
consummate the Transactions, including the Merger (the &ldquo;<B>Company Stockholder Approval</B>&rdquo;). This Agreement has been duly
executed and delivered by the Company and constitutes a legal, valid and binding agreement of the Company, enforceable against the Company
in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other
laws affecting creditors&rsquo; rights generally and general principles of equity (the &ldquo;<B>Bankruptcy and Equity Exception</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) At
a meeting duly called and held, the Company Board has unanimously (i) determined that this Agreement and the Transactions, including
the Merger, are advisable, fair to and in the best interests of the Company and its stockholders; (ii) approved the execution, delivery
and performance by the Company of this Agreement and the consummation of the Transactions; (iii) declared advisable this Agreement and
the Transactions; (iv) resolved to recommend that the Company&rsquo;s stockholders vote to approve and adopt this Agreement and the Transactions
(such recommendation, the &ldquo;<B>Company Board Recommendation</B>&rdquo;), which Company Board Recommendation has not been withdrawn,
rescinded or modified in any way as of the date of this Agreement; and (v) directed this Agreement be submitted to the Company stockholders
for adoption at the Company Stockholder Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) True
and complete copies of the Company&rsquo;s certificate of incorporation and bylaws, in each case as in effect on the date of this Agreement,
are included in the Company SEC Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.3 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental Authorization. <FONT STYLE="font-style: normal">The
execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the Transactions require
no action by or in respect of, or filing with, any Governmental Authority other than (i) the filing of a certificate of merger with respect
to the Merger with the Secretary of State of the State of Texas and appropriate documents with the relevant authorities of other states
in which the Company is qualified to do business, (ii) compliance with any applicable requirements of the HSR Act and those filings set
forth in <U>Section 8.1(b)</U> of the Company Disclosure Schedule, (iii) compliance with any applicable requirements of the 1934 Act,
and any other applicable state or federal securities laws and (iv) any actions or filings the absence of which would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.4 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-contravention. <FONT STYLE="font-style: normal">Except
as set forth on <U>Section 4.4</U> of the Company Disclosure Schedule, the execution, delivery and performance by the Company of this
Agreement and the consummation of the Transactions do not and will not (i) contravene, conflict with, or result in any violation or breach
of any provision of the certificate of incorporation or bylaws of the Company or similar organizational documents of any of the Company&rsquo;s
Subsidiaries, (ii) assuming compliance with the matters referred to in &lrm;<U>Section 4.3</U>, contravene, conflict with or result in
any violation or breach of any provision of any Applicable Law, (iii) assuming compliance with the matters referred to in <U>Section
4.3</U>, require any notice, consent or other action by any Person under, constitute a default under, or cause or permit the termination,
cancellation, acceleration or other change of any right or obligation or the loss of any benefit to which the Company or any of its Subsidiaries
is entitled under any provision of any Material Contract binding upon the Company or any of its Subsidiaries or (iv) result in the creation
or imposition of any Lien (other than a Permitted Lien) on any asset of the Company or any of its Subsidiaries, with only such exceptions,
in the case of each of clauses (ii) through (iv), as would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.5 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
authorized capital stock of the Company consists of 20,000,000 shares of Company Stock and 2,000,000 shares of preferred stock, par value
$1.00 per share. As of <B>July 27,</B> 2026, there were no outstanding shares of preferred stock of the Company and 9,193,061 outstanding
shares of Company Stock. All outstanding shares of capital stock of the Company have been, and all shares that may be issued pursuant
to the Company Equity Plans will be, when issued in accordance with the respective terms thereof, duly authorized, validly issued, fully
paid and nonassessable and not subject to subscription or preemptive rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) As
of <B>July 27</B>, 2026, the Company has reserved <B>1,000,000</B> shares of Company Stock for issuance pursuant to the Company Equity
Plans. As of <B>July 27</B>, 2026, there was outstanding (x) Company Restricted Stock with respect to 410,877 shares of Company Stock
and (y) Company Options with respect to 10,218 shares of Company Stock. Other than the Company Restricted Stock and Company Options described
in the prior sentence and as set forth on <U>Schedule 4.5(d)</U> of the Company Disclosure Schedule, there are no other awards outstanding
under the Company Equity Plans or otherwise as of <B>July 27</B>, 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Except
as set forth in this &lrm;<U>Section 4.5</U> and for changes since <B>July 27</B>, 2026 resulting from the vesting of Company Restricted
Stock or exercise of Company Options, in each case outstanding on such date or granted to the extent not prohibited by this Agreement,
there are no issued, reserved for issuance or outstanding (i) shares of capital stock or other voting securities of or ownership interests
in the Company, (ii) securities of the Company convertible into or exchangeable for shares of capital stock or other voting securities
of or ownership interests in the Company or (iii) warrants, calls, options or other rights to acquire from the Company, or other obligation
of the Company to issue, any capital stock, voting securities or securities convertible into or exchangeable for capital stock or voting
securities of the Company or (iv) restricted shares, stock appreciation rights, performance units, contingent value rights, &ldquo;phantom&rdquo;
stock or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value
or price of, any capital stock of or voting security of the Company (the items in clauses &lrm;(i) through &lrm;(iv) being referred to
collectively as the &ldquo;<B>Company Securities</B>&rdquo; ). There are no outstanding obligations of the Company or any of its Subsidiaries
to repurchase, redeem or otherwise acquire any of the Company Securities. The Company has no accrued and unpaid dividends with respect
to any outstanding shares of Company Stock or Company Restricted Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Section
4.5(d)</U> of the Company Disclosure Schedule lists each award of Company Restricted Stock and each award of Company Options as of <B>July
27,</B> 2026, whether or not granted under any Company Equity Plan, including (i) the name or employee identification number of the holder
of such Company Restricted Stock and/or Company Options, (ii) the Company Equity Plan under which the award was granted; (iii) the number
of shares of Company Stock subject to such outstanding award of Company Restricted Stock or Company Option, (iv) the date on which such
Company Restricted Stock or Company Option was granted or issued, (v) the applicable vesting schedule of such Company Restricted Stock
or Company Option, (vi) the exercise price for the Company Option and (vi) whether the holder of such Company Restricted Stock made a
timely Section 83(b) election with respect to such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.6 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Each
Subsidiary of the Company has been duly organized, is validly existing and (where applicable) in good standing under the laws of its
jurisdiction of organization, has all organizational powers and all governmental licenses, authorizations, permits, consents and approvals
required to carry on its business as now conducted, except for those licenses, authorizations, permits, consents and approvals the absence
of which would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Each such Subsidiary
is duly qualified to do business as a foreign entity and is in good standing in each jurisdiction where such qualification is necessary,
except for those jurisdictions where failure to be so qualified would not reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) All
of the outstanding capital stock of or other voting securities of, or ownership interests in, each Subsidiary of the Company, is owned
by the Company, directly or indirectly, free and clear of any Liens, other than Permitted Liens, and is duly authorized, validly issued,
fully paid and nonassessable. As of the date hereof, there are no issued, reserved for issuance or outstanding (i) securities of the
Company or any of its Subsidiaries convertible into, or exchangeable for, shares of capital stock or other voting securities of, or ownership
interests in, any Subsidiary of the Company, (ii) warrants, calls, options or other rights to acquire from the Company or any of its
Subsidiaries, or other obligations of the Company or any of its Subsidiaries to issue, any capital stock or other voting securities of,
or ownership interests in, or any securities convertible into, or exchangeable for, any capital stock or other voting securities of,
or ownership interests in, any Subsidiary of the Company or (iii) restricted shares, stock appreciation rights, performance units, contingent
value rights, &ldquo;phantom&rdquo; stock or similar securities or rights that are derivative of, or provide economic benefits based,
directly or indirectly, on the value or price of, any capital stock or other voting securities of, or ownership interests in, any Subsidiary
of the Company (the items in clauses &lrm;(i) through &lrm;(iii) being referred to collectively as the &ldquo;<B>Company Subsidiary Securities</B>&rdquo;).
There are no outstanding obligations of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any of the
Company Subsidiary Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Section
4.6(c)</U> of the Company Disclosure Schedule sets forth the name, jurisdiction of incorporation or organization (as applicable), entity
form and the Company&rsquo;s direct or indirect percentage ownership of each Subsidiary of the Company. The Company does not (i) own
or hold the right to acquire any equity securities, ownership interests, profit-sharing interests or voting interests (including voting
debt) of, or securities exchangeable or exercisable therefor, or investments in, any Person other than a Subsidiary of the Company or
(ii) have any obligation to make any investment or capital contribution in any other Person other than a Subsidiary of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.7 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC Filings and the Sarbanes-Oxley Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Company has filed with or furnished to the SEC, on a timely basis, all reports, schedules, forms, statements, prospectuses, registration
statements, certifications and other documents required to be publicly filed or furnished by the Company, including pursuant to the 1933
Act, the 1934 Act or the Sarbanes-Oxley Act, since the Applicable Date (collectively, together with any exhibits and schedules thereto
and other information incorporated therein, the &ldquo;<B>Company SEC Documents</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) As
of its filing date or on the date on which it was furnished (or, if amended, as of the date of such amendment), each Company SEC Document
complied as to form in all material respects with the applicable requirements of the 1933 Act, the 1934 Act and the Sarbanes-Oxley Act,
as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) As
of its filing date or on the date on which it was furnished (or, if amended, as of the date of such amendment), each Company SEC Document
filed pursuant to the 1933 Act, the 1934 Act and the Sarbanes-Oxley Act did not contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the
circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
Company and each of its officers are in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act.
The management of the Company has complied in all material respects with Rule 13a-15 or 15d-15 under the 1934 Act, and designed, and
maintained at all times since the Applicable Date, disclosure controls and procedures to ensure that material information relating to
the Company, including its consolidated Subsidiaries, is recorded, processed and made known on a timely basis to the management of the
Company and any other individuals responsible for the preparation of the Company&rsquo;s filings with the SEC. Since the Applicable Date,
no executive officer of the Company has failed to make the certifications required of such executive officer under Sections 302 or 906
of the Sarbanes-Oxley Act with respect to the Company SEC Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Since
the Applicable Date, none of the Company, any of its Subsidiaries or, to the Knowledge of the Company, the Company&rsquo;s auditors,
has identified or been made aware of (A) any significant deficiencies or material weaknesses in the design, maintenance or operation
of internal control over financial reporting (&ldquo;<B>Internal Controls</B>&rdquo;) which would adversely affect the Company&rsquo;s
ability to record, process, summarize and report financial data or (B) any fraud, whether or not material, that involves management or
other employees who have a significant role in the Company&rsquo;s Internal Controls or the preparation of financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) To
the Knowledge of the Company, as of the date of this Agreement, none of the Company SEC Documents is the subject of an ongoing SEC review
or outstanding SEC comment. As of the date of this Agreement, there are no SEC inquiries or investigations, or other inquiries by any
Governmental Entities pending or, to the Knowledge of the Company, threatened regarding the Company&rsquo;s accounting practices. Since
the Applicable Date, there have been no internal investigations of the Company or any of its Subsidiaries regarding the Company&rsquo;s
accounting practices, revenue recognition or other accounting or auditing issues, discussed with, reviewed by or initiated by or at the
direction of the chief executive officer, chief financial officer, general counsel or similar legal officer, the Company Board or any
committee of the Company Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.8 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements. <FONT STYLE="font-style: normal">The
audited consolidated financial statements and unaudited consolidated interim financial statements of the Company and its consolidated
Subsidiaries included or incorporated by reference in the Company SEC Documents (including the related notes and schedules) (a) have
complied, as of their respective dates, in all material respects with the then-applicable accounting requirements of the 1933 Act and
the 1934 Act and the rules and regulations of the SEC with respect thereto, (b) have been prepared in all material respects in accordance
with GAAP consistently applied during the periods involved (except as may be indicated therein or in the notes thereto or, in the case
of the unaudited financial statements, for normal and recurring year-end adjustments and as may be permitted by the SEC on Form 10-Q,
Form 8-K, Regulation S-X or any successor or like form under the Exchange Act) and (c) fairly present in all material respects, the consolidated
financial position of the Company and its consolidated Subsidiaries as of the dates thereof and their consolidated results of operations
and cash flows for the periods then ended (subject to normal and recurring year-end audit adjustments and the absence of footnotes in
the case of any unaudited interim financial statements).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.9 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
proxy statement of the Company to be filed with the SEC in connection with the Merger (the &ldquo;<B>Proxy Statement</B>&rdquo;) will,
when filed, comply as to form in all material respects with the applicable requirements of the 1934 Act. At the time the Proxy Statement
and any amendment or supplement thereto is first mailed to the stockholders of the Company and at the time of the Company Stockholder
Meeting, the Proxy Statement, as supplemented or amended, if applicable, will not contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. The representations and warranties contained in this <U>&lrm;Section 4.9(a)</U> will not
apply to statements or omissions included or incorporated by reference in the Proxy Statement based upon information supplied by Parent,
Merger Subsidiary or any of their respective Representatives specifically for use or incorporation by reference therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
information supplied by the Company for inclusion in the Registration Statement will not, at the time the Registration Statement and
any amendment or supplement thereto is filed with the SEC, contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. The representations and warranties contained in this Section 4.9(b) will not apply to statements or omissions
included or incorporated by reference in the Registration Statement based upon information supplied by Parent, Merger Subsidiary or any
of their Representatives specifically for use or incorporation by reference therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.10 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence of Certain Changes. <FONT STYLE="font-style: normal">Since
the Company Balance Sheet Date through the date of this Agreement, (a) the business of the Company and its Subsidiaries has been conducted
in the ordinary course in all material respects; (b) there has not been any Effect that has had or would reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect; and (c) neither the Company nor any of its Subsidiaries has taken any action
that would have required Parent&rsquo;s consent pursuant to <U>Section 6.1(b)(i), 6.1(b)(ii), 6.1(b)(iv), 6.1(b)(v), 6.1(b)(vi)</U>,
<U>6.1(b)(vii)</U>, <U>6.1(b)(x)</U>, <U>6.1(b)(xi)</U>, <U>6.1(b)(xiv)</U>, <U>6.1(b)(xv)</U> or <U>6.1(b)(xvi)</U> had the covenants
set forth therein applied since the Company Balance Sheet Date.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.11 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Undisclosed Material Liabilities. <FONT STYLE="font-style: normal">There
are no liabilities or obligations, whether accrued, contingent, absolute or otherwise of the Company or any of its Subsidiaries that
would be required by GAAP to be reflected or reserved against on a consolidated balance sheet of the Company and its Subsidiaries (or
disclosed in the notes thereto), other than: (i) liabilities or obligations disclosed and provided for in the Company Balance Sheet or
in the notes thereto; (ii) liabilities or obligations incurred in the ordinary course of business consistent with past practices since
the Company Balance Sheet Date (other than liabilities that arise out of or relate to any breach or violation of, or default under, any
Contract or any violation of Law), none of which has had, or would reasonably be expected to be, individually or in the aggregate, material
to the Company and its Subsidiaries, taken as a whole; (iii) liabilities or obligations with respect to legal, financial advisory or
similar professional fees and expenses incurred in connection with the Transactions, and (iv) liabilities or obligations that would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Neither the Company nor any of its Subsidiaries
is a party to, or has any commitment to become a party to, any &ldquo;off balance sheet arrangement&rdquo; within the meaning of Item
303 of Regulation S-K promulgated under the 1933 Act.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.12 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance with Laws and Court Orders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Company and each of its Subsidiaries is, and since the Applicable Date has been, in compliance with all Applicable Laws and all Orders
applicable to the Company or any of its Subsidiaries, except for failures to comply or violations that would not reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect. Except as set forth on <U>Schedule 4.12(a)</U>, since Applicable
Date neither the Company nor its Subsidiaries has received any written or, to the Knowledge of the Company, verbal communication from
any Governmental Authority alleging any noncompliance with any Applicable Laws, Healthcare Laws, or any Orders applicable to the Company
or any of its Subsidiaries, and no investigation by any Governmental Authority regarding an alleged or actual material violation of any
such Applicable Law, Healthcare Law, or Order is pending or, to the Knowledge of the Company, threatened, in each case except as would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Except
as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, in the past five (5) years,
neither the Company nor any of its Subsidiaries, nor, to the Knowledge of the Company, any director, officer, agent or employee of the
Company or any of its Subsidiaries has (i) taken any action, directly or indirectly, that would result in a violation by any such Persons
of the U.S. Foreign Corrupt Practices Act of 1977, the Anti-Kickback Act of 1986, the U.K. Bribery Act of 2010, or any other anti-bribery,
anti-corruption, or anti-money laundering Applicable Law, (ii) used any funds of the Company for unlawful contributions, gifts, entertainment
or other unlawful expenses relating to political activity, or (iii) given, offered, promised or authorized the giving of money or anything
of value, to any Government Official, for the purpose of (A) influencing an act or decision of such Government Official or improperly
inducing such Government Official to use his or her influence or position to affect any act or decision of a Governmental Authority,
(B) obtaining an improper business advantage, or (C) obtaining or retaining business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Except
as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, in the past five (5) years,
neither the Company nor any of its Subsidiaries, nor, to the Knowledge of the Company, any directors, officers, agents or employees of
the Company or any of its Subsidiaries, (i) has been a Sanctioned Person; (ii) has engaged in or otherwise participated in, or assisted
or facilitated any direct or indirect dealing or transaction with, or for the benefit of, a Sanctioned Person; or (iii) has otherwise
violated applicable Sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Neither
the Company nor any of its Subsidiaries is required to be registered as an investment company under the Investment Company Act of 1940,
as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.13 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory Matters</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Since
January 1, 2023, each of the Company and its Subsidiaries is and has been operating in compliance in all material respects with all Healthcare
Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Since
January 1, 2023, the Products have been developed, tested, manufactured, stored, sourced, packaged, used, distributed, labeled, promoted,
marketed, sold and otherwise commercialized, as applicable, in compliance in all material respects with all Applicable Law, including
all Healthcare Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Except
as set forth on <U>Section 4.13(c) </U>of the Company Disclosure Schedule, since January 1, 2023, neither the Company nor any of its
Subsidiaries has received any (i) written, or to the Company&rsquo;s Knowledge, oral notice from the FDA or any other Governmental Authority
alleging that the Company or any of its Subsidiaries has been or is in violation in any material respect of (A) any Applicable Law, including
any Healthcare Law with respect to the development, testing, manufacturing, storage, distribution, promotion, marketing, sale, or commercialization
of the Products, or (B) any other Applicable Law, the violation of which is cause for civil penalties or mandatory or permissive exclusion
from Medicare, Medicaid, or any other state or federal health care program; (ii) written notice of inspectional observation (including
those recorded on form FDA 483), establishment inspection report, warning letter, notice of adverse finding, penalty, fine, sanction,
request for recall, notice of violation or &ldquo;untitled letters&rdquo;, or other remedial action with respect to the Products from
any Governmental Authority; or (iii) other written documents issued by any Governmental Authority alleging lack of compliance by the
Company or any of its Subsidiaries in any material respect with any Applicable Law, including any Healthcare Law with respect to the
Products. Since January 1, 2021, there have been no Proceedings pending or, to the Company&rsquo;s Knowledge, threatened with respect
to the Company&rsquo;s or its Subsidiaries&rsquo; violation of any Applicable Law, including any Healthcare Law, with respect to the
development, testing, manufacturing, storage, distribution, promotion, marketing, sale, or commercialization of the Products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Since
January 1, 2023, (i) the Company and its Subsidiaries have complied in all material respects with all Applicable Laws in connection with
the preparation and submission to the FDA and any other Regulatory Authority with respect to the Products, and (ii) all reports, documents,
data, forms, applications, records, claims and notices required to be filed, maintained or furnished to the FDA or any other Governmental
Authority by the Company and its Subsidiaries with respect to the Products have been so filed, maintained or furnished and were true,
accurate and complete in all material respects on the date filed (or were corrected in or supplemented by a subsequent filing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Since
January 1, 2023, the Company and its Subsidiaries have operated in compliance in all material respects with all required Regulatory Approvals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Neither
the Company nor any of its Subsidiaries has received, since January 1, 2023, any written or, to the Company&rsquo;s Knowledge, oral notice
from any Governmental Authority with respect to, and, to the Company&rsquo;s Knowledge, no event has occurred that would reasonably be
expected to result in, the loss, termination, suspension, withdrawal or revocation of any Regulatory Approval with respect to any of
the Products or the loss, withdrawal or revocation of any of the Products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Since
January 1, 2023, no Products have been subject to, nor, to the Knowledge of the Company, are there any facts or circumstances reasonably
likely to lead to, any (i) recalls, field notifications, warnings, &ldquo;dear doctor&rdquo; letters, safety alerts, detentions, holds,
or other notices of action relating to an alleged lack of safety or regulatory compliance, (ii) correction, removal action, or other
market withdrawal, or (iii) suspension, withdrawal or discontinuation as a result of any action by FDA or any other Governmental Authority.
To the Company&rsquo;s Knowledge, no event has occurred, and no condition or circumstance exists, that would reasonably be expected to
(with or without notice or lapse of time or both) give rise to or serve as a basis for any recall, correction, removal action, market
withdrawal or other similar action of any Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) Since
January 1, 2023, neither the Company nor any of its Subsidiaries have made any materially false or fraudulent statements on, or material
omissions from, any notifications, applications, approvals, reports and other submission to any Governmental Authority with respect to
its business, including any such statement or omission that would reasonably be expected to provide a basis for the FDA to invoke its
policy respecting &ldquo;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Neither
the Company nor any of its Subsidiaries nor, to the Company&rsquo;s Knowledge, any of their employees, agents, or independent contractors
has been suspended, excluded, debarred, or convicted of any crime or engaged in any conduct that would reasonably be expected to result
in (i) debarment under 21 U.S.C. Section 335(a) or (b) or any similar Applicable Law, (ii) exclusion under 42 U.S.C. Section 1320a-7
or any similar Applicable Law or (iii) prohibition from participating in any procurement program of or otherwise contracting with any
Governmental Authority. Neither the Company nor any of its Subsidiaries nor, to the Company&rsquo;s Knowledge, any of its respective
directors, officers, employees, or agents is a party to any corporate integrity agreement, monitoring agreement, consent decree, settlement
order, or other similar written agreement, in each case, entered into with or imposed by any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) Any
Contracts between the Company or any of its Subsidiaries and personnel, whether employed, contracted or otherwise engaged, who provide
clinical services on behalf of or to the Company or its business comply in all material respects will applicable Healthcare Laws. .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) To
the Knowledge of the Company, since January 1, 2023, none of the Company or its Subsidiaries have received any written inquiries from
the HHS Office of Civil Rights, any state Attorney General or any other Governmental Authority regarding material noncompliance with
Privacy Laws. Since January 1, 2023, the Company and its Subsidiaries have complied in all material respects with, any applicable Business
Associate Agreements (as defined under the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. &sect; 1320d et seq.),
as amended, by the Health Information Technology for Economic and Clinical Health Act and its implementing regulations (collectively
&ldquo;<B>HIPAA</B>&rdquo;)). Since January 1, 2023, to the Knowledge of the Company, there has been no material unauthorized use or
disclosure of protected health information (&ldquo;<B>PHI</B>&rdquo;) by the Company, its Subsidiaries, or its personnel. Since January
1, 2023, the Company has complied in all material respects with its obligations under HIPAA, including with respect to conducting security
risk assessment, and has addressed all material identified deficiencies, if any..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.14 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation. <FONT STYLE="font-style: normal">As
of the date hereof, there is no Proceeding pending against, or, to the Knowledge of the Company, threatened against, the Company or any
of its Subsidiaries or, to the Knowledge of the Company, against any director, officer or employee of the Company or any of its Subsidiaries,
that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Neither the Company nor any of
its Subsidiaries is a party to or subject to the provisions of any Order or any settlement, compromise, conciliation or similar agreement
with any Person, in each case, that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.15 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permits. <FONT STYLE="font-style: normal">Since
January 1, 2023, the Company and its Subsidiaries have held and currently hold all Permits necessary for the lawful conduct of their
businesses, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. All such
Permits are valid and in full force and effect. All material fees payable to any Governmental Authority with respect to such Permits
have been timely paid. Since January 1, 2023, neither the Company nor any of its Subsidiaries has received written notice from any Governmental
Authority of any actual or possible violation of any Permit or of any actual or possible revocation, suspension, refusal to renew, cancellation,
rescission, loss, expiration, modification, or limitation of any Permit, except as would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect. No event has occurred and, to the Knowledge of the Company, no circumstances exist that,
with or without notice or lapse of time or both, would reasonably be expected to result in any revocation, suspension, lapse, rescission,
loss, refusal to renew, cancellation, modification, or limitation of any such Permit. To the Knowledge of the Company, any required material
updates, changes, corrections, or modifications to, or material notifications, submissions, filings, or information required by, any
Permit have been submitted to the relevant Governmental Authority, except as would not reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.16 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Except
as set forth on <U>Section 4.16(a)</U> of the Company Disclosure Schedule and except as would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect, the Company and its Subsidiaries have good title to, or valid and enforceable leasehold
interests in, all property and assets reflected on the Company Balance Sheet or acquired after the Company Balance Sheet Date (except
for properties and assets that have been disposed of since the Company Balance Sheet Date in the ordinary course of business), free and
clear of all Liens other than Permitted Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) As
of the date hereof, &lrm;<U>Section 4.16(b)</U> of the Company Disclosure Schedule sets forth a true and complete list of (i) all material
real property owned by the Company or any of its Subsidiaries (the &ldquo;<B>Owned Real Property</B>&rdquo;), and (ii) all material real
property leased by or for the benefit of the Company or any of its Subsidiaries (the &ldquo;<B>Leased Real Property</B>&rdquo; and, together
with the Owned Real Property, the &ldquo;<B>Real Property</B>&rdquo;). The Company has delivered or made available to Parent copies of
(i) all material Contracts and all material amendments and modifications thereof that are in the possession of the Company with respect
to the Owned Real Property, and (ii) all material leases or subleases, and all material amendments and modifications thereof, with respect
to the Leased Real Property (each, a &ldquo;<B>Real Property Lease</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
Owned Real Property is the only real property owned by the Company or a Subsidiary thereof and used in connection with the business of
the Company and its Subsidiaries. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, (i) the Company or a Subsidiary thereof has good, marketable and insurable fee simple title to the parcel of Owned Real Property
owned by the Company or such Subsidiary, free and clear of all Liens except for Permitted Liens, (ii) the interest of the Company or
applicable Subsidiary thereof in the Owned Real Property has not been conveyed, leased, pledged, or otherwise transferred or encumbered,
whether in whole or in part, (iii) neither the Company nor any Subsidiary thereof is a lessor, sublessor or grantor under any lease,
sublease, consent, license or other instrument granting to another Person any right to the possession, use, occupancy or enjoyment of
the Owned Real Property, and (iv) no Person, other than the Company or a Subsidiary thereof, has any right, option, right of first refusal
or any other Contract, whether oral or written, with respect to the purchase, assignment or transfer of all or any portion of the Owned
Real Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Except
as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i) the Company or a Subsidiary
thereof has a valid and existing leasehold interest in each Leased Real Property, free and clear of all Liens except for Permitted Liens,
(ii) each Real Property Lease is valid and in full force and effect (subject to the Bankruptcy and Equity Exception), (iii) neither the
Company nor any of its Subsidiaries, nor to the Company&rsquo;s Knowledge any other party to a Real Property Lease, has violated any
provision of, or taken or failed to take any act which, with or without notice, lapse of time, or both, would constitute a material breach
or default under the provisions of such Real Property Lease, and neither the Company nor any of its Subsidiaries has received or given
notice that it has materially breached, violated or defaulted under any Real Property Lease, and (iv) there is no sublease, license,
occupancy agreement, option to purchase, right of first refusal, right of first offer or other Contract granting the Company or its Subsidiaries
or, to the Company&rsquo;s Knowledge, any other Person, any right to acquire, sublease or use the Leased Real Property, and no Person
(other than the Company or a Subsidiary thereof) is in possession of the Leased Real Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Except
as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Company
has not received any written notice that all or any portion of Real Property is subject to any governmental order to be sold or is being
condemned, expropriated or otherwise taken by any Governmental Authority with or without payment of compensation therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Except
for any Permitted Liens or as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect, (i) there are no Liens (other than Permitted Liens) that prevent the Company or any of its Subsidiaries from using, occupying
or operating any Real Property for its current use, occupancy, or operation, (ii) all structures and other buildings on the Real Property
are in operating condition and none of such structures or buildings is in need of maintenance or repairs except for ordinary, routine
maintenance and repairs, and except for ordinary wear and tear, (iii) no construction (excluding routine maintenance and repair work)
is currently being performed or is anticipated to be performed on the Real Property, (iv) the Real Property has adequate access to public
roads, and (v) all utilities necessary to serve the Real Property and the business of the Company and its Subsidiaries as conducted as
of the date of this Agreement are properly installed, available to and connected with the Real Property in sufficient quantities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.17 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Except
as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect: (i) the conduct of the businesses
of the Company and each of its Subsidiaries is not infringing, misappropriating, or otherwise violating, and since the Applicable Date
has not infringed, misappropriated, or otherwise violated, any Intellectual Property of any other Person, (ii) the Company or one of
its Subsidiaries exclusively owns all Intellectual Property owned or purported to be owned by the Company or one of its Subsidiaries
(the &ldquo;<B>Owned Intellectual Property</B>&rdquo;), or licenses or has a valid right to use all other Intellectual Property necessary
for the conduct of its business as currently conducted (the &ldquo;<B>Company Intellectual Property</B>&rdquo;); (iii) all Owned Intellectual
Property is subsistent, valid, and enforceable; and (iv) since the Applicable Date, neither the Company nor its Subsidiaries has instituted
or threatened in writing any Proceedings against any Third Party alleging any infringement, misappropriation or other violation of any
Owned Intellectual Property. To the Knowledge of the Company, no Third Party is infringing upon, violating, or misappropriating any Owned
Intellectual Property in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Company has furnished to Parent a complete and accurate list of (i) all registered and applied for Patents, Trademarks, Copyrights, and
domain names included in the Owned Intellectual Property or that are exclusively licensed by the Company or one of its Subsidiaries and
(ii) all material unregistered trademarks in the Owned Intellectual Property as of the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) There
is no Proceeding pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries alleging that
the Company or any of its Subsidiaries infringes, violates, or otherwise misappropriates, or since the Applicable Date has infringed,
violated, or otherwise misappropriated, any Intellectual Property rights of any Person, in each case except for such Proceedings that
would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
Company and its Subsidiaries take, and since the Applicable Date, have taken commercially reasonable actions to protect the confidentiality
of the Trade Secrets of the Company or its Subsidiaries, except as would not reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect. Since the Applicable Date, all current and former officers and employees of, and consultants and independent
contractors to, the Company or its Subsidiaries whose duties to the Company or its Subsidiaries reasonably contemplate or contemplated
access to Trade Secrets included in the Company Intellectual Property have executed a valid and enforceable written agreement with the
Company or one of its Subsidiaries agreeing to protect the confidentiality of Trade Secrets included in the Company Intellectual Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) All
current and former officers and employees of, and consultants and independent contractors to, the Company or its Subsidiaries whose duties
to the Company or its Subsidiaries reasonably contemplate or contemplated the development of Intellectual Property have executed a valid
and enforceable written agreement with the Company or one of its Subsidiaries that assigns to such Company or Subsidiary all of such
Person&rsquo;s rights, title and interest in and to any and all Company Intellectual Property such Person contributed to the creation
or development of, and, to the extent applicable, irrevocably waives such Person&rsquo;s moral rights in such Intellectual Property,
except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Since
the Applicable Date, there has been no malfunction, failure, continued substandard performance, denial-of-service, any event constituting
a Security Incident, including any cyberattack, or other impairment of the Company IT Systems in each case except as would not reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect. The Company and its Subsidiaries have taken commercially
reasonable efforts to safeguard the confidentiality, availability, security, and integrity of the Company IT Systems, in each case except
as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) The
Company and each of its Subsidiaries have complied with all applicable Data Privacy and Security Requirements, including the collection,
use, processing, storage, transfer, and security of Personal Information in the conduct of the Company&rsquo;s and its Subsidiaries&rsquo;
businesses, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Since the
Applicable Date, the Company and its Subsidiaries have not received any written notice of any Proceeding by any Governmental Authority
concerning the Company&rsquo;s or any of its Subsidiaries&rsquo; collection, use, processing, storage, transfer, or protection of Personal
Information or actual, alleged, or suspected violation of any Data Privacy and Security Requirement, including concerning privacy, data
security, or data breach notification, and to the Knowledge of Company, there are no facts or circumstances that could reasonably be
expected to give rise to any such Proceedings, except as would not reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) The
Company maintains and, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect,
is in compliance with a written information security program that: (i) includes reasonable administrative, technical, and physical safeguards
designed to protect and safeguard the availability, confidentiality, and integrity of transactions and Personal Information, including
implementing procedures designed to prevent introduction of any virus or malware, and taking and storing on site and off site backup
copies of such Personal Information; (ii) is designed to protect against unauthorized access to the IT assets or Personal Information
and the systems of any third-party service providers that have access to the IT assets or Personal Information; and (iii) includes breach
notification policies and procedures to provide notice to Persons regarding information security incidents involving acquisition, access,
loss, theft, use or disclosure of Personal Information in an unauthorized manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Since
the Applicable Date, except as would not be material, individually or in the aggregate, to the Company and its Subsidiaries, taken as
a whole, no Personal Information in the possession or control of the Company has been subject to any known or suspected data breach or
other Security Incident that presents a risk of unauthorized access, disclosure, use, denial of use, alteration, corruption, destruction,
compromise or loss of such Personal Information or that has caused or would reasonably be expected to cause a disruption to the conduct
of the business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.18 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) All
income Tax Returns and other material Tax Returns required by Applicable Law to be filed with any Governmental Authority by, or on behalf
of, the Company or its Subsidiaries have been filed when due (including extensions) in accordance with all Applicable Law, and all such
Tax Returns are, or shall be at the time of filing, true, correct and complete in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Company and each of its Subsidiaries has paid (or has had paid on its behalf) to the appropriate Governmental Authority all income Taxes
and other material Taxes due and payable (whether or not shown on a Tax Return), or, where payment is not yet due, has established (or
has had established on its behalf and for its sole benefit and recourse) in accordance with GAAP an adequate accrual for all material
Taxes through the end of the last period for which the Company and its Subsidiaries ordinarily record items on their respective books.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) No
claim has been made in the past five (5) years by a Governmental Authority in a jurisdiction where the Company or any of its Subsidiaries
does not file material Tax Returns that it is or may be subject to material Tax by that jurisdiction or required to file material Tax
Returns in that jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
Company and each of its Subsidiaries is not and has never been a member of an affiliated group within the meaning of Section 1504(a)
of the Code with which it has filed (or been required to file) consolidated, combined, unitary or similar Tax Returns (other than a group
which the Company is the common parent of). The Company and each of its Subsidiaries has no liability for the Taxes of any Person (other
than the Company or its Subsidiaries) under Section 1.1502-6 of the &ldquo;Treasury Regulations&rdquo; (or any similar provision of state,
local or foreign law), as a transferee or successor, by Contract (other than any Contract entered into the principal purpose of which
does not relate to Taxes), or by operation of law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) There
is no Proceeding now pending or, to the Company&rsquo;s Knowledge, threatened in writing, against or with respect to the Company or its
Subsidiaries in respect of any material Tax, other than any audits with respect to which the Company or its Subsidiaries have paid or
accrued, in accordance with GAAP, any Taxes associated with such audits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) During
the two-year period ending on the date hereof, neither the Company nor any of its Subsidiaries was a distributing corporation or a controlled
corporation in a transaction intended to be governed by Section 355 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) The
Company and each of its Subsidiaries has properly withheld, and paid over to the appropriate Governmental Authority, all material Taxes
that it was required to withhold from any payment to any employee, independent contractor, creditor, stockholder, vendor or other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) Neither
the Company nor any of its Subsidiaries has been party to any &ldquo;listed transaction&rdquo; within the meaning of Treasury Regulation
Section 1.6011-4(b)(2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) There
are no Liens, other than Permitted Liens, on any of the assets of the Company or its Subsidiaries in connection with any failure (or
alleged failure) to pay any Tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) Neither
the Company nor any of its Subsidiaries is a party to or bound by any Tax indemnity, sharing, allocation, gross-up or similar agreement
primarily relating to Taxes (other than any such agreement between any of the Company and any of its Subsidiaries).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) Neither
the Company nor any of its Subsidiaries is or has been subject to Tax in any jurisdiction outside the United States by virtue of having
a permanent establishment, trade or business, office or other fixed place of business or other presence in that jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) No
equity interest in the Company is a United States real property interest within the meaning of Section 897(c) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) Neither
the Company nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of deduction
from, taxable income for any taxable period (or portion thereof) ending on or after the Closing Date as a result of (i) an open transaction
disposition made on or before the Closing Date, (ii) a prepaid amount, deposit, advanced payment received or paid, or deferred revenue
accrued, on or before the Closing Date, (iii) the application of the installment method of accounting to any transaction occurring on
or before the Closing Date, (iv) any intercompany transactions occurring on or before the Closing Date or any excess loss account in
existence on or before the Closing Date described in Treasury Regulations promulgated under Section 1502 of the Code (or any similar
or corresponding provision of any state, local or non-U.S. Law), (v) any change in its method of accounting for a taxable period (or
portion thereof) ending on or before the Closing Date, including by reason of Section 481 of the Code, or any comparable provisions of
other applicable state, local or non-U.S. Tax Law, or use of an improper method of accounting on or prior to the Closing Date, (vi) any
&ldquo;closing agreement&rdquo; under Section 7121 of the Code (or any comparable provisions of other applicable state, local or non-U.S.
Tax Law) entered into with any Governmental Authority on or prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) There
have been no private letter rulings issued by the Internal Revenue Service to the Company or any of its Subsidiaries (and any similar
or corresponding ruling or determination of any state, local or non-U.S. Governmental Authority) and there are no pending written requests
for any such rulings (or corresponding determinations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) Neither
the Company nor any of its Subsidiaries has claimed any &ldquo;employee retention credit&rdquo; pursuant to Section 2301 of the CARES
Act (or any corresponding or similar provision of state, local or foreign Law) for any taxable period that remains open for audit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.19 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee Benefit Plans and Labor and Employment
Matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Section
4.19(a)</U> of the Company Disclosure Schedule contains a correct and complete list of each material Employee Plan. With respect to each
material Employee Plan, true, current and complete copies of the plan document together with all &lrm;amendments and material contracts
relating thereto (including, for any unwritten plan, a summary of the material terms), have been made available to Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) No
Employee Plan is or was within the past six (6) years, and neither the Company nor any ERISA Affiliate has or reasonably expects to have
any material liability or obligation under (including current or potential withdrawal liability): (i) a &ldquo;defined benefit plan&rdquo;
(as defined in Section 3(35) of ERISA), (ii) a multiemployer plan, as defined in Section 3(37) of ERISA, (iii) a &ldquo;multiple employer
plan&rdquo; as described in Section 413(c) of the Code; or (iv) a &ldquo;multiple employer welfare arrangement&rdquo; as described in
Section 3(40) of ERISA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Each
Employee Plan that is intended to be qualified under Section 401(a) of the Code has received a favorable determination letter from the
IRS or is entitled to rely on a favorable opinion letter from the IRS that such plan is qualified and no event has occurred and no condition
exists with respect to the form or operation of such Employee Plan which would reasonably be expected to cause the loss of such qualification
or exemption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Except
as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i) each Employee
Plan has been established and maintained in accordance with and in compliance with its terms and all Applicable Laws, including ERISA
and the Code; (ii) all contributions, premiums and other similar payments to, and payments from, such Employee Plan with respect to any
period ending on or before the Closing Date have been timely made; and (iii) all reports, returns and similar documents required to be
filed with any Governmental Authority or distributed to any plan participant have been duly and timely filed or distributed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Except
as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Company,
each Subsidiary and each ERISA Affiliate has complied in all respects with (i) the notice and continuation coverage requirements, and
all other requirements, of Section 4980B of the Code and Parts 6 and 7 of Title I of ERISA, and the regulations thereunder, and (ii)
the affordability and minimum essential coverage requirements, and all other requirements, of the Patient Protection and Affordable Care
Act of 2010, as amended, in each case, with respect to each Employee Plan that is a group health plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Section
4.19(f)</U> of the Company Disclosure Schedule sets forth all material Employee Plans, Contracts or other obligations of the Company
or any of its Subsidiaries which provides for health, life or other welfare benefits to past or present employees beyond their retirement
or other termination of service, other than coverage mandated by the Consolidated Omnibus Budget Reconciliation Act of 1985, Section
4980B of the Code, Title I of ERISA or any similar state group health plan continuation Laws, the cost of which is fully paid by such
employees or their dependents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Neither
the Company nor any of its Subsidiaries has any material obligation (whether pursuant to an Employee Plan or otherwise) to indemnify,
&ldquo;gross-up&rdquo;, reimburse or otherwise compensate any individual with respect to the additional Taxes or interest imposed pursuant
to Sections 409A or 4999 of the Code (or any corresponding provision of state, local, or foreign Law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) Except
as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, there are
no Proceedings (other than routine claims for benefits) pending or, to the Knowledge of the Company, threatened against or relating to
any of the Employee Plans and, to the Knowledge of the Company, no facts exist which would reasonably be expected to give rise to any
such Proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Neither
the Company nor any of its Subsidiaries nor any Employee Plan nor, to the Knowledge of the Company, any &ldquo;disqualified person&rdquo;
(as defined in Section 4975 of the Code) or &ldquo;party in interest&rdquo; (as defined in Section 3(18) of ERISA) has engaged in any
non-exempt prohibited transaction (within the meaning of Section 4975 of the Code or Section 406 of ERISA), except as would not reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) The
Company and its Subsidiaries are in compliance with all Applicable Laws relating to labor and employment, including, those relating to
fair employment practices, anti-discrimination, -harassment, and -retaliation, workplace safety and health, terms and conditions of employment,
wages and hours, the proper classification and treatment of employees as exempt or non-exempt, and the proper classification and treatment
of any independent contractor, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) Except
as provided by <U>&lrm;Section 2.6</U>, neither the execution of this Agreement nor the consummation of the Transactions (either alone
or together with any other event) will (i) entitle any past or present Company Employee, director and/or independent contractor of the
Company or any of its Subsidiaries to any material bonuses, severance pay, unemployment compensation, transaction related payments or
any similar payments, or (ii) accelerate the time of the payment, funding or vesting of, or increase the amount of, any material compensation
and/or material benefits due to any past or present Company Employee, director, independent contractor other individual service provider
of the Company or any of its Subsidiaries. Neither the execution of this Agreement nor the consummation of the Transactions (either alone
or together with any other event) will result in any payments or benefits which would not reasonably be expected to be deductible under
Section 280G of the Code, or which would cause any Tax or penalty under Section 4999 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) Except
as set forth on <U>Section 4.19(l)(i)</U> of the Company Disclosure Schedule, there are currently, and for the last three (3) years have
been, no pending, or to the Company&rsquo;s Knowledge, threatened, Proceedings by any employee, independent contractor, former employee,
or former independent contractor of the Company or any of its Subsidiaries before the National Labor Relations Board, the Equal Employment
Opportunity Commission or any other Governmental Authority relating to any labor and employment matters. Except as set forth on <U>Section
4.19(l)(ii)</U> of the Company Disclosure Schedule, to the Company&rsquo;s Knowledge, none of the employment policies or practices of
the Company or any of its Subsidiaries are currently being audited or investigated by any Governmental Authority or subject to imminent
audit or investigation by any Governmental Authority, except as would not reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) Neither
the Company nor any of its Subsidiaries is a party to or subject to, or is currently negotiating in connection with entering into, any
collective bargaining agreement (each, a &ldquo;<B>Labor Agreement</B>&rdquo;). To the Company&rsquo;s Knowledge, there has been no petition
for representation filed with respect to any Company Employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) Since
the Applicable Date, neither the Company nor any of its Subsidiaries has effectuated (i) a &ldquo;plant closing&rdquo; (as defined in
the Worker Adjustment and Retraining Notification Act of 1988 or similar Applicable Law (the &ldquo;<B>WARN Act</B>&rdquo;)) affecting
any site of employment or one or more facilities or operating units within any site of employment or facility of the Company or any of
its Subsidiaries; or (ii) a &ldquo;mass layoff&rdquo; (as defined in the WARN Act) affecting any site of employment or facility of the
Company or any of its Subsidiaries; and neither the Company nor any of its Subsidiaries has been affected by any transaction or engaged
in layoffs or employment terminations sufficient in number to trigger application of any similar state or local Applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) The
Company has furnished to Parent a complete and accurate list of the current employees and officers of the Company and any of its Subsidiaries
as of the date hereof and shows with respect to each such employee: his or her name or employee identification number; direct employing
entity (i.e., the Company or a specific Subsidiary); date of hire; primary location of employment (country, state or province, and city);
job position or title; job department; full- or part-time status; overtime exempt or non-exempt status for wage and hour purposes; base
compensation rate (for overtime exempt employees, annual base salary rate) (for overtime nonexempt employees, base hourly wage rate);
type of incentive compensation if eligible (e.g., commissions, bonuses); annualized target incentive compensation; the frequency of payment
for such incentive compensation (e.g., monthly, quarterly, semi-annually, annually); visa status; annualized vacation or paid time off
(or designation of &ldquo;flexible&rdquo; if a non-accrual-based vacation or paid time off system is used); eligibility for severance
and the potential amount of such severance; eligibility for change of control benefits (cash or otherwise) to be paid at the Closing
or otherwise in connection with the Acquisition and the amount of such benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) The
Company has furnished to Parent a complete and accurate list of all current independent contractors, consultants or advisors to the Company
or any of its Subsidiaries that the Company and/or the applicable Subsidiary classify as other than employees, describing for each such
independent contractor, consultant, or advisor: his, her or its personal or corporate name; primary location from which services are
performed (country, state or province, and city); designation as to whether such independent contractor regularly performs more or less
than an average of 30 hours per week; most recent rate of all regular, bonus or any other compensation rate; description of services
provided; initial date retained to perform services; the expected end date of services (if known); and whether he, she or it is required
to work, or in fact works, exclusively for the Company or one of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.20 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental Matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Except
as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) no
written notice, order, complaint or penalty has been received by the Company or any of its Subsidiaries arising out of any Environmental
Laws or relating to Hazardous Substances, and there are no Proceedings pending or, to the Company&rsquo;s Knowledge, threatened which
allege any liability of or violation by the Company or any of its Subsidiaries relating to any Environmental Laws or Hazardous Substances;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) neither
the Company nor any of its Subsidiaries, nor any of their respective predecessors or controlled Affiliates, has treated, stored, disposed
of, arranged for or permitted the disposal of, transported, handled, released or exposed any person to any Hazardous Substance, or owned
or operated any property or facility contaminated by any Hazardous Substance, in each case, as has given or would give rise to liabilities
or obligations under any Environmental Laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Company and each of its Subsidiaries are and have been since the Applicable Date in compliance with all applicable Environmental Laws,
environmental Permits necessary for their operations and any applicable Orders relating to (A) pollution, contamination, protection of
the environment, health, safety or sanitation, (B) emissions, discharges, disseminations, releases or threatened releases of Hazardous
Substances into the air (indoor or outdoor), surface water, groundwater, soil, land surface or subsurface, buildings, facilities, real
or personal property or fixtures or (C) the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling
of Hazardous Substances, in each case except as would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.21 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material Contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Section
4.21</U> of the Company Disclosure Schedule sets forth each of the following Contracts to which the Company or any of its Subsidiaries
is a party or bound and has continuing obligations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) any
Contract that constitutes a &ldquo;material contract&rdquo; (as such term is defined in Item 601(b)(10) of Regulation S-K of the SEC),
whether or not filed by the Company with the SEC;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) any
Contract limiting in any material respect the ability of the Company or its Subsidiaries (or, after the consummation of the Merger, Parent,
the Surviving Corporation or any of their respective Subsidiaries) to (A) sell any products or services of or to any other Person or
in any geographic region, (B) engage in any line of business or (C) compete with or to obtain products or services from any Person or
limiting the ability of any Person to provide products or services to the Company or its Subsidiaries (or, after the consummation of
the Merger, Parent, the Surviving Corporation or any of their respective Subsidiaries);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) any
Contract with any of the ten (10) largest suppliers by dollar volume of purchases made by the Company and its Subsidiaries during the
twelve (12) months ended December 31, 2025;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) any
distributor, broker, dealer, manufacturer&rsquo;s representative, franchise, agency, sales promotion, market research, marketing consulting,
advertising and similar Contract requiring payments on an annual or aggregate basis in excess of $500,000;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) any
Contract that obligates the Company or any of its Subsidiaries to make directly or indirectly, any advance, loan, extension of credit
or capital commitment or contribution to, or other investment in, any Person, or any capital expenditure in excess of $250,000 individually
or $500,000 in the aggregate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) any
Contract (A) between the Company and any of its Subsidiaries, on the one hand, and any Affiliate (including any director or executive
officer) thereof, on the other hand, or (B) otherwise of the type that would be required to be disclosed under Item 404 of Regulation
S-K of the SEC;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii) any
Contract that (A) grants any right of first refusal, right of first offer or similar right with respect to any material property or asset
of the Company or any of its Subsidiaries or (B) limits or purports to limit the ability of the Company or any of its Subsidiaries (or,
following the Closing, the Surviving Corporation, Parent or any of its Affiliates) to own, operate, sell, transfer, pledge or otherwise
dispose of any material properties or assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii) any
Contract that requires the Company or any of its Subsidiaries to purchase or obtain from any given Person either (1) a minimum or specified
amount of any product or service or (2) all or a material portion of the Company&rsquo;s or any of its Subsidiaries&rsquo; requirements
for any product or service;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix) any
Contract that requires, during the remaining term of such Contract, either (A) annual payments to or from the Company or its Subsidiaries
of more than $1,000,000 or (B) aggregate payments to or from the Company or its Subsidiaries of more than $2,500,000 during the term
of such Contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) any
Contract (other than the organizational documents of the Company and its Subsidiaries) that relates to the formation, creation, governance
or control of, or the economic rights or obligations of the Company or any of its Subsidiaries in, any joint venture or other similar
arrangement involving a sharing of profits or expenses or payments or other triggering events based on revenues or profits of the Company
or its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi) any
Contract that (A) provides for the disposition or acquisition, directly or indirectly (whether by merger, consolidation, the sale of
equity interests, the sale of all or substantially all of the assets, or otherwise), of any business or any equity interests of any Person,
or (B) includes any earn-out or other similar contingent payment obligation of the Company or any of its Subsidiaries in excess of $1,000,000
outstanding as of the date hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii) any
Contract with a Governmental Authority;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii) any
Labor Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv) any
Contract relating to the settlement or resolution of any litigation or other Proceeding that provides for any continuing material obligations
on the part of the Company or any of its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv) any
Contract (A) under which the Company or its Subsidiaries has granted or received a license or other right to any Intellectual Property
(excluding non-exclusive licenses or rights granted in the ordinary course of business), (B) relating to the acquisition, ownership,
or development of Intellectual Property, or (C) otherwise adversely affecting the Company&rsquo;s or its Subsidiaries&rsquo; ability
to use, enforce, or disclose any Intellectual Property (excluding non-exclusive end-user licenses for unmodified, commercially available,
off-the-shelf software that are provided in executable form only and used solely for the Company&rsquo;s and its Subsidiaries&rsquo;
internal business purposes, with an aggregate replacement cost of less than $500,000); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi) any
Contract relating to any material Indebtedness or any security interest in any material assets or properties of the Company or any of
its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(each
Contract constituting any of the foregoing types described in clauses (i)-(xv), a &ldquo;<B>Material Contract</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Company has made available to Parent or its Representatives a true, complete and correct copy of each Material Contract (including any
material amendments, attachments or supplements thereto). Except for breaches, violations or defaults which would not reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect, (a) each of the Material Contracts is valid and in full force and
effect and constitutes a legal, valid, binding and enforceable obligation of the Company or its Subsidiaries party thereto and, to the
Knowledge of the Company, of the other parties thereto (subject to the Bankruptcy and Equity Exception), and (b) neither the Company
nor any of its Subsidiaries, nor to the Company&rsquo;s Knowledge any other party to a Material Contract, has violated any provision
of, or taken or failed to take any act which, with or without notice, lapse of time, or both, would constitute a breach or default under
the provisions of such Material Contract or result in the right to terminate, amend or cancel such Material Contract or cause or permit
the acceleration or other material changes of any right or obligation or the loss of any material benefit thereunder by the Company or
its Subsidiaries, and neither the Company nor any of its Subsidiaries has received notice that it has breached, violated or defaulted
under any Material Contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.22 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related Party Transactions. <FONT STYLE="font-style: normal">Except
as set forth in the Company SEC Documents, to the Knowledge of the Company, since the Applicable Date, there have been no transactions,
or series of related transactions, agreements, arrangements or understandings in effect, nor are there any currently proposed transactions,
or series of related transactions, agreements, arrangements or understandings, that would be required to be disclosed under Item 404(a)
of Regulation S-K.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.23 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers. <FONT STYLE="font-style: normal">Except
for Truist Securities, Inc., there is no investment banker, broker, finder or other intermediary that has been retained by or is authorized
to act on behalf of the Company or any of its Subsidiaries that is entitled to any fee or commission from the Company or any of its Affiliates
in connection with the Transactions.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.24 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of the Company&rsquo;s Financial Advisor.
<FONT STYLE="font-style: normal">The Company Board has received the opinion of Truist Securities, Inc., financial advisor to the Company,
to the effect that, as of the date of such opinion and based on and subject to the matters, assumptions, qualifications and limitations
set forth therein, the Merger Consideration is fair, from a financial point of view, to holders of Company Stock (other than holders
who execute a Voting Agreement in connection with the Merger, Parent, Merger Subsidiary, and their respective affiliates).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.25 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeover Laws. <FONT STYLE="font-style: normal">The
Company has taken all action necessary to exempt the Merger, this Agreement and the Transactions from the requirements of any Takeover
Laws.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.26 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance. <FONT STYLE="font-style: normal">The
Company has furnished to Parent complete and accurate copies of all material (x) insurance policies, binders and insurance contracts
that are maintained by or for the benefit of the Company and its Subsidiaries and (y) self-insurance programs and arrangements relating
to the business, assets and operations of the Company and its Subsidiaries as of the date of this Agreement (collectively, the &ldquo;<B>Insurance
Policies</B>&rdquo;). Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect,
(a) each such Insurance Policy is in full force and effect with all premiums due having been paid in full, and the Company is not in
default under any Insurance Policy, (b) neither the Company nor any of its Subsidiaries has received any written or, to the Company&rsquo;s
Knowledge, oral notice of cancellation, termination, non-renewal or denial of coverage with respect to any Insurance Policy, (c) none
of the policy limits under any of the Insurance Policies have been eroded by the payment of claims and (d) since the Applicable Date
there has not been any claim that has been denied or rejected by any insurer and not successfully appealed and covered.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.27 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Other Representations and Warranties. <FONT STYLE="font-style: normal">Except
for the representations and warranties expressly made by the Company in this <U>Article 4</U> or in any certificate delivered by the
Company pursuant to this Agreement, neither the Company nor any other Person makes any representation or warranty of any kind whatsoever,
express or implied, at law or in equity, with respect to the Company, any of its Subsidiaries or their respective business, operations,
assets, liabilities, condition (financial or otherwise) or the Transactions, notwithstanding any other statements made or the delivery
or disclosure to the Parent and Merger Subsidiary or any of their respective Representatives of any documentation, forecasts or other
information with respect to any one or more of the foregoing.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.28 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusivity of Parent Representations and Warranties.
<FONT STYLE="font-style: normal">The Company, on behalf of itself and its Subsidiaries, acknowledges and agrees that, except for the
representations and warranties expressly set forth in <U>Article 5</U> or in any certificate delivered by Parent pursuant to this Agreement:
(i) neither Parent nor Merger Subsidiary (or any other Person) makes, or has made, any representation or warranty relating to Parent,
Merger Subsidiary or any of their businesses, operations or otherwise in connection with this Agreement or the Transactions; (ii) no
Person has been authorized by Parent, Merger Subsidiary or any of its or their respective Representatives to make any representation
or warranty relating to the Parent, Merger Subsidiary or any of their businesses or operations or otherwise in connection with this Agreement
or the Transactions, and if made, such representation or warranty must not be relied upon by the Company, any of its Subsidiaries or
any of their respective Representatives as having been authorized by the Parent, Merger Subsidiary or any of its or their respective
Representatives (or any other Person); and (iii) the representations and warranties made by the Parent in this Agreement are in lieu
of and are exclusive of all other representations and warranties, including any express or implied or as to merchantability or fitness
for a particular purpose, and the Parent hereby disclaims any other or implied representations or warranties, notwithstanding the delivery
or disclosure to Company or its Subsidiaries or any of their respective Representatives of any documentation or other information (including
any financial information, supplemental data or financial projections or other forward-looking statements).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
4.29 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Reliance. <FONT STYLE="font-style: normal">The
Company, on behalf of itself and its Subsidiaries, acknowledges and agrees that, except for the representations and warranties expressly
set forth in <U>Article 5</U>, it is not acting (including, as applicable, by entering into this Agreement or consummating the Transaction)
in reliance on: (i) any other representation or warranty, express or implied; (ii) any estimate, projection, prediction, data, financial
information, memorandum, presentation or other materials or information provided or addressed to the Company or any of its Representatives,
including any materials shared by Parent or Merger Subsidiary in connection with the Merger, or in any other forum or setting; or (iii)
the accuracy or completeness of any other representation, warranty, estimate, projection, prediction, data, financial information, memorandum,
presentation or other materials or information.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Representations and Warranties of Parent</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth in the Parent Disclosure Schedule (each section of which qualifies the correspondingly numbered representation and warranty
or covenant to the extent specified therein, provided that any disclosure set forth with respect to any particular section shall be deemed
to be disclosed in reference to all other applicable sections of this Agreement if the relevance of such disclosure to such other sections
is reasonably apparent on its face), Parent hereby represents and warrants to the Company as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Existence and Power. <FONT STYLE="font-style: normal">Each
of Parent and Merger Subsidiary is a corporation duly incorporated, validly existing and in good standing under the laws of its jurisdiction
of incorporation and has all corporate powers and all governmental licenses, authorizations, permits, consents and approvals required
to carry on its business as now conducted, except for those licenses, authorizations, permits, consents and approvals the absence of
which would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Since the date of
its incorporation, Merger Subsidiary has not engaged in any activities other than in connection with or as contemplated by this Agreement.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Authorization. <FONT STYLE="font-style: normal">The
execution, delivery and performance by Parent and Merger Subsidiary of this Agreement and the consummation by Parent and Merger Subsidiary
of the Transactions are within the corporate powers of Parent and Merger Subsidiary and have been duly authorized by all necessary corporate
action. This Agreement constitutes a legal, valid and binding agreement of each of Parent and Merger Subsidiary, enforceable against
Parent and Merger Subsidiary in accordance with its terms, subject to the Bankruptcy and Equity Exception.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.3 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental Authorization. <FONT STYLE="font-style: normal">The
execution, delivery and performance by Parent and Merger Subsidiary of this Agreement and the consummation by Parent and Merger Subsidiary
of the Transactions require no action by or in respect of, or filing with, any Governmental Authority, other than (i) the filing of a
certificate of merger with respect to the Merger with the Secretary of State of the State of Texas and appropriate documents with the
relevant authorities of other states in which Parent is qualified to do business, (ii) compliance with any applicable requirements of
the HSR Act and those filings set forth in <U>Section 8.1(b)</U> of the Company Disclosure Schedule, (iii) compliance with any applicable
requirements of the 1934 Act and any other state or federal securities laws and (iv) any actions or filings the absence of which would
not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.4 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-contravention. <FONT STYLE="font-style: normal">The
execution, delivery and performance by Parent and Merger Subsidiary of this Agreement and the consummation by Parent and Merger Subsidiary
of the Transactions do not and will not (i) contravene, conflict with, or result in any violation or breach of any provision of the certificate
of incorporation or bylaws of Parent or Merger Subsidiary, (ii) assuming compliance with the matters referred to in </FONT>&lrm;<FONT STYLE="font-style: normal"><U>Section
5.3</U>, contravene, conflict with or result in any violation or breach of any provision of any Applicable Law, (iii) assuming compliance
with the matters referred to in </FONT><U>&lrm;<FONT STYLE="font-style: normal">Section 5.3</FONT></U><FONT STYLE="font-style: normal">,
require any consent or other action by any Person under, constitute a default under, or cause or permit the termination, cancellation,
acceleration or other change of any right or obligation or the loss of any benefit to which Parent or any of its Subsidiaries is entitled
under any provision of any Contract binding upon Parent or any of its Subsidiaries or (iv) result in the creation or imposition of any
Lien on any asset of the Parent or any of its Subsidiaries, with only such exceptions, in the case of each of clauses (ii) through (iv),
as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.5 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
information supplied by Parent for inclusion in the Proxy Statement will not, at the time the Proxy Statement and any amendment or supplement
thereto is first mailed to the stockholders of the Company and at the time of the Company Stockholder Meeting, contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading. The representations and warranties contained in this &lrm;<U>Section
5.5(a)</U> will not apply to statements or omissions included or incorporated by reference in the Proxy Statement based upon information
supplied by the Company or any of its Representatives specifically for use or incorporation by reference therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Registration Statement will, when filed, comply as to form in all material respects with the applicable requirements of the 1933 Act.
At the time the Registration Statement is filed with the SEC, the Registration Statement, as supplemented or amended, if applicable,
will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The representations
and warranties contained in this Section 5.5(b) will not apply to statements or omissions included or incorporated by reference in the
Registration Statement based upon information supplied by the Company, its Subsidiaries or any of their Representatives specifically
for use or incorporation by reference therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.6 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC Filings and the Sarbanes-Oxley Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Parent
has filed with or furnished to the SEC, on a timely basis, all material reports, schedules, forms, statements, prospectuses, registration
statements, certifications and other documents required to be publicly filed or furnished by Parent, including pursuant to the 1933 Act,
the 1934 Act or the Sarbanes-Oxley Act, since the Applicable Date (collectively, together with any exhibits and schedules thereto and
other information incorporated therein, the &ldquo;<B>Parent SEC Documents</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) As
of its filing date or on the date on which it was furnished (or, if amended, as of the date of such amendment), each Parent SEC Document
complied as to form in all material respects with the applicable requirements of the 1933 Act, the 1934 Act and the Sarbanes-Oxley Act,
as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) As
of its filing date or on the date on which it was furnished (or, if amended, as of the date of such amendment), each Parent SEC Document
filed pursuant to the 1933 Act, the 1934 Act and the Sarbanes-Oxley Act did not contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the
circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Parent
and each of its officers are in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act. The management
of Parent has complied in all material respects with Rule 13a-15 or 15d-15 under the 1934 Act, and designed, and maintained at all times
since the Applicable Date, disclosure controls and procedures to ensure that material information relating to Parent, including its consolidated
Subsidiaries, is recorded, processed and made known on a timely basis to the management of Parent and any other individuals responsible
for the preparation of the Parent&rsquo;s filings with the SEC. Since the Applicable Date, no executive officer of Parent has failed
to make the certifications required of such executive officer under Sections 302 or 906 of the Sarbanes-Oxley Act with respect to the
Parent SEC Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.7 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers. <FONT STYLE="font-style: normal">Except
for Centerview Partners LLC, whose fees will be paid by Parent, there is no investment banker, broker, finder or other intermediary that
has been retained by or is authorized to act on behalf of Parent who might be entitled to any fee or commission from the Company or any
of its Affiliates upon consummation of the Transactions.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.8 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Parent
has delivered to the Company a true, complete and correct copy of the fully executed debt commitment letter, together with any related
fee letters (in the case of the fee letters, redacted solely for confidential provisions related to the amount or percentage basis points
of fees (including in &ldquo;flex&rdquo; terms) and other commercially sensitive economic terms), dated as of the date of this Agreement,
by and among the Debt Financing Sources party thereto and Parent, providing for debt financing as described therein (together with all
exhibits, schedules and annexes thereto, the &ldquo;<B>Debt Commitment Letter</B>&rdquo;), pursuant to which, upon the terms and subject
to the conditions set forth therein, the Debt Financing Sources party thereto have agreed to lend amounts set forth therein (the &ldquo;<B>Debt
Financing</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) As
of the date of this Agreement, the Debt Commitment Letter is in full force and effect and constitutes the valid, binding and enforceable
obligation of Parent and, to the knowledge of Parent, the other parties thereto, enforceable in accordance with its terms, subject to
the Bankruptcy and Equity Exception. As of the date of this Agreement, there are no conditions precedent related to the funding of the
full amount of the Debt Financing, other than the conditions precedent expressly set forth in the Debt Commitment Letter. As of the date
of this Agreement, the Debt Commitment Letter has not been amended or modified in any respect, and the respective commitments contained
therein have not been terminated, reduced, withdrawn or rescinded in any respect and, to the knowledge of Parent, except as expressly
permitted under <U>Section 7.6(a)</U>, no such termination, reduction, withdrawal or rescission is contemplated by Parent, or any other
party thereto. As of the date of this Agreement, except for the Debt Commitment Letter and the related fee letter, there are no side
letters or other Contracts or arrangements (written or oral) related to the funding or investing, as applicable, of the financing contemplated
pursuant to the Debt Commitment Letter other than as expressly set forth in the Debt Commitment Letter furnished to the Company pursuant
to this <U>Section 5.7</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) As
of the date hereof, assuming the satisfaction of the conditions precedent in <U>Section 9.1</U> and <U>Section 9.2</U>, Parent has no
reason to believe that (i) any of the conditions precedent expressly set forth in the Debt Commitment Letter that are required to be
satisfied on or prior to the Closing Date will not be satisfied on a timely basis or (ii) the Debt Financing in the aggregate amounts
contemplated by the Debt Commitment Letter to be funded on the Closing Date will not be available to Parent on the Closing Date, and,
to the Parent&rsquo;s Knowledge, there does not exist any fact or event as of the date hereof that would reasonably be expected to cause
such conditions to funding not to be satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Parent
or an Affiliate of Parent on its behalf has fully paid or caused to be paid any and all commitments or other fees and amounts required
by the Debt Commitment Letter to be paid on or prior to the date of this Agreement, and, to the Parent&rsquo;s Knowledge, there does
not exist any fact or event as of the date hereof that would reasonably be expected to make any of the assumptions or any of the statements
set forth in the Debt Commitment Letter inaccurate in any material respect or that would reasonably be expected to cause the Debt Commitment
Letter to be ineffective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Assuming
(x) the Debt Financing is funded in accordance with the Debt Commitment Letter (including after giving effect to any &ldquo;flex&rdquo;
provisions) and (y) satisfaction of all of the conditions to the obligations of Parent set forth in <U>Section 9.1</U> and <U>Section
9.2</U>, proceeds from the Debt Financing when aggregated together with other sources of immediately available funds, will provide Parent
with cash proceeds on the Closing Date sufficient to enable Parent to perform all of its obligations under this Agreement and to consummate
the Transactions. Each of Parent and Merger Subsidiary affirms that it is not a condition to the Closing or to any of its other obligations
under this Agreement that the Parent and Merger Subsidiary obtain financing for, or related to, any of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.9 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solvency. <FONT STYLE="font-style: normal">Assuming
(i) the satisfaction of the conditions to Parent&rsquo;s obligation to consummate the Merger, (ii) the accuracy of the representations
and warranties set forth in <U>Article 4</U> of this Agreement (for this purpose, such representations and warranties shall be true and
correct in all material respects) and (iii) after giving effect to the Transactions, any alternative financing, the payment of the aggregate
Merger Consideration, any repayment or refinancing of debt contemplated in this Agreement and the payment of all related fees and expenses,
the Surviving Corporation, on a consolidated basis and taken as a whole, will be Solvent as of the Effective Time and immediately after
the consummation of the Transactions. For purposes of this Agreement, &ldquo;Solvent&rdquo; when used with respect to any Person, together
with its Subsidiaries on a consolidated basis and taken as a whole, means that, as of any date of determination, (A) the amount of the
&ldquo;fair saleable value&rdquo; of the assets of such Persons will, as of such date, exceed (1) the value of all &ldquo;liabilities
of such Persons, including contingent and other liabilities,&rdquo; as of such date, as such quoted terms are generally determined in
accordance with Applicable Laws of the United States governing determinations of the insolvency of debtors, and (2) the amount that will
be required to pay the probable liabilities of such Person on its existing debts (including a reasonable estimate of the amount of all
contingent liabilities) as such debts become absolute and matured, (B) such Persons will not have, as of such date, an unreasonably small
amount of capital to carry on their businesses as presently conducted and (C) such Persons will be able to pay their liabilities, including
contingent and other liabilities, as they become absolute and mature.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.10 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership of Company Stock. <FONT STYLE="font-style: normal">Parent
and its Affiliates (as such term is defined in Rule 13d-3 promulgated under the 1934 Act) do not directly or indirectly beneficially
own (as such term is defined in Rule 13d-3 promulgated under the 1934 Act) five percent (5%) or more of the outstanding shares of Company
Stock or other securities of the Company (assuming for this purpose the full exercise of any options, warrants or other rights to acquire
Company Stock or other securities of the Company held by such persons).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.11 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder and Management Arrangements. <FONT STYLE="font-style: normal">As
of the date hereof, other than this Agreement, the Voting Agreements and any ancillary agreements entered into hereunder or thereunder,
neither Parent or Merger Subsidiary nor any of their respective Affiliates is a party to any Contract, or has authorized, made or entered
into, or committed or agreed to enter into, any formal or informal arrangements or other understandings (whether or not binding) with
any stockholder, director, officer, employee or other Affiliate of the Company or any of its Subsidiaries (a) relating to (i) this Agreement
or the Transactions; (ii) the Company or (iii) the Surviving Corporation or any of its Subsidiaries, businesses or operations (including
as to continuing employment) from and after the Effective Time; or (b) pursuant to which (i) any such holder of shares of Company Stock
would be entitled to receive consideration of a different amount or nature than the Merger Consideration in respect of such holder&rsquo;s
shares of Company Stock; or (ii) any Person (including any stockholder, director, officer, employee or other Affiliate of the Company)
has agreed to provide, directly or indirectly, equity investment to Parent, Merger Subsidiary or the Company to finance any portion of
the Transactions.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
5.12 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exclusivity of Representations and Warranties;</I>
<I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><R><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</FONT></R>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No Other Representations and Warranties</I>. Each of Parent
and Merger Subsidiary, on behalf of itself and its Subsidiaries, acknowledges and agrees that, except for the representations and warranties
expressly set forth in <U>Article 4</U> or in any certificate delivered by the Company pursuant to this Agreement: (i) neither the Company
nor any of its Subsidiaries (or any other Person) makes, or has made, any representation or warranty relating to the Company, its Subsidiaries
or any of their businesses, operations or otherwise in connection with this Agreement or the Transactions; (ii) no Person has been authorized
by the Company, any of its Subsidiaries or any of its or their respective Representatives to make any representation or warranty relating
to the Company, its Subsidiaries or any of their businesses or operations or otherwise in connection with this Agreement or the Transactions,
and if made, such representation or warranty must not be relied upon by Parent, Merger Subsidiary or any of their respective Representatives
as having been authorized by the Company, any of its Subsidiaries or any of its or their respective Representatives (or any other Person);
and (iii) the representations and warranties made by the Company in this Agreement are in lieu of and are exclusive of all other representations
and warranties, including any express or implied or as to merchantability or fitness for a particular purpose, and the Company hereby
disclaims any other or implied representations or warranties, notwithstanding the delivery or disclosure to Parent, Merger Subsidiary
or any of their respective Representatives of any documentation or other information (including any financial information, supplemental
data or financial projections or other forward-looking statements).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <I>No
Reliance</I>. Each of Parent and Merger Subsidiary, on behalf of itself and its Subsidiaries, acknowledges and agrees that, except for
the representations and warranties expressly set forth in <U>Article 4</U>, it is not acting (including, as applicable, by entering into
this Agreement or consummating the Transaction) in reliance on: (i) any other representation or warranty, express or implied; (ii) any
estimate, projection, prediction, data, financial information, memorandum, presentation or other materials or information provided or
addressed to Parent, Merger Subsidiary or any of their respective Representatives, including any materials or information made available
in the electronic data room hosted by or on behalf of the Company in connection with the Merger, in connection with presentations by
the Company&rsquo;s management or in any other forum or setting; or (iii) the accuracy or completeness of any other representation, warranty,
estimate, projection, prediction, data, financial information, memorandum, presentation or other materials or information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Covenants of the Company</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company agrees that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
6.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Except
as required by Applicable Law, as expressly contemplated by this Agreement, or as set forth in <U>Section 6.1</U> of the Company Disclosure
Schedule, from the date hereof until the Effective Time (or such earlier date and time on which this Agreement is terminated pursuant
to <U>Article 10</U>), unless Parent otherwise consents in writing (such consent not to be unreasonably withheld, conditioned or delayed),
the Company shall, and shall cause each of its Subsidiaries to, use commercially reasonable efforts to (i) conduct its business in the
ordinary course consistent with past practices and (ii) maintain and preserve intact its business organization, to retain the services
of its present officers and key employees, and to preserve the good will of its customers, suppliers and other Persons with whom it has
business relationships; <I>provided, however</I>, that no action taken or omitted to be taken by the Company or any of its Subsidiaries
with respect to the matters specifically addressed by <U>Section 6.1(b)</U> shall be deemed to be a breach of this <U>Section 6.1(a)</U>
unless such action would constitute a breach of <U>Section 6.1(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Except
with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), as expressly contemplated
by this Agreement, as set forth in <U>Section 6.1</U> of the Company Disclosure Schedule, or as required by Applicable Law, from the
date hereof until the Effective Time (or such earlier date and time on which this Agreement is terminated pursuant to <U>Article 10</U>),
the Company shall not, nor shall it permit any of its Subsidiaries to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) amend,
modify, waive or otherwise alter its certificate of incorporation, bylaws or other similar organizational documents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) (A)
split, combine or reclassify any shares of its capital stock, (B) make, declare, set aside or pay any dividend or other distribution
(whether in cash, stock or property or any combination thereof) in respect of its capital stock, except for dividends by any of its wholly-owned
Subsidiaries to the Company or to any other wholly-owned Subsidiary of the Company or (C) redeem, repurchase or otherwise acquire or
offer to redeem, repurchase, or otherwise acquire any Company Securities or any Company Subsidiary Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) (A)
issue, authorize, grant, sell, transfer, pledge or otherwise dispose of or encumber any Company Securities, Company Subsidiary Securities
or any securities convertible or exchangeable into or exercisable for any Company Securities or Company Subsidiary Securities, including
any options, warrants, stock appreciation rights, shares of restricted stock, restricted stock units, performance-based restricted stock
units, in each case other than issuance of (x) any shares of Company Stock upon exercise of any Company Options that are outstanding
as of the date of this Agreement, or (y) any Company Subsidiary Securities to the Company or any other Subsidiary of the Company; or
(B) amend, modify or waive any material terms of any Company Securities, Company Subsidiary Securities or any options, warrants, restricted
stock units, performance-based restricted stock units, restricted stock or other rights to acquire any shares of its capital stock or
any securities convertible or exchangeable into or exercisable for any shares of its capital stock (including, for the avoidance of doubt,
by reducing the exercise price and/or extending the expiration date of any such options, warrants or other rights);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) directly
or indirectly acquire or purchase (by merger, consolidation, acquisition of stock or assets or otherwise) any corporation or partnership
or other business organization, or a material amount of the assets, securities, properties, interests or businesses of such Person, other
than (A) pursuant to Contracts existing as of the date hereof or (B) the purchase of raw materials, supplies, equipment or other similar
assets in the ordinary course of business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) merge,
consolidate, statutorily convert, transfer, continue, domesticate or redomesticate the Company or any of its Subsidiaries with any Person
or otherwise or adopt a plan of complete or partial liquidation or resolutions providing for a complete or partial liquidation, dissolution,
restructuring, recapitalization or other reorganization of the Company or any of its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) directly
or indirectly sell, lease, license, pledge transfer or otherwise dispose of or encumber (whether by merger, consolidation, other business
combination, sale or otherwise) all or any material portion of its assets, securities, properties, interests or businesses, other than
(A) pursuant to Contracts existing as of the date hereof, (B) the sale of inventory in the ordinary course of business, (C) the sale
or transfer of aged or obsolete inventory, or (D) assets or properties sold, leased or transferred pursuant to this clause (D) having
a value of less than $250,000 individually or $1,000,000 in the aggregate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii) make
any material loans, advances or capital contributions to, or investments in, any other Person, other than (A) in connection with actions
permitted by <U>Section 6.1(b)(iv)</U>, (B) extensions of credit to customers in the ordinary course of business, (C) advances to directors,
officers and other employees for travel and other business-related expenses, in each case in the ordinary course of business and in compliance
with the Company&rsquo;s (or applicable Subsidiary of the Company&rsquo;s) policies related thereto, or (D) loans, advances or capital
contributions to, or investments in, wholly-owned Subsidiaries of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii) (A)
incur any Indebtedness or issue any debt securities, (B) assume, guarantee or endorse, or otherwise become liable or responsible for
(whether directly, contingently or otherwise), any Indebtedness of any Person (other than a wholly owned Subsidiary of the Company),
or (C) redeem, repurchase, cancel or otherwise acquire any Indebtedness (directly, contingently or otherwise), except in each case for
(1) letters of credit issued for the benefit of Company customers (2) capital leases, or (3) other Indebtedness or guarantees having
a value of less than $250,000 individually or $1,000,000 in the aggregate, in each case, incurred in the ordinary course of business
consistent with past practices;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix) other
than as required by an Employee Plan as in effect on the date hereof and disclosed to Parent, (A) grant, announce or accelerate the vesting
or payment of any compensatory equity award or increase any severance or termination pay (or amend any existing severance pay or termination
arrangement) or grant any retention bonus or enter into any retention arrangement, in each case for the benefit of any of the employees,
directors, or other service providers of the Company or its Subsidiaries, (B) establish, adopt, terminate or materially amend any Employee
Plan (other than general changes to the Company&rsquo;s health and welfare plans made during the open enrollment process in the ordinary
course of business) or any service, consulting, deferred compensation or other similar Contract (or any Contract which, if in existence
as of the date hereof, would constitute an Employee Plan), (C) increase compensation or bonus opportunity payable or to become payable
or benefits provided under an Employee Plan or otherwise to a current or former employee of the Company or its Subsidiaries with annual
base salary of less than $200,000, in each case except for increases in the ordinary course of business with respect, or (D) terminate
(other than for cause) the employment of, furlough or temporarily layoff or hire or promote any officer, director, employee or consultant,
unless such hiring is in the ordinary course of business consistent with past practice and is with respect to officers, directors, employees
or consultants having an annual base salary not to exceed $200,000;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) change
the Company&rsquo;s accounting policies, practices, principles methods or procedures, except as required by concurrent changes in GAAP
or in Regulation S-X of the 1934 Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi) make,
change or revoke any material Tax election, adopt or change any accounting method for Tax purposes, agree to any extension or waiver
of the statute of limitations relating to a material amount of Taxes, file any amendment to any material Tax Return in respect of Taxes,
enter into any &ldquo;closing agreement&rdquo; described in Section 7121 of the Code, surrender any right to claim a material Tax refund,
or settle or compromise any material Tax liability;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii) waive,
release, assign, settle or compromise any material rights, claims or Proceeding involving or against the Company or any of its Subsidiaries,
other than any such settlement that involves no remedies other than the payment of monetary damages not in excess of $250,000 individually
or $1,000,000 in the aggregate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii) (A)
other than new Contracts with customers or suppliers entered into in the ordinary course of business consistent with past practice, enter
into any Contract that, if in existence on the date of this Agreement, would have been a Material Contract or (B) materially modify or
amend or terminate any Material Contract (other than, in each case, the expiration or renewal of any Material Contract in accordance
with its terms);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv) except
as provided for in the Company&rsquo;s budget for such fiscal year (a correct and complete copy of which has been provided to Parent,
or which will be provided to Parent for any subsequent fiscal year), make or authorize any capital expenditures in excess of $1,000,000,
individually or in the aggregate, or authorize any capital expenditure that would result in post-Closing obligations of the Surviving
Company in excess of $1,000,000, individually or in the aggregate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv) waive
or release any noncompetition, non-solicitation, nondisclosure, noninterference, non-disparagement or similar obligations of any current
or former officer, employee or consultant, except, solely in respect of rank-and-file non-management current or former employees or consultants,
in the ordinary course of business consistent with past practices, or forego enforcement of any such obligations under any existing agreement
or arrangement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi) (A)
negotiate, modify, extend, or enter into any Labor Agreement or (B) recognize or certify any labor union, labor organization, works council,
or group of employees as the bargaining representative for any Company Employees; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii) agree,
resolve or commit to do any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, nothing contained in this Agreement shall give Parent, directly or indirectly, the right to control or direct
the operations of the Company, the Company&rsquo;s business, or any employee of the Company prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
6.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Stockholder Meeting. <FONT STYLE="font-style: normal">(a)
The Company and Parent shall coordinate in good faith with respect to establishing a record date to be used for determining Company stockholders
entitled to vote at the Company Stockholder Meeting in accordance with the Company organizational documents, including running a broker
search(es) following initial submission to the SEC of the preliminary Proxy Statement. Promptly following the Clearance Date, the Company
shall by resolutions of the Company Board cause a meeting of its stockholders (the &ldquo;<B>Company Stockholder Meeting</B>&rdquo;)
to be duly called and held as soon as reasonably practicable (but in no event later than forty-five (45) days after the Clearance Date)
for the purpose of obtaining the Company Stockholder Approval. Once established, the Company shall not change the record date for the
Company Stockholder Meeting without the prior written consent of Parent (such consent not to be unreasonably withheld, delayed or conditioned)
or as required by Applicable Law. Subject to &lrm;<U>Section 6.3</U>, the Company Board shall (i) include the Company Board Recommendation
in the Proxy Statement, (ii) use its reasonable best efforts, including engaging a nationally recognized proxy solicitation firm pursuant
to a written engagement letter with customary terms (including with respect to compensation payable to the proxy solicitation firm) to
solicit or cause to be solicited from its stockholders proxies in favor of the adoption of this Agreement and to obtain the Company Stockholder
Approval, and (iii) otherwise comply with all Applicable Laws relating to such meeting. Notwithstanding anything to the contrary in this
Agreement, to the fullest extent permitted by Applicable Law, the Company shall not adjourn or postpone the Company Stockholder Meeting
without the prior written consent of Parent; </FONT><I>provided</I><FONT STYLE="font-style: normal">, </FONT><I>however</I><FONT STYLE="font-style: normal">,
if on a date for which the Company Stockholder Meeting is scheduled, the Company has not received proxies representing a sufficient number
of shares of Company Stock to constitute a quorum and to obtain the Company Stockholder Approval, whether or not a quorum is present,
nothing will prevent the Company from postponing or adjourning the Company Stockholder Meeting, after consultation with Parent: (i) for
up to ten (10) Business Days, to allow additional solicitation of votes in order to obtain the Company Stockholder Approval; (ii) if
there are holders of an insufficient number of shares of the Company Stock present or represented by proxy at the Company Stockholder
Meeting to constitute a quorum at the Company Stockholder Meeting; (iii) if the Company is required to postpone or adjourn the Company
Stockholder Meeting by applicable Law or a request from the SEC or its staff; or (iv) in order to give the Company&rsquo;s stockholders
sufficient time to evaluate any information or disclosure that the Company has sent to the Company&rsquo;s stockholders or otherwise
made available to the Company&rsquo;s stockholders (including in connection with any Adverse Recommendation Change in accordance with
this Agreement), as reasonably determined to be necessary by the Company Board, after consultation with Parent and outside legal counsel.
To the fullest extent permitted by Applicable Law, the Company shall, if requested by Parent, postpone or adjourn the Company Stockholder
Meeting (A) if there are holders of an insufficient number of shares of the Company Stock present or represented by proxy at the Company
Stockholder Meeting to constitute a quorum at the Company Stockholder Meeting or (B) to allow additional solicitation of votes in order
to obtain the Company Stockholder Approval. The Company shall, unless there has been an Adverse Recommendation Change (to the extent
permitted under <U>Section 6.3</U>), use reasonable best efforts to cooperate with Parent and keep Parent reasonably informed regarding
its solicitation efforts and voting results following the dissemination of the Proxy Statement to its stockholders. Without the prior
written consent of Parent, the adoption of this Agreement and the Transactions (including the Merger) shall be the only matter (other
than procedural matters including stockholder approval of golden parachute compensation and adjournments) that the Company shall propose
to be acted on at the Company Stockholder Meeting. Except as otherwise expressly provided in this Agreement, the Company&rsquo;s obligations
pursuant to this <U>Section 6.2</U>, including the Company&rsquo;s obligation to hold the Company Stockholder Meeting, shall not be affected
by the notice, commencement, public proposal, public disclosure or communication to the Company, Parent or any other Person of any purchase
or acquisition of the Company by any Person, or the making of an Adverse Recommendation Change.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
6.3 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Solicitation; Other Offers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <I>General
Prohibitions</I>. Except as expressly permitted by <U>Section 6.3(b)</U>, from the date hereof until the Effective Time, neither the
Company nor any of its Subsidiaries shall, nor shall the Company or any of its Subsidiaries authorize or permit any of its or their respective
directors, officers, employees, consultants, investment bankers, attorneys, accountants and other advisors or representatives (collectively,
&ldquo;<B>Representatives</B>&rdquo;) to, directly or indirectly, (i) solicit, initiate or induce, or knowingly take any action to facilitate,
assist in or encourage the submission or announcement of, any Acquisition Proposal, (ii) enter into or participate in any discussions
or negotiations with, furnish any non-public information relating to the Company or any of its Subsidiaries to, or afford access to the
business, properties, assets, personnel, books or records of the Company or any of its Subsidiaries to any Third Party or its Representatives
in connection with or in furtherance of any Acquisition Proposal, (iii) (A) fail to make, or withdraw or qualify or modify in a manner
adverse to Parent, the Company Board Recommendation, (B) adopt, approve, endorse, recommend or otherwise declare advisable (or propose
to adopt, approve, endorse, recommend or otherwise declare advisable) any Acquisition Proposal (it being understood that it shall be
considered a modification of the Company Board Recommendation adverse to Parent if (1) any Acquisition Proposal structured as a tender
or exchange offer is commenced and the Company Board fails to publicly recommend against, acceptance of such tender or exchange offer
by the Company stockholders in any solicitation or recommendation statement on Schedule 14D-9 filed by the Company with the SEC in connection
with such tender offer or exchange offer, or (2) any Acquisition Proposal is publicly announced (other than by the commencement of a
tender or exchange offer) and the Company Board fails to issue a public press release within ten (10) Business Days of such public announcement
providing that the Company Board reaffirms the Company Board Recommendation), (C) make any public statement inconsistent with the Company
Board Recommendation or (D) fail to include the Company Board Recommendation in the Proxy Statement (any of the foregoing in this clause
(iii), an &ldquo;<B>Adverse Recommendation Change</B>&rdquo;), (iv) accept, approve, recommend or enter into any agreement in principle,
merger agreement, acquisition agreement, option agreement, letter of intent, memorandum of understanding, or other similar agreement,
arrangement or understanding (whether or not written or oral, binding or non-binding) relating to an Acquisition Proposal (other than
an Acceptable Confidentiality Agreement) (any such agreement, an &ldquo;<B>Alternative Acquisition Agreement</B>&rdquo;), or (v) resolve,
agree, publicly propose or publicly announce an intention to do any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <I>Exceptions</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <I>Exception
for Diligence and Discussions</I>. Notwithstanding <U>Section 6.3(a)</U> or any other provision of this Agreement, if, after the date
hereof and prior to obtaining the Company Stockholder Approval, the Company or any of its Representatives has received a <I>bona fide</I>,
written Acquisition Proposal that is not a result of a breach of this <U>Section 6.3</U>, then, subject to the Company&rsquo;s compliance
with the provisions of this <U>Section 6.3(b)</U>, (x) the Company and its Representatives may make inquiries solely for the purpose
of clarifying the terms of such Acquisition Proposal and (y) if the Company Board, acting reasonably and in good faith, has determined,
based on the information then available and (1) after consultation with the Company&rsquo;s financial advisor and outside legal counsel,
that such Acquisition Proposal constitutes or would reasonably be expected to lead to a Superior Proposal and (2) after consultation
with the Company&rsquo;s outside legal counsel, the failure by the Company to take such action would be reasonably likely to be inconsistent
with its fiduciary duties under applicable Law, then the Company and its Representatives may (A) engage in negotiations or discussions
with the Third Party making such Acquisition Proposal and its Representatives and (B) furnish to such Third Party or its Representatives
non-public information relating to the Company and its Subsidiaries and afford access to the business, properties, assets, personnel,
books and records of the Company and its Subsidiaries pursuant to an Acceptable Confidentiality Agreement; <I>provided</I> that all such
information (to the extent that such information has not been previously provided or made available to Parent) is provided or made available
to Parent, as the case may be, prior to or substantially concurrently with the time it is provided or made available to such Third Party
or its Representatives. From and after the date hereof, the Company shall promptly (and in any event within twenty-four (24) hours) after
such determination advise Parent in writing if the Company determines to begin providing information or engaging in discussions or negotiations
relating to any Acquisition Proposal pursuant to this <U>Section 6.3(b)</U>. Furthermore and notwithstanding any other provision of this
Agreement, except as expressly permitted by this <U>Section 6.3</U>, from the date hereof until the Effective Time, the Company shall
not, and shall cause its Subsidiaries and its and their respective Representatives not to, directly or indirectly, (1) terminate or grant
a waiver, amendment or release under any &ldquo;standstill&rdquo; or similar provisions (including provisions that restrict or prohibit
the making or soliciting of any offer or proposal), (2) grant any waiver, amendment or release under any Takeover Laws, or (3) resolve,
agree or publicly propose to do any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <I>Exception
for Superior Proposal</I>. Notwithstanding any other provision of this Agreement, but subject to compliance with this <U>Section 6.3</U>,
at any time prior to obtaining the Company Stockholder Approval, if (A) the Company has received a <I>bona fide</I>, written Acquisition
Proposal that is not a result of a breach of this <U>Section 6.3</U> and (B) the Company Board, acting reasonably and in good faith,
has determined, based on the information then available and (1) after consultation with the Company&rsquo;s financial advisor and outside
legal counsel, that such Acquisition Proposal constitutes a Superior Proposal and (2) after consultation with the Company&rsquo;s outside
legal counsel, the failure by the Company to take such action would be reasonably likely to be inconsistent with its fiduciary duties
under applicable Law, then the Company Board may make an Adverse Recommendation Change with respect to such Superior Proposal and/or
cause the Company to terminate this Agreement pursuant to and in accordance with &lrm;<U>Section 10.1(d)</U> and enter into a definitive
Alternative Acquisition Agreement in respect of such Superior Proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <I>Exception
for Intervening Events</I>. Notwithstanding any other provision of this Agreement, but subject to compliance with <U>Section 6.3(c)</U>,
at any time prior to obtaining the Company Stockholder Approval, if the Company Board, acting reasonably and in good faith, has determined,
based on the information then available and after consultation with the Company&rsquo;s outside legal counsel, that the failure to take
such action would be reasonably likely to be inconsistent with its fiduciary duties under Applicable Law, the Company Board may, in response
to an Intervening Event, make an Adverse Recommendation Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) <I>Compliance
with Rule 14e-2(a)</I>. In addition, nothing contained herein shall prevent the Company Board from (i) complying with Rule 14e-2(a) under
the 1934 Act with regard to an Acquisition Proposal so long as any action taken or statement made to so comply is consistent with this
<U>Section 6.3</U> or (ii) issuing a customary &ldquo;stop, look and listen&rdquo; disclosure or similar communication of the type contemplated
by Rule 14d-9(f) under the 1934 Act; <I>provided</I> that the foregoing shall in no way eliminate or modify the effect that any such
disclosure or communication would otherwise have under this Agreement or permit the Company Board to effect an Adverse Recommendation
Change except in accordance with <U>Section 6.1(b)(ii)</U> or <U>Section 6.1(b)(iii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <I>Required
Notices</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) At
any time until the Effective Time, the Company shall notify Parent promptly (and in any event no later than within one (1) Business Day)
after receipt by the Company (or any of its Representatives) of (A) any Acquisition Proposal, (B) any request for non-public information
relating to the Company or any of its Subsidiaries or for access to the business, properties, assets, personnel, books or records of
the Company or any of its Subsidiaries by any Third Party that could reasonably be expected to make, or has made, an Acquisition Proposal,
or (C) any discussions or negotiations that are sought to be initiated or continued with the Company or any of its Subsidiaries or any
of its or their respective Representatives from any Person (other than Parent or Merger Subsidiary or their Affiliates) with respect
to any Acquisition Proposal, including in such notification, a copy (if in writing) of documents and other materials or written summary
of material terms (if oral) relating to such expression of interest, proposal, offer or request for information, and the identity of
the Person from which such expression of interest, proposal, offer or request for information was received. The Company shall keep Parent
reasonably informed, on a reasonably prompt basis, of the status of any such Acquisition Proposal (including any copies (if in writing)
of documents and other materials or written summaries of material terms (if oral) of any proposed agreements and amendments or modifications
thereto, and a copy of any other documents provided by the relevant counterparty relating thereto) and the status of any discussions
or negotiations regarding any such Acquisition Proposal, and in the case of any material modification to the terms of any such Acquisition
Proposal, the Company shall notify Parent of such material modification promptly (and in any event within one (1) Business Day) of the
Company&rsquo;s or any of its Subsidiaries&rsquo; or any of its or their respective Representatives&rsquo; knowledge of any such material
modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) Prior
to taking any action described in <U>Section 6.3(b)(ii)</U> or <U>Section 6.3(b)(iii)</U>, the Company shall notify Parent of its intent
to take such proposed action, which notice shall specify, as applicable, the (A) the basis for such proposed action, (B) identity of
the Person making any Superior Proposal and describe the material terms and conditions thereof in reasonable detail (including any proposed
draft Alternative Acquisition Agreement) or (C) describe in reasonable detail the facts, events, changes or developments in circumstances
giving rise to an Intervening Event. After delivery of such notice, the Company shall, and shall cause its Representatives to, negotiate
with Parent and its Representatives (to the extent Parent desires to do so) reasonably and in good faith for a period ending at 11:59
p.m. (New York City time) on the fourth (4<SUP>th</SUP>) Business Day immediately following the date of such notice (the &ldquo;<B>Notice
Period</B>&rdquo;) in furtherance of making commercially reasonable amendments or modifications to the terms and conditions of this Agreement
such that (x) the Superior Proposal giving rise to such notice would no longer constitute a Superior Proposal or (y) the Intervening
Event giving rise to such notice would no longer provide the basis for an Adverse Recommendation Change. If the financial or other material
terms of the relevant Acquisition Proposal are materially amended or modified, then the Company will deliver to Parent a new notice pursuant
to this clause (ii), except that the Notice Period shall instead end at 11:59 p.m. (New York City time), on the second (2<SUP>nd</SUP>)
Business Day immediately following the date such new notice is delivered to Parent (but no such new notice will shorten the initial Notice
Period). Notwithstanding anything to the contrary in this Agreement, the Company shall not take any action described in <U>Section 6.1(b)(ii)</U>
or <U>Section 6.1(b)(iii)</U> unless, after the end of the Notice Period, the Company&rsquo;s Board of Directors, acting reasonably and
in good faith, has determined, (1) after consultation with the Company&rsquo;s financial advisor and outside legal counsel and taking
into account any amendments or modifications to the terms and conditions of the Agreement proposed by Parent, that such Acquisition Proposal
continues to constitute a Superior Proposal and (2) after consultation with the Company&rsquo;s outside legal counsel, the failure to
take such action would be reasonably likely to be inconsistent with its fiduciary duties under applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Notwithstanding
anything to the contrary in this Agreement, the giving of a notice required by or otherwise complying with this <U>Section 6.3(c)</U>
shall not constitute an Adverse Recommendation Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <I>Application
of this Provision to Representatives</I>. Any violation of the restrictions on the Company set forth in this <U>&lrm;Section 6.3</U>
by any Representative of the Company or any of its Subsidiaries shall be a breach of this &lrm;<U>&lrm;Section 6.3</U> by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <I>Obligation
to Terminate Discussions</I>. Subject to this <U>Section 6.</U>3, on the date hereof, the Company and its Subsidiaries shall, and shall
cause its and their respective directors and officers, and shall instruct its and their respective Representatives (including the Company&rsquo;s
financial advisor and its Representatives) to, (i) cease immediately and cause to be terminated any and all existing activities, discussions
or negotiations, if any, with any Third Party and its Representatives with respect to any Acquisition Proposal, (ii) cease providing
any information to any Third Party or its Representatives with respect to the Company or any of its Subsidiaries, or their respective
businesses, properties, assets, personnel, books or records, in connection with any Acquisition Proposal, (iii) promptly request that
all copies of all confidential information that the Company or any of its Representatives have distributed or made available to any such
Third Party in connection with their consideration of any Acquisition Proposal (and all analyses and other materials prepared by or on
behalf of such Third Party that contains, reflects or analyzes that information) be promptly destroyed or returned to the Company, to
the extent required by any confidentiality or similar agreement with such Third Party, and (iv) cause any physical or virtual data room
to no longer be accessible to or by any such Third Party or its Representatives. The Company shall promptly inform its and its Subsidiaries&rsquo;
Representatives of the Company&rsquo;s obligations under this <U>&lrm;Section 6.3</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <I>Certain
Definitions</I>. As used in this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &ldquo;<B>Acceptable
Confidentiality Agreement</B>&rdquo; means a confidentiality agreement that (A) is in effect as of the date hereof or (B) is effected
after the date hereof and contains provisions (including confidentiality and use terms) that are no less favorable in any substantive
respect to the Company than those contained in the Confidentiality Agreement (other than with respect to any standstill or similar provision);
provided that such confidentiality agreement does not contain provisions that (A) prohibit the Company from providing any information
to Parent in accordance with <U>Section 6.3</U> or otherwise prohibit the Company from complying with its obligations under this Agreement,
including the provisions of <U>Section 6.3</U>, or (B) require the Company to negotiate exclusively with any party thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) &ldquo;<B>Intervening
Event</B>&rdquo; means a fact, event, change or development in circumstances that materially affects the business, assets or operations
of the Company and its Subsidiaries, taken as a whole, and that (A) was not known, or reasonably foreseeable by, to the Company Board
on or prior to the date hereof (or, if known or reasonably foreseeable, the consequences or magnitude of which were not known, or reasonably
foreseeable by, to the Company Board on or prior to the date hereof), and becomes known to the Company Board prior to obtaining the Company
Stockholder Approval and (B) does not involve or relate to (1) an Acquisition Proposal, (2) any changes in the market price or trading
volume of the Company, (3) any changes in the Company&rsquo;s credit ratings or (4) the Company meeting, failing to meet, or exceeding
published or unpublished revenue or market consensus earnings projections, in each case, in and of itself; <I>provided</I>, that the
underlying causes of any of the changes referred to in the foregoing clauses (2) through (4) may be considered and taken into account
for determining whether an Intervening Event has occurred, to the extent not otherwise excluded from this definition; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) &ldquo;<B>Superior
Proposal</B>&rdquo; means a <I>bona fide</I> written Acquisition Proposal that (A) is received after the date of this Agreement, (B)
is for at least a majority of the outstanding shares of Company Stock or all or substantially all of the consolidated assets of the Company
and its Subsidiaries that (i) is on terms that the Company Board, acting reasonably and in good faith, has determined, after considering
the advice of the Company&rsquo;s financial advisor and outside legal counsel and taking into account all the terms and conditions of
the Acquisition Proposal, are more favorable to the Company&rsquo;s stockholders than the terms of this Agreement, (ii) is reasonably
likely to be consummated on the proposed terms (taking into account any legal, regulatory, financial and other aspects of such Acquisition
Proposal that the Company Board considers relevant), and (iii) for which financing, to the extent required, is then committed or reasonably
likely to be available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
6.4 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access to Information. <FONT STYLE="font-style: normal">Subject
to Applicable Law and the Confidentiality Agreement, from the date hereof until the earlier to occur of the Effective Time and the termination
of this Agreement pursuant to <U>Article 10</U>, upon reasonable advance notice, the Company shall (i) afford Parent and its Representatives
reasonable access during normal business hours to the offices, properties, personnel, and books and records of the Company and its Subsidiaries;
and (ii) furnish to Parent and its Representatives such financial and operating data and other information concerning the business and
operations of the Company and its Subsidiaries as Parent and its Representatives may reasonably request; </FONT><I>provided</I><FONT STYLE="font-style: normal">,
that the Company shall not be obligated to provide such access or furnish such data or other information pursuant to this <U>Section
6.4</U> if the Company determines, in its reasonable judgment, that doing so would reasonably be expected to (A) violate Applicable Law
or any Contract to which the Company or any Subsidiary thereof is a party (provided that the Company shall use its commercially reasonable
efforts to provide such access or make such disclosure in a manner that does not violate such Applicable Law or Contract, including using
commercially reasonable efforts to obtain any necessary third-party consents), (B) waive the protection of an attorney-client privilege,
attorney work product protection or other legal privilege (provided that the Company shall use its commercially reasonable efforts to
allow for such access or disclosure (or as much of it as possible) in a manner that does not result in a loss of such privilege), (C)
be adverse to the interests of the Company or any of its Subsidiaries in any pending or threatened Proceeding against any member of the
Parent Group or (D) involve documents or information relating to (x) the Company&rsquo;s interactions with other prospective buyers of
the Company that occurred prior to the date of this Agreement, (y) the Company&rsquo;s evaluation or negotiation of this Agreement or
the Transactions, or (z) the Company&rsquo;s analysis, valuation, or consideration of the Transactions. Any investigation conducted by
Parent and its Representatives pursuant to this <U>Section 6.4</U> shall be conducted in a manner that does not (i) unreasonably interfere
with the conduct of the business or operations of the Company or any of its Subsidiaries or (ii) create an unreasonable risk of damage
or destruction to any property or assets of the Company or any of its Subsidiaries. Any access to the offices or other properties of
the Company or any of its Subsidiaries granted pursuant to this <U>Section 6.4</U> will be subject to the Company&rsquo;s and its Subsidiaries&rsquo;
reasonable security measures and insurance requirements, and will not include the right of Parent or any of its Representatives to (and
neither Parent nor its Representative shall) conduct or cause to be conducted any sampling, testing or other invasive investigation of
the air, soil, soil gas, surface water, groundwater, building materials or other environmental media. The terms and conditions of the
Confidentiality Agreement will apply to any information obtained by Parent or any of its Representatives in connection with any investigation
conducted pursuant to the access contemplated by this <U>Section 6.4</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
6.5 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignations. <FONT STYLE="font-style: normal">At
the written request of Parent, the Company shall cause any director or officer of the Company or any director or officer of any of the
Company&rsquo;s Subsidiaries to resign in such capacity, with such resignations to be effective as of the Effective Time and to be delivered
to Parent at or prior to the Closing.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
6.6 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payoff Letters; Lien Releases; Transaction Expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) At
or prior to the Closing, the Company shall use its commercially reasonable efforts to, no less than seven (7) days prior to the anticipated
Closing Date, obtain and deliver to Parent (x) customary payoff letters executed by the holders of Indebtedness set forth in <U>Section
6.6(a)</U> of the Company Disclosure Schedule, and (y) any termination statements on Form UCC-3 or other releases and terminations reasonably
necessary to evidence the satisfaction and release of all Liens and guarantees on the assets or properties of the Company or any Subsidiary
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Company shall use its commercially reasonable efforts to deliver to Parent, at least three (3) Business Days prior to the Closing Date,
invoices from the vendors set forth in <U>Section 6.6(b)</U> of the Company Disclosure Schedule to evidence the full payment and satisfaction
of such transaction expenses as of the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
6.7 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing Cooperation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Prior
to the Closing, the Company and its Subsidiaries shall use their reasonable best efforts, and shall cause their respective officers,
directors, employees and representatives to use their reasonable best efforts, to provide such customary cooperation as may be reasonably
requested by Parent in connection with the Debt Financing and is customarily provided for borrowers in financings of the type contemplated
by the Debt Commitment Letter, at Parent&rsquo;s sole expense, including, without limitation, using reasonable best efforts to: (i) participate
in a reasonable number of meetings, presentations and due diligence and other sessions with the Debt Financing Sources or other potential
providers of the Debt Financing at reasonable times and upon reasonable notice to be agreed, (ii) provide assistance with the preparation
of bank information memoranda, lender presentations and similar materials required in connection with the Debt Financing and execute
and deliver one or more customary representation or authorization letters with respect to the foregoing in form and substance reasonably
satisfactory to the Company, (iii) reasonably assist Parent in the preparation of definitive financing documents with respect to the
Debt Financing, (iv) provide reasonably promptly to Parent and its Debt Financing Sources such additional financial and other pertinent
information regarding the Company and its Subsidiaries that is readily available or in their possession and customary for financing of
the type similar to the Debt Financing, in each case, as is reasonably requested in connection with the Debt Financing, (v) execute and
deliver reasonable and customary certificates and other documentation required by the Debt Financing Sources and the definitive financing
documents with respect to the Debt Financing, subject to the occurrence of the Closing and solely by such officers that remain with the
Company after the Closing, (vi) reasonably facilitate the pledging of collateral, including taking all actions reasonably necessary to
establish bank and other accounts and blocked account agreements in connection with the foregoing; <U>provided</U>, that any obligations
contained in all such agreements and documents shall be executed and effective no earlier than the Closing, (vii) provide at least five
(5) Business Days prior to the Closing Date all documentation and other information about the Company and its Subsidiaries as is required
by bank regulatory authorities under applicable &ldquo;know-your-customer&rdquo; and anti-money laundering rules and regulations, including
the USA PATRIOT Act and, as applicable, any beneficial ownership regulations, to the extent requested in writing by Parent at least ten
(10) Business Days prior to the Closing Date, (viii) [reserved], (ix) cooperate in satisfying the conditions precedent set forth in the
Debt Commitment Letter or any definitive financing documents relating to the Debt Financing to the extent satisfaction thereof requires
the cooperation, or is within the control of, the Company and its Subsidiaries or their respective representatives and (x) taking customary
organizational company actions, subject to and only effective upon the occurrence of the Closing, reasonably requested by Parent to permit
the consummation of the Debt Financing. The conditions precedent set forth in <U>Section 9.2(a)</U>, as applied to the Company&rsquo;s
obligations under this <U>Section 6.7</U>, shall be deemed to be satisfied unless the financing contemplated by the Debt Commitment Letter
has not been obtained as a direct result of the Company&rsquo;s failure to undertake reasonable best efforts with respect to its obligations
under this <U>Section 6.7</U>, taken as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Notwithstanding
anything to the contrary, neither the Company, any of its Subsidiaries, nor any of their respective officers, directors, employees or
representatives, will be required to (i) adopt resolutions to authorize the Debt Financing or execute and deliver any definitive financing
documents, in each case, the effectiveness of which is not conditioned upon the occurrence of the Closing (other than the representation
or authorization letters described in clause (a)(ii) above), or cause any definitive financing documents to be signed by any officer
or director of the Company or any of its Subsidiaries that is not contingent on the occurrence of the Closing, (ii) take any action that
would reasonably be expected to conflict with, or violate, any of the Company&rsquo;s or its Subsidiaries&rsquo; organization documents
or applicable law or result in a breach of the terms of this Agreement, (iii) (A) pay any commitment fee or other similar fee in connection
with the Debt Financing prior to the Closing or (B) incur any other liability or obligation in connection with the Debt Financing prior
to the Closing for which it will not be reimbursed or indemnified by or on behalf of Parent on or prior to the Closing Date, (iv) provide
access to or disclose information that the Company determines could jeopardize any attorney-client privilege of, or conflict with in
any material respect any confidentiality requirements applicable to, the Company or any of its Affiliates, (v) cooperate or take other
actions in connection to the Debt Financing to the extent it would interfere unreasonably with the business or operation of the Company
or any of its Subsidiaries, (vi) consent to any grant of any Lien on or security interest in the assets of the Company or any of its
Subsidiaries the effectiveness of which is not conditioned upon the occurrence of the Closing or the pre-filing of UCC-1 financing statements
prior to the Closing in connection therewith or (vii) prepare (x) pro forma financial information, including pro forma cost savings,
synergies, capitalization or other pro forma adjustments desired to be incorporated into any pro forma financial information or (y) projections,
risk factors or other forward-looking statements relating to all or any component of the Debt Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) None
of the Company, the Company&rsquo;s Subsidiaries and their respective Representatives shall be required to take any action that would
subject such Person to actual or potential liability, to bear any cost or expense or to pay any commitment or other similar fee or make
any other payment or incur any other liability or provide or agree to provide any indemnity prior to the Closing in connection with their
performance of their respective obligations under this <U>Section 6.7</U>. Parent will indemnify and hold harmless the Company and its
Subsidiaries and their respective officers, directors, employees and representatives from and against all liabilities, losses, damages,
claims, costs, expenses, interest, awards, judgments and penalties actually suffered or incurred by any of them in connection with the
performance of their respective obligations under this <U>Section 6.7</U>, in each case, except for any such liabilities, losses, damages,
claims, costs, expenses, interest, awards, judgments and penalties that arise from the bad faith, gross negligence or fraud of, or Willful
Breach by, the Company or any of its Subsidiaries or any of their respective officers, directors, employees or representatives. Parent
will promptly (and in any event, within ten (10) Business Days) upon written request by the Company, reimburse the Company and its Subsidiaries
for all reasonable and documented out-of-pocket costs and expenses incurred by the Company or its Subsidiaries in connection with the
cooperation contemplated by this <U>Section 6.7</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
Company hereby consents to the use of its and its Subsidiaries&rsquo; logos in connection with the Debt Financing; provided that such
logos are used solely in a manner that is not intended to, nor reasonably likely to, harm or disparage the Company or any of its Subsidiaries
or the reputation or goodwill thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Covenants of Parent</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent
agrees that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
7.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct of Parent. <FONT STYLE="font-style: normal">Parent
shall not, and shall cause its Subsidiaries not to, from the date of this Agreement to the Effective Time, take any action or fail to
take any action that is intended to, or would reasonably be expected to, individually or in the aggregate, prevent, materially delay
or materially impede the ability of Parent and Merger Subsidiary to consummate the Merger or the other Transactions.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
7.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations of Merger Subsidiary. <FONT STYLE="font-style: normal">Parent
shall execute a written consent approving and adopting this Agreement and the Transactions in its capacity as the sole stockholder of
Merger Subsidiary and take all other actions necessary to cause Merger Subsidiary to perform its obligations under this Agreement and
to consummate the Merger and the other Transactions on the terms and conditions set forth in this Agreement.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
7.3 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting of Shares. <FONT STYLE="font-style: normal">Parent
shall vote all shares of Company Stock beneficially owned by it or any of its Subsidiaries in favor of the approval and adoption of this
Agreement and the Transactions at the Company Stockholder Meeting.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
7.4 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director and Officer Liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) For
six (6) years after the Effective Time, Parent shall cause to be maintained in effect provisions in the Surviving Corporation&rsquo;s
certificate of incorporation and bylaws (or in such documents of any successor to the Surviving Corporation) regarding elimination of
liability of directors and officers, indemnification of officers, directors and employees and advancement of expenses, in each case,
existing in favor of the present and former officers, directors and employees of the Company (each, an &ldquo;<B>Indemnified Person</B>&rdquo;)
in respect of acts or omissions occurring at or prior to the Effective Time, that are no less advantageous to the intended beneficiaries
than the corresponding provisions in existence in the Company&rsquo;s certificate of incorporation and bylaws on the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Prior
to the Effective Time, the Company shall or, if the Company is unable to, Parent shall cause the Surviving Corporation as of the Effective
Time to, obtain and fully pay the premium for the non-cancellable extension of the directors&rsquo; and officers&rsquo; liability coverage
of the Company&rsquo;s existing directors&rsquo; and officers&rsquo; insurance policies and the Company&rsquo;s existing fiduciary liability
insurance policies (collectively, &ldquo;<B>D&amp;O Insurance</B>&rdquo;), in each case for a claims reporting or discovery period of
at least six (6) years from and after the Effective Time with respect to any claim related to any period or time at or prior to the Effective
Time (including in connection with this Agreement or the transactions or actions contemplated hereby) from an insurance carrier with
the same or better credit rating as the Company&rsquo;s current insurance carrier with respect to D&amp;O Insurance with terms, conditions,
retentions and limits of liability that are no less favorable than the coverage provided under the Company&rsquo;s existing policies
with respect to any actual or alleged error, misstatement, misleading statement, act, omission, neglect, breach of duty or any matter
claimed against a director or officer of the Company or any of its Subsidiaries by reason of him or her serving in such capacity at or
prior to the Effective Time. If the Company or the Surviving Corporation for any reason fail to obtain such &ldquo;tail&rdquo; insurance
policies as of the Effective Time, the Surviving Corporation shall continue to maintain in effect, for a period of at least six (6) years
from and after the Effective Time, the D&amp;O Insurance in place as of the date hereof with respect to claims arising out of or relating
to events that occurred before or at the Effective Time, with the Company&rsquo;s current insurance carrier or with an insurance carrier
with the same or better credit rating as the Company&rsquo;s current insurance carrier with respect to D&amp;O Insurance with terms,
conditions, retentions and limits of liability that are no less favorable than the coverage provided under the Company&rsquo;s existing
policies as of the date hereof (but excluding cyber ransomware coverage), or the Surviving Corporation shall purchase from the Company&rsquo;s
current insurance carrier or from an insurance carrier with the same or better credit rating as the Company&rsquo;s current insurance
carrier with respect to D&amp;O Insurance comparable D&amp;O Insurance for such six-year period with terms, conditions, retentions and
limits of liability that are no less favorable than as provided in the Company&rsquo;s existing policies as of the date hereof (but excluding
cyber ransomware coverage); <I>provided</I> that in no event shall Parent or the Surviving Corporation be required to expend for such
policies pursuant to this sentence an aggregate amount in excess of 300% of the amount per annum the Company paid in its last full fiscal
year, which amount is set forth in &lrm;<U>Section 7.4(b)</U> of the Company Disclosure Schedule; and <I>provided further</I> that if
the aggregate premiums of such insurance coverage exceed such amount, the Surviving Corporation shall be obligated to obtain a policy
with the greatest coverage available, with respect to matters occurring prior to the Effective Time, for a cost not exceeding such amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) If
Parent, the Surviving Corporation or any of its successors or assigns (i) consolidates with or merges with or into any other Person and
shall not be the continuing or surviving Person of such consolidation or merger, or (ii) transfers or conveys all or substantially all
of its properties and assets to any Person, then, and in each such case, to the extent necessary, proper provision shall be made so that
the successors and assigns of Parent or the Surviving Corporation, as the case may be, shall assume the obligations set forth in this
<U>&lrm;Section 7.4</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
rights of each Indemnified Person under this <U>&lrm;Section 7.4</U> shall be in addition to any rights such Person may have under the
certificate of incorporation or bylaws of the Company or any of its Subsidiaries, or under the TBOC or any other Applicable Law or under
any agreement of any Indemnified Person with the Company or any of its Subsidiaries, and nothing herein shall modify, abridge, narrow
or restrict any such rights. These rights shall survive consummation of the Merger and are intended to benefit, and shall be enforceable
by, each Indemnified Person, and such Indemnified Person&rsquo;s successors, heirs and representatives. Each Indemnified Person shall
be a third-party beneficiary of this <U>Section 7.4</U>. The Surviving Corporation shall pay all reasonable expenses, including reasonable
attorneys&rsquo; fees, that may be incurred by any Indemnified Person in enforcing its indemnity, advancement and other rights under
this <U>Section 7.4</U>. Notwithstanding any other provision of this Agreement, this <U>Section 7.4</U> shall survive the consummation
of the Merger indefinitely and shall be binding, jointly and severally, on all successors and assigns of Parent and the Surviving Corporation,
and shall be enforceable by each Indemnified Person and their successors, heirs or representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
7.5 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee Matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) For
a period of twelve (12) months following the Effective Time (the &ldquo;<B>Continuation Period</B>&rdquo;), Parent shall provide or cause
the Surviving Corporation to provide to individuals who are Company Employees immediately prior to the Effective Time and continue to
be employed immediately following the Effective Time by Parent or the Surviving Corporation or any Subsidiary thereof (each, a &ldquo;<B>Continuing
Employee</B>&rdquo;), (i) annual base salary or wages and incentive opportunities that are each no less favorable in the aggregate than
those provided to such Continuing Employees immediately prior to the Effective Time, and (ii) other employee benefits that are substantially
comparable in the aggregate to those provided to such Company Employees by the Company or the applicable Subsidiary immediately prior
to the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) With
respect to each employee benefit plan, program or arrangement established or maintained by Parent, Surviving Corporation or any of its
respective affiliates (each, a &ldquo;<B>Surviving Corporation Plan</B>&rdquo;) to the extent such plan replaces coverage under a comparable
Employee Plan in which such Continuing Employee participates immediately prior to the Effective Time, Parent shall, and shall cause the
Surviving Corporation to, give or cause to be given to each Continuing Employee credit for eligibility, vesting and level of benefit
purposes (but not for benefit accrual under any defined benefit plan or retiree welfare benefit plan or vesting under any equity compensation
plan or change in control plan), for each Continuing Employee&rsquo;s service with the Company or any of its Subsidiaries (as well as
service with any predecessor employer of the Company or any such Subsidiary, to the extent service with the predecessor employer is recognized
by the Company or such Subsidiary) prior to the Effective Time; <I>provided, however</I>, that such service need not be recognized to
the extent that such recognition would result in any duplication of benefits for the same period of service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) With
respect to any Surviving Corporation Plan that is a welfare benefit plan in which any Continuing Employee is eligible to participate
after the Effective Time, Parent shall, and shall cause the Surviving Corporation to, use commercially reasonable efforts (i) waive all
limitations as to preexisting conditions and exclusions and waiting periods and actively-at-work requirements with respect to participation
and coverage requirements applicable to such employees and their eligible dependents and beneficiaries, to the extent such limitations
were waived, satisfied or did not apply to such employees or eligible dependents or beneficiaries under the corresponding welfare Employee
Plan in which such employees participated immediately prior to the Effective Time and (ii) provide Continuing Employees and their eligible
dependents and beneficiaries with credit for any co-payments and deductibles paid in the calendar year prior to the Effective Time in
satisfying any analogous deductible or out-of-pocket maximum requirements to the extent applicable under any such plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) With
respect to the annual cash-based bonus for calendar year 2026 (the &ldquo;<B>Annual Bonus</B>&rdquo;), the following provisions shall
apply:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
Surviving Corporation shall pay the Annual Bonus to each Continuing Employee in accordance with Parent&rsquo;s past practice regarding
timing of annual bonus payments, which shall be no later than March 30, 2027 (the &ldquo;<B>Customary Payment Date</B>&rdquo;), subject
to such Continuing Employee&rsquo;s continued employment through the Customary Payment Date, except as otherwise provided in clause (ii)
below. Subject to clause (ii) below, the Annual Cash bonus shall pay out at the greater of (x) actual achievement against performance
metrics, measured as of December 31, 2026 or (y) at target level, in either case less any portion of the annual cash-based bonuses previously
paid for 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) Notwithstanding
anything to the contrary in this Agreement or in any Employee Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) In
the event that the Surviving Corporation terminates the employment of a Continuing Employee without cause after the Closing but prior
to December 31, 2026, the Surviving Corporation shall pay such terminated Continuing Employee a pro-rata portion of such Continuing Employee&rsquo;s
Annual Bonus (less any portion of the annual cash-based bonuses previously paid in 2026) at target level, calculated based on the number
of days elapsed in 2026 through and including the date of such employee&rsquo;s termination, divided by 365, with such pro-rata amount
to be paid on the later of the Customary Payment Date and the date the Separation Agreement becomes effective; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) In
the event that the Surviving Corporation terminates the employment of a Continuing Employee without cause on or after January 1, 2027
but prior to the Customary Payment Date, the Surviving Corporation shall pay such terminated Continuing Employee the greater of (x) actual
achievement against performance metrics, measured as of December 31, 2026 or (y) at target level, less any portion of the annual cash-based
bonuses previously paid for 2026, with such amount to be paid on the later of the Customary Payment Date and the date the Separation
Agreement becomes effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
payment of any Annual Bonus under this clause (ii) shall be subject to the Continuing Employee within sixty (60) days of the date such
Continuing Employee&rsquo;s termination without cause (x) first signing and, if applicable, not revoking a separation agreement containing
a general release of claims and nondisparagement in favor of the Surviving Corporation and affiliated persons and entities (a &ldquo;<B>Separation
Agreement</B>&rdquo;) and (y) remaining in compliance with any continuing obligations to the Surviving Corporation and its affiliated
entities with respect to confidentiality, return of property, noncompetition, and nonsolicitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) For
the avoidance of doubt, (x) no portion of the Annual Bonus shall be paid at or in connection with the Closing, and the consummation of
the Merger shall not, in and of itself, accelerate the payment or vesting of any Annual Bonus amount and (y) nothing in this Section
7.5(d) shall create Annual Bonus eligibility for a Continuing Employee who was not eligible for an Annual Bonus as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) With
respect to any Continuing Employees whose principal place of employment is outside of the United States, Parent&rsquo;s obligations under
this <U>Section 7.5(e)</U> shall be modified to the extent necessary to comply with Applicable Law where such Company Employees primarily
perform their duties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) The
provisions of this <U>Section 7.5</U> are solely for the benefit of the parties to this Agreement, and no Company Employee, Continuing
Employee or any other Person (including any beneficiary or dependent thereof) shall be regarded for any purpose as a Third Party beneficiary
of this Agreement, and no provision of this <U>Section 7.5</U> shall (i) be deemed to guarantee employment for any period of time for,
or preclude the ability of Parent, the Company, the Surviving Corporation or their respective Subsidiaries to terminate, any Continuing
Employee for any reason or (ii) create such rights in any such Persons in respect of any benefits that may be provided, directly or indirectly,
under any Employee Plan or any compensation or benefit plan, program, agreement or policy of Parent or any of its Subsidiaries. Nothing
herein shall be construed as an amendment to, modification, termination or establishment of, any Employee Plan or compensation or benefit
plan, program, agreement or policy of Parent or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
7.6 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Parent
and Merger Subsidiary shall use their reasonable best efforts to take (taking into account the expected time for Closing), or cause to
be taken, all actions and do, or cause to be done, all things, necessary or advisable to obtain, no later than the Closing Date, the
proceeds of the Debt Financing on the terms and conditions described in the Debt Commitment Letter, including (i) maintaining in effect
the Debt Commitment Letter in accordance with and subject to the terms and conditions set forth therein (it being understood that the
Debt Commitment Letter may be replaced or amended as provided below); (ii) negotiating definitive financing agreements with respect to
the Debt Financing consistent with the terms and conditions contained in the Debt Commitment Letter (including, as necessary, any &ldquo;flex&rdquo;
provisions); (iii) satisfying on a timely basis (or obtaining a waiver of) all conditions in the Debt Commitment Letter and the definitive
financing agreements for the Debt Financing applicable to Parent or its Affiliates; (iv) complying with the covenants applicable to them
in the Debt Commitment Letter and in the definitive financing agreements for the Debt Financing; and (v) upon the satisfaction of the
conditions contained in the Debt Commitment Letter, cause the Debt Financing Sources to fund the Debt Financing at the Closing. Other
than amendments, modifications or supplements to add lenders, lead arrangers, bookrunners, syndication agents or similar entities as
parties to the Debt Commitment Letter, prior to the Closing, Parent shall not, without the prior written consent (which shall not be
unreasonably withheld, conditioned or delayed) of the Company, agree to or permit any amendment or modification to, or any waiver of
any material provision or remedy under, the Debt Commitment Letter or definitive financing agreements with respect to the Debt Financing
if such amendment, modification, waiver or remedy (A) would change the conditions precedent set forth therein, change the timing of the
funding of the commitments thereunder, reduce the cash amount of the funding commitments thereunder, or otherwise affect the ability
of Parent and Merger Sub to enforce their rights under the Debt Commitment Letter or consummate the transactions contemplated by this
Agreement or the timing of the Closing, in each case, in a manner that would reasonably be expected to (1) make the funding of the Debt
Financing (or the satisfaction of the conditions to obtaining the Debt Financing) less likely to occur or (2) materially delay or prevent
the Closing, (B), would waive any provision or remedy under the Debt Commitment Letter, (C) would have the effect of causing the early
termination of the Debt Commitment Letter, or (D) would reasonable be expected to prevent, impede or materially delay the consummation
of the Transactions. Upon the reasonable written request of the Company prior to the Closing Date, Parent shall keep the Company informed
on a reasonably current basis and in reasonable detail of the status of its efforts to arrange the Debt Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) In
the event that any portion of the Debt Financing becomes unavailable on the terms and conditions in the Debt Commitment Letter, or the
Debt Commitment Letter or any of the definitive financing agreements with respect to the Debt Financing shall be withdrawn, repudiated,
terminated or rescinded, regardless of the reason therefor, Parent will use its reasonable best efforts to obtain alternative debt financing
from the same or other sources on terms and conditions that are not less favorable in any material respect to Parent than those contained
in the Debt Commitment Letter assuming any &ldquo;flex&rdquo; rights have been exercised. Parent and Merger Sub shall promptly deliver
to the Company true and complete copies of any debt commitment letter and related fee letter associated therewith (in the case of any
such fee letter, redacted in a manner consistent with the fee letters delivered in connection with the Debt Commitment Letter) pursuant
to which any such alternative source shall have committed to provide any alternative financing. In the event any alternative financing
is obtained in accordance with this <U>Section 7.6(b)</U> (&ldquo;<B>Alternative Financing</B>&rdquo;), references in this Agreement
to the &ldquo;Debt Financing&rdquo; shall also be deemed to refer to such Alternative Financing, and if one or more commitment letters
or definitive financing agreements are entered into or proposed to be entered into in connection with such Alternative Financing, references
in this Agreement to the &ldquo;Debt Commitment Letter&rdquo; and the &ldquo;definitive financing agreements&rdquo; shall also be deemed
to refer to such commitment letters and definitive financing agreements relating to such Alternative Financing, and all obligations of
Parent pursuant to this <U>Section 7.6</U> shall be applicable thereto to the same extent as Parent&rsquo;s obligations with respect
to the Debt Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Prior
to the Closing Date, Parent shall promptly notify the Company in writing (i) after it becomes aware of the occurrence of any material
breach or material default (or any event or circumstance that, with or without notice, lapse of time or both, would give rise to any
material breach or material default) by any party to the Debt Commitment Letter or definitive agreement related thereto, (ii) after it
becomes aware of the receipt by Parent or Merger Subsidiary or any of their Affiliates or Representatives of any notice or other communication
from any Person with respect to any (A) actual or potential material breach, material default, termination (other than in accordance
with its terms) or repudiation by any party to the Debt Commitment Letter or any definitive agreement related thereto or any provision
of the financing contemplated pursuant to the Debt Commitment Letter or any definitive agreement related thereto (including any proposal
by any lender named in the Debt Commitment Letter to withdraw, terminate or make a material change in the terms of (including the amount
of financing contemplated by) the Debt Commitment Letter) or (B) material dispute or disagreement between or among any parties to the
Debt Commitment Letter or any definitive agreement related thereto, and (iii) if for any reason Parent or Merger Subsidiary believes
in good faith that (A) there is (or there is reasonably likely to be) a material dispute or disagreement between or among any parties
to the Debt Commitment Letter or any definitive agreement related thereto or (B) there is a material possibility that it will not be
able to obtain all or any portion of the financing contemplated in the Debt Commitment Letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Covenants of Parent and the Company</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
8.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory Authorizations and Consents</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Subject
to the terms and conditions of this Agreement, (i) the Company and Parent shall use their reasonable best efforts to take, or cause to
be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to consummate the
Transactions, including preparing and filing as promptly as practicable with any Governmental Authority or other Third Party all documentation
to effect all necessary filings, notices, petitions, statements, registrations, submissions of information, applications and other documents,
including under any applicable Antitrust Laws, and (ii) the Company shall use its reasonable best efforts, and Parent shall use its reasonable
best efforts to cooperate with the Company, to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary,
proper or advisable, in obtaining and maintaining all approvals, consents, registrations, permits, authorizations and other confirmations
required to be obtained from any Governmental Authority or other Third Party that are necessary, proper or advisable to consummate the
Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) In
furtherance and not in limitation of the foregoing, each of Parent and the Company shall make an appropriate filing of a Notification
and Report Form pursuant to the HSR Act and any other filings set forth in <U>Section 8.1(b)</U> of the Company Disclosure Schedule with
respect to the Transactions as promptly as practicable and in any event within ten (10) Business Days of the date hereof and will respond
as promptly as practicable to any requests for additional information and documentary material from any Governmental Authority and to
take all other actions necessary to cause the expiration or termination of the applicable waiting periods under the HSR Act and Antitrust
Laws as soon as practicable. Parent will pay all filing fees under the HSR Act and Antitrust Laws. Neither party will, and each will
cause their respective Affiliates not to, take any action that would reasonably be expected to adversely affect or materially delay the
approval of any Governmental Authority with respect to the Transactions. Neither party will extend directly or indirectly any waiting
period under the HSR Act (including by withdrawing and refiling any filing pursuant to the HSR Act) or enter into any agreement with
a Governmental Authority to delay or not to consummate the transactions contemplated hereby, except upon mutual agreement by Parent and
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Each
party to this Agreement shall promptly notify the other parties hereto of any oral or written communication it receives from any Governmental
Authority relating to the matters that are the subject of <U>Section 8.1</U>, permit the other parties hereto to review in advance any
written communication proposed to be made by such party (or its Representatives) to any Governmental Authority and provide the other
parties hereto with copies of all correspondence, filings or other written communications between them or any of their Representatives,
on the one hand, and any Governmental Authority, on the other hand, with respect to this Agreement, subject to appropriate limitations
on the exchange of competitively sensitive information consistent with Antitrust Laws (it being understood that such information will
be made available on an outside counsel basis only). No party to this Agreement shall agree to participate in any meeting or substantive
discussion with any Governmental Authority in respect of any such filings, investigation or other inquiry unless, to the extent reasonably
practicable, it consults with the other parties hereto in advance and, to the extent reasonably practicable and permitted by such Governmental
Authority, gives the other parties hereto the opportunity to attend and participate at such meeting. Subject to the Confidentiality Agreement
and to appropriate limitations on internal valuation or the exchange of competitively sensitive information consistent with Antitrust
Laws (it being understood that such information will be made available on an outside counsel basis only), the parties to this Agreement
will coordinate and cooperate fully with each other in exchanging such information and providing such assistance as the other parties
hereto may reasonably request in connection with the foregoing and in seeking the expiration or termination of any applicable waiting
period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Parent
will, and will cause its Affiliates to, undertake reasonable best efforts to ensure that no (x) requirement for any non-action, consent
or approval of the Federal Trade Commission, the Antitrust Division of the United States Department of Justice or other Governmental
Authority, (y) decree, judgment, injunction, temporary restraining order or any other order in any Proceeding, or (z) other matter relating
to any antitrust or competition law would preclude the Closing by the End Date. In furtherance of the foregoing, the reasonable best
efforts of the Company and Parent under this <U>Section 8.1</U> shall require that either party, in connection with the receipt of any
regulatory approval, offer or agree to (i) sell or hold separate and agree to sell, divest, license or to discontinue or limit, before
or after the Closing, any assets, businesses, licenses, rights or interest in any assets or businesses of (or held by) Parent, the Company,
or any of their respective Affiliates (or to consent to any sale, or agreement to sell, license or discontinuance or limitation by Parent
or the Company, as the case may be, of any of its assets, businesses, licenses or rights, including those of their respective Affiliates)
or (ii) agree to any conditions relating to, or changes or restriction in, the operations of any such asset, businesses, licenses or
rights ((i) and (ii) hereafter, a &ldquo;<B>Divestiture Action</B>&rdquo;) to the extent necessary to prevent the issuance of an Order
or the establishment of any Law preliminarily or permanently restraining, enjoining or prohibiting the consummation of the Transactions
by the End Date. Notwithstanding anything herein to the contrary, in no event will Parent or any of its Affiliates be required to propose
or agree to (or to consent to the Company or any of its Subsidiaries proposing or agreeing to) any Divestiture Action that would, if
such Divestiture Action were taken, reasonably be expected, individually or in the aggregate with any other Divestiture Actions, to have
a materially adverse effect on the aggregate net benefits expected to be received by Parent arising from the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) In
the event any claim, action, suit, investigation or other Proceeding by any Governmental Authority or other Person is commenced which
questions the validity or legality of the Transactions under Antitrust Laws, the parties hereto agree to cooperate and use reasonable
best efforts to defend against such claim, action, suit, investigation or other Proceeding and, if any decree, judgment, injunction or
other order is issued in any such action, suit or other Proceeding, to use reasonable best efforts to have such injunction or other order
vacated, lifted, reversed or overturned and to cooperate reasonably regarding any other impediment to the consummation of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
8.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy Statement and Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) As
soon as reasonably practicable following the date hereof, (i) the Company and Parent shall cooperate in preparing, and the Company shall
file with the SEC the Proxy Statement relating to the matters to be submitted to holder of Company Stock at the Company Stockholder Meeting,
and (ii) the Company and Parent shall cooperate in preparing, and Parent shall file with the SEC, the Registration Statement (of which
the Proxy Statement will be a part). The Company and Parent shall use reasonable best efforts to cause the Registration and the Proxy
Statement to be filed with the SEC no later than thirty (30) days following the date hereof. The Company shall cause the Proxy Statement,
and Parent shall cause the Registration Statement, to comply as to form and substance in all material respects with Applicable Law. Each
of the Company and Parent shall use reasonable best efforts to ensure that none of the information supplied by it, any of its controlled
Affiliates or its or their respective Representatives for inclusion or incorporation by reference in the Proxy Statement or the Registration
Statement shall, (A) in the case of the Proxy Statement, at the time of filing with the SEC, on the date of mailing to stockholders of
the Company, or at the time of the Company Stockholders Meeting, and (B) in the case of the Registration Statement, at the time of filing
with the SEC, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they were made, not misleading, <I>provided</I>, that
(1) the Company assumes no responsibility with respect to information supplied by or on behalf of Parent, its Subsidiaries or its or
their respective Representatives for inclusion or incorporation by reference to the Proxy Statement or the Registration Statement, and
(2) Parent and Merger Subsidiary assume no responsibility with respect to any information supplied by or on behalf of the Company or
any of its Subsidiaries or its and their respective Representatives for inclusion or incorporation by reference in the Proxy Statement
or the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Parent
and the Company shall each use its commercially reasonable efforts to cause the Registration Statement to become effective under the
Securities Act as soon as practicable after such filing, and Parent shall use commercially reasonable efforts to keep the Registration
Statement effective as long as is necessary to consummate the Merger. The Company shall use commercially reasonable efforts to file with
the SEC and disseminate to the Company Stockholders the Proxy Statement in definitive form, as promptly as practicable after the date
on which the Registration Statement becomes effective (such date, the &ldquo;<B>Clearance Date</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Each
of the Company and Parent shall notify the other promptly upon the receipt of any written or oral requests by the SEC or its staff for
an amendment or supplement to the Proxy Statement or the Registration Statement, any receipt of or comments from the SEC or its staff
thereon, and responses thereto or requests by the SEC or its staff for additional information. Prior to filing or mailing the Proxy Statement
(or any amendment or supplement thereto) or filing the Registration Statement (or any amendment or supplement thereto), or responding
to any comments of the SEC with respect to any of the foregoing, each of the Company and Parent (i) will provide the other with a reasonable
opportunity to review and comment on such document or response (including the proposed final version of such document or response), (ii)
will include in such document or response all comments reasonably proposed by the other, and (iii) will not file or mail such document
or respond to the SEC prior to receiving the approval of the other, which approval shall not be unreasonably withheld, conditioned or
delayed; provided, however, that with respect to documents filed by a party that are incorporated by reference in the Proxy Statement
or the Registration Statement, this right of approval shall apply only with respect to information relating to the other party, its Subsidiaries
and its Affiliates, their business, financial condition or results of operations or the Transactions. If, prior to the Company Stockholder
Meeting, any event occurs with respect to Company or any Subsidiary of Company, on the one hand, or Parent or Merger Subsidiary, on the
other hand, or any change occurs with respect to information supplied by or on behalf of Company or Parent, respectively, for inclusion
in the Proxy Statement or the Registration Statement or any information relating to Company, Parent or any of their Representatives shall
be discovered by Company, Parent or Merger Subsidiary, that, in each case, is required to be described in an amendment of, or a supplement
to, the Proxy Statement or the Registration Statement, Company or Parent, as applicable, shall promptly notify the other of such event,
and Company and Parent shall cooperate in the prompt filing with the SEC of any necessary amendment or supplement to the Proxy Statement
or the Registration Statement so that the Proxy Statement or the Registration Statement would not include any misstatement of a material
fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were
made, not misleading, and, as required by Applicable Law, in disseminating the information contained in such amendment or supplement
to Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Parent
and the Company shall each make all necessary filings with respect to the Merger and the Transactions under the 1933 Act and 1934 Act
and applicable state securities laws and the rules and regulations thereunder, except qualifying to do business in any jurisdiction in
which it is not now so qualified or filing a general consent to service of process in any such jurisdiction. Parent will advise the Company,
promptly after it receives notice thereof, of the time when the Registration Statement has become effective or any supplement or amendment
has been filed, the issuance of any stop order or the suspension of the qualification of the Parent Common Stock issuable in connection
with the Merger for offer or sale in any jurisdiction. Parent will use commercially reasonable efforts to have any such stop order or
suspension lifted, reversed or otherwise terminated (and the Company will cooperate as may be reasonably requested by Parent in writing
in connection therewith).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
8.3 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Announcements. <FONT STYLE="font-style: normal">Parent
and the Company have agreed to the text of the joint press release announcing the signing of this Agreement. Parent and the Company shall
consult with each other before issuing any press release, having any communication with the press (whether or not for attribution), making
any other public statement or scheduling any press conference or conference call with investors or analysts with respect to this Agreement
or the Transactions and, except in respect of any public statement or press release as may be required by Applicable Law or any listing
agreement with or rule of the Nasdaq Capital Market, shall not issue any such press release or make any such other public statement or
schedule any such press conference or conference call without the consent of the other party; </FONT><I>provided</I> <FONT STYLE="font-style: normal">that
this <U>Section 8.3</U> shall not restrict the Company from taking any actions expressly permitted under this Agreement in connection
with any Acquisition Proposal or Intervening Event.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
8.4 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further Assurances. <FONT STYLE="font-style: normal">At
and after the Effective Time, the officers and directors of the Surviving Corporation shall be authorized to execute and deliver, in
the name and on behalf of the Company or Merger Subsidiary, any deeds, bills of sale, assignments or assurances and to take and do, in
the name and on behalf of the Company or Merger Subsidiary, any other actions and things to vest, perfect or confirm of record or otherwise
in the Surviving Corporation any and all right, title and interest in, to and under any of the rights, properties or assets of the Company
acquired or to be acquired by the Surviving Corporation as a result of, or in connection with, the Merger.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
8.5 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices of Certain Events. <FONT STYLE="font-style: normal">To
the extent reasonably practicable and permitted by Applicable Law, each of the Company and Parent shall promptly notify the other of:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) any
notice or other communication from any Person alleging that the consent of such Person is or may be required in connection with the Transactions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) subject
to <U>Section 8.1</U>, any notice or other communication from any Governmental Authority in connection with the Transactions; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) any
Proceeding commenced or threatened against or otherwise affecting the Company or any of its Subsidiaries that would reasonably be expected,
individually or in the aggregate, to be materially adverse to the Company and its Subsidiaries, taken as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
8.6 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 16 Matters. <FONT STYLE="font-style: normal">Prior
to the Effective Time, the Company, the Company Board and Parent shall use reasonable best efforts as may be required to cause the Transactions
and any disposition of Company Stock (including derivative securities with respect to Company Stock) or acquisition of Parent Common
Stock, in connection with the Transactions by each individual who is subject to the reporting requirements of Section 16(a) of the 1934
Act with respect to the Company to be exempt under Rule 16b-3 promulgated under the 1934 Act.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
8.7 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction Litigation. <FONT STYLE="font-style: normal">The
Company shall notify Parent promptly of the commencement of any stockholder litigation brought or threatened in writing against the Company,
any of its Subsidiaries or any of their respective present or former directors or officers arising out of or relating to this Agreement
or the Transactions (&ldquo;<B>Transaction Litigation</B>&rdquo;) and shall keep Parent reasonably and promptly informed (including by
providing copies of all pleadings with respect thereto) with respect to the status thereof. The Company shall not settle or offer to
settle any Transaction Litigation without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned
or delayed). The Company shall (a) give Parent reasonable opportunity to participate in the defense or settlement of any Transaction
Litigation, (b) consult in good faith with Parent with respect to the defense, settlement and prosecution of any Transaction Litigation,
and (c) direct its counsel to consider in good faith Parent&rsquo;s advice, comments, recommendations and suggestions relating to proposed
strategy and other significant decisions with respect to such Transaction Litigation. The Company shall not cooperate with any Person
that may seek to restrain, enjoin, prohibit or otherwise oppose the Transactions, and the Company shall consider in good faith Parent&rsquo;s
advice and recommendations with respect to any such effort to restrain, enjoin, prohibit or otherwise oppose the Transactions.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
8.8 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeover Laws. <FONT STYLE="font-style: normal">If
the restrictions on business combinations in any Takeover Law (or provision in the certificate of incorporation or bylaws of the Company)
becomes, or may purport to be, applicable to this Agreement or the Transactions, each of Parent, Merger Subsidiary and the Company and
the members of their respective Boards of Directors shall use their respective reasonable best efforts to grant such approvals and take
such actions as are necessary so that the Transactions may be consummated by the date required by <U>Section 2.1(b)</U> on the terms
and conditions contemplated hereby and otherwise act to lawfully eliminate the restrictions on business combinations contained in any
Takeover Law (or provision in the certificate of incorporation or bylaws of the Company).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
8.9 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Exchange Listing; Delisting and Deregistration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Parent
shall use commercially reasonable efforts to cause the shares of Parent Common Stock to be issued in connection with the Merger to be
listed on the Nasdaq Stock Market (&ldquo;<B>Nasdaq</B>&rdquo;), subject to official notice of issuance, prior to the Effective Time,
and the Company shall reasonably cooperate with Parent in connection therewith, including by providing all information reasonably requested
by Parent in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) During
the period between the date of this Agreement and the Effective Time, the Company shall cooperate with Parent and use its reasonable
best efforts to take, or cause to be taken, all actions, and do or cause to be done all things, reasonably necessary, proper or advisable
on its part under Applicable Laws and rules and policies of the Nasdaq Capital Market to enable the delisting by the Surviving Corporation
of the Company Stock from the Nasdaq Capital Market and the deregistration of the Company Stock under the 1934 Act as promptly as practicable
after the Effective Time, and in any event no more than the first Business Day that occurs ten (10) days after the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Conditions to the Merger</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
9.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to the Obligations of Each Party.
<FONT STYLE="font-style: normal">The obligations of the Company, Parent and Merger Subsidiary to consummate the Merger are subject to
the satisfaction or waiver (where permissible pursuant to Applicable Law) of the following conditions:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) the
Company Stockholder Approval shall have been obtained;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) no
Governmental Authority of competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any Applicable Law (whether
temporary, preliminary or permanent) that restrains, enjoins or otherwise prohibits the consummation of the Merger that is still in effect;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) (i)
any applicable waiting periods (and any extensions thereof) applicable to the Transactions under the HSR Act, and any commitment to,
or agreement with, any Governmental Authority in the United States to delay the consummation of, or not to consummate before a certain
date, the transactions contemplated by this Agreement, shall have expired or been terminated, and (ii) any approvals, consents, registrations,
permits, authorizations and other confirmations required to be obtained from any Governmental Authority under Antitrust Laws shall have
been obtained or deemed obtained and shall remain in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) the
Registration Statement shall have been declared effective by the SEC under the Securities Act, and no stop order suspending the Registration
Statement shall have been issued by the SEC; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) the
shares of Parent Common Stock to be issued in connection with the Merger shall have been approved for listing on Nasdaq, subject to official
notice of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
9.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to the Obligations of Parent and Merger
Subsidiary</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The obligations of Parent and Merger Subsidiary to consummate the Merger are subject to the satisfaction or waiver (where permissible
under Applicable Law) of the following further conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) the
Company shall have performed in all material respects all of its obligations hereunder required to be performed by it at or prior to
the Effective Time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) (i)
all of the representations and warranties of the Company contained in the first and second sentence of <U>Section 4.5(a)</U>, the second
sentence of <U>Section 4.5(b)</U>, and the first sentence of <U>Section 4.5(c)</U> shall have been true and correct in all respects as
of the date of this Agreement and shall be true and correct in all respects (except, with respect to the second sentence of <U>Section
4.5(a)</U> and the second sentence of <U>Section 4.5(b)</U>, for any de minimis inaccuracies) at and as of the Effective Time as if made
at and as of such time (other than representations and warranties that by their terms address matters only as of another specified time,
which shall be true only as of such time), (ii) all of the representations and warranties of the Company contained in <U>Section 4.1</U>,
<U>Section 4.2</U> and <U>Section 4.23</U> (disregarding all materiality and Material Adverse Effect qualifications contained therein)
shall have been true and correct in all material respects as of the date of this Agreement and shall be true and correct in all material
respects at and as of the Effective Time as if made at and as of such time (other than representations and warranties that by their terms
address matters only as of another specified time, which shall be true only as of such time) and (iii) all of the other the representations
and warranties of the Company contained in this Agreement (disregarding all materiality and Material Adverse Effect qualifications contained
therein) shall have been true and correct as of the date of this Agreement and shall be true and correct at and as of the Effective Time
as if made at and as of such time (other than representations and warranties that by their terms address matters only as of another specified
time, which shall be true only as of such time), with only such exceptions as have not had and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Since
the date of this Agreement, there shall not have been a Material Adverse Effect; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Parent
shall have received a certificate signed by an executive officer of the Company to the foregoing effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
9.3 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to the Obligations of the Company.
<FONT STYLE="font-style: normal">The obligations of the Company to consummate the Merger are subject to the satisfaction or waiver (where
permissible under Applicable Law) of the following further conditions:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) each
of Parent and Merger Subsidiary shall have performed in all material respects all of its obligations hereunder required to be performed
by it at or prior to the Effective Time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) (i)
all of the representations and warranties of Parent contained in <U>Section 5.1</U>, <U>Section 5.2</U>, and <U>Section 5.7</U> shall
have been true and correct in all material respects as of the date of this Agreement and shall be true and correct in all material respects
at and as of the Effective Time as if made at and as of such time (other than representations and warranties that by their terms address
matters only as of another specified time, which shall be true only as of such time) and (ii) all of the other representations and warranties
of Parent contained in this Agreement (disregarding all materiality and Parent Material Adverse Effect qualifications contained therein)
shall have been true and correct in all material respects as of the date of this Agreement and shall be true and correct at and as of
the Effective Time as if made at and as of such time (other than representations and warranties that by their terms address matters only
as of another specified time, which shall be true only as of such time), with only such exceptions as have not had and would not reasonably
be expected to have, individually or in the aggregate, a Parent Material Adverse Effect; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) the
Company shall have received a certificate signed by an executive officer of Parent to the foregoing effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Termination</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
10.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination. <FONT STYLE="font-style: normal">This
Agreement may be terminated and the Merger may be abandoned at any time prior to the Effective Time (notwithstanding receipt of the Company
Stockholder Approval) as follows:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) by
mutual written agreement of the Company and Parent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) by
either the Company or Parent, if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) the
Merger has not been consummated on or before July 29, 2027 (the &ldquo;<B>End Date</B>&rdquo;), which each of the Company and Parent
may extend to a date not later than January 29, 2028 if the conditions set forth in <U>Section 9.1(b)</U> (if the Applicable Law or Order
relates to Antitrust Laws) or <U>Section 9.1(c)</U> shall not have been satisfied prior to the End Date; <I>provided</I> that the right
to terminate this Agreement pursuant to this <U>Section 10.1(b)(i)</U> shall not be available to a party if the failure of the Merger
to be consummated by such time was primarily caused by the failure of such party to perform any of its obligations under this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) any
Applicable Law shall have been enacted, issued, promulgated, enforced or entered by any Governmental Authority of competent jurisdiction
that restrains, enjoins or otherwise prohibits consummation of the Merger, or any Order by a court or other Governmental Authority of
competent jurisdiction permanently restraining, enjoining or otherwise prohibiting consummation of the Merger shall have become final
and non-appealable; <I>provided</I> that the right to terminate this Agreement pursuant to this <U>Section 10.1(b)(ii)</U> shall not
be available to a party if issuance, enforcement or entry of any such Applicable Law or Order, or such Order becoming final and non-appealable,
was primarily caused by the failure of such party to perform any of its obligations under this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) at
the Company Stockholder Meeting (including any adjournment or postponement thereof), the Company Stockholder Approval shall not have
been obtained; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) by
Parent, if at any time prior to obtaining the Company Stockholder Approval, an Adverse Recommendation Change shall have occurred;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) by
the Company, if at any time prior to obtaining the Company Stockholder Approval, (i) the Company has received a Superior Proposal that
is not a result of a material breach of <U>Section 6.3 and (ii) </U>the Company concurrently enters into a definitive Alternative Acquisition
Agreement concerning such Superior Proposal and, simultaneously with such termination, the Company pays the Termination Fee payable pursuant
to <U>Section 11.4</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) by
Parent if (i) there shall have been a breach of any covenant or agreement on the part of the Company set forth in this Agreement or (ii)
any representation or warranty of the Company set forth in <U>Article 4</U> of this Agreement has become inaccurate, that would, in either
case, (A) result in the conditions set forth in <U>Section 9.2(a)</U> or <U>Section 9.2(b)</U> not being satisfied, and (B) such breach
is not curable by the End Date or, if earlier, within thirty (30) days, or, if curable, is not cured by the End Date or, if earlier,
within thirty (30) days of notice by Parent to the Company of such breach; <I>provided, </I>that the right to terminate this Agreement
pursuant to this <U>Section 10.1(e)</U> shall not be available to Parent if Parent or Merger Subsidiary is then in breach of any covenant,
agreement, representation or warranty contained in this Agreement which breach would result in a failure of a condition set forth in
<U>Section 9.1</U> or <U>Section 9.3</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) by
the Company if (i) there shall have been a breach of any covenant or agreement on the part of Parent or Merger Subsidiary set forth in
this Agreement or (ii) any representation or warranty of Parent and Merger Subsidiary set forth in <U>Article 5</U> of this Agreement
has become inaccurate, that would, in either case, (A) result in the conditions set forth in <U>Section 9.3(a)</U> or <U>Section 9.3(b)</U>
not being satisfied, and (B) such breach is not curable by the End Date or, if earlier, within thirty (30) days, or, if curable, is not
cured by the End Date or, if earlier, within thirty (30) days of notice by the Company to Parent of such breach; <I>provided, </I>that
the right to terminate this Agreement pursuant to this <U>Section 10.1(f)</U> shall not be available to the Company if the Company is
then in breach of any covenant, agreement, representation or warranty contained in this Agreement which breach would result in a failure
of a condition set forth in <U>Section 9.1</U> or <U>Section 9.2</U>; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) by
the Company if (i) all of the conditions set forth in <U>Section 9.1</U> and <U>Section 9.2</U> (other than conditions that by their
nature are to be satisfied at the Closing, so long as such conditions are capable of being satisfied at such time as if such time were
the Closing) have been satisfied, (ii) Parent fails to consummate the Merger by the date on which Parent is required to consummate the
Closing pursuant to <U>Section 2.1(b)</U>, and (iii) the Company has irrevocably confirmed to Parent in writing (that has not been withdrawn
or revoked) that (A) all of the conditions set forth in <U>Section 9.1</U> and <U>Section 9.3</U> (other than conditions that by their
nature are to be satisfied at the Closing, so long as such conditions are capable of being satisfied at such time as if such time were
the Closing) have been satisfied or, to the extent permissible, waived by the Company, and (B) the Company is prepared, willing and able
to consummate the Closing, (iv) the Company shall have given Parent written notice at least three (3) Business Days prior to such termination
stating the Company&rsquo;s intention to terminate this Agreement pursuant to this <U>Section 10.1(g)</U> and (v) Parent fails to consummate
the Merger within three (3) Business Days following the delivery of such notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
party desiring to terminate this Agreement pursuant to this <U>&lrm;Section 10.1</U> (other than pursuant to &lrm;<U>Section 10.1(a)</U>)
shall give written notice of such termination to the other party specifying the provisions hereof pursuant to which such termination
is being effected and describing the basis therefor in reasonable detail. Except as otherwise set forth above, any valid termination
of this Agreement by either the Company or Parent pursuant to <U>Section 10.1</U> shall be effective immediately upon the delivery of
such written notice by the terminating party to the other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
10.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of Termination. <FONT STYLE="font-style: normal">If
this Agreement is validly terminated pursuant to <U>Section 10.1</U>, this Agreement shall become void and of no effect and the Transactions
shall be abandoned without liability of any party (or any stockholder or Representative of such party) to any other party hereto; </FONT><I>provided</I>
<FONT STYLE="font-style: normal">that:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
provisions of this <U>&lrm;Section 10.2</U>, the indemnification and reimbursement obligations in <U>Section 6.7(c)</U>, <U>Section 8.3</U>,
and <U>Article 11</U> (and the corresponding definitions of any defined terms used in each of those sections) shall survive any termination
hereof pursuant to &lrm;<U>Section 10.1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Neither
the Company nor Parent shall be relieved or released from any liabilities or obligations (which the parties acknowledge and agree shall
not be limited to reimbursement of expenses or out-of-pocket costs, and may include the benefit of the bargain lost the non-breaching
party (taking into consideration, to extent proven, opportunity costs, the time value of money and, in the case of the Company as the
non-breaching party, the Merger Consideration payable to the Company&rsquo;s stockholders) arising out of its Willful Breach or fraud
prior to such termination. For purposes of this Agreement, &ldquo;<B>Willful Breach</B>&rdquo; means a material breach of this Agreement
that is the consequence of a deliberate action or omission by any party if such party has actual knowledge that the taking of such action
or the failure to take such action would be a material breach of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article
11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Miscellaneous</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.1 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
All notices, requests and other communications to any party hereunder shall be in writing (including electronic mail (&ldquo;<B>e-mail</B>&rdquo;)
transmission, so long as a receipt of such e-mail is requested and received) and shall be given,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
to the Company, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
MedTech Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1200
Summit Avenue, Suite 414</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fort Worth, Texas 76102</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Seth Yon</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail: <U>syon@sanaramedtech.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alston
&amp; Bird LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Atlantic Center</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1201 West Peachtree Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Atlanta, GA 30309</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: J. Mark Ray; Kyle G. Healy; Tyler W. Pate</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:  mark.ray@alston.com; kyle.healy@alston.com; tyler.pate@alston.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
to the Parent or Merger Subsidiary, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MiMedx
Group, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1775
West Oak Commons Ct. NE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>Marietta, GA 30062</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">Attention: William &ldquo;Butch&rdquo; Hulse</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">E-mail: <U>BHulse@mimedx.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greenberg
Traurig, P.A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">401 East Las Olas Blvd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite
2000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>Fort Lauderdale, FL 33301</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">Attention: Flora Perez and Matthew Miller</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">E-mail: <U>perezf@gtlaw.com; millerma@gtlaw.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
to such other address as such party may hereafter specify for the purpose by notice to the other parties hereto. All such notices, requests
and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00 p.m. on a
Business Day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed to have been received on the
next succeeding Business Day in the place of receipt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.2 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Survival of Representations, Warranties and
Agreements. <FONT STYLE="font-style: normal">The representations, warranties and agreements contained herein and in any certificate or
other writing delivered pursuant hereto shall not survive the Effective Time, except that any covenants and agreements that are to be
performed in whole or in part after the Effective Time shall survive the Effective Time for the longest period permitted by Texas law.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.3 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments and Waivers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Any
provision of this Agreement may be amended or waived prior to the Effective Time if, but only if, such amendment or waiver is in writing
and is signed, in the case of an amendment, by each party to this Agreement or, in the case of a waiver, by each party against whom the
waiver is to be effective; <I>provided</I> that after the Company Stockholder Approval has been obtained there shall be no amendment
or waiver that would require the further approval of the stockholders of the Company under the TBOC without such approval having first
been obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) No
failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single
or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The
rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by Applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.4 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses and Termination Fee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <I>General</I>.
Except as otherwise provided herein, all costs and expenses incurred in connection with this Agreement shall be paid by the party incurring
such cost or expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <I>Termination
Fee</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) If
this Agreement is validly terminated by Parent pursuant to <U>Section 10.1(c)</U>, then the Company shall pay to Parent the Termination
Fee within two (2) Business Days after such termination, by wire transfer of immediately available funds to an account designated in
writing by Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) If
this Agreement is validly terminated by the Company pursuant <U>Section 10.1(d)</U>, then the Company shall pay to Parent the Termination
Fee concurrently with and as a condition to such termination, by wire transfer of immediately available funds to an account designated
in writing by Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) If
(A) this Agreement is validly terminated by Parent or the Company pursuant to &lrm;<U>Section 10.1(b)(i)</U> or <U>Section 10.1(b)(iii)
or by Parent pursuant to Section 10.1(e)</U>; <I>provided</I> that in the case of termination by the Company pursuant to &lrm;<U>Section
10.1(b)(i)</U>, the failure of the Merger to be consummated by the End Date did not result from a breach by Parent of any covenant, agreement,
representation or warranty contained in this Agreement which breach has resulted in a failure of a condition set forth in <U>Section
9.1</U> or <U>Section 9.3</U>, (B) after the date of this Agreement and (x) prior to such termination in the case of a termination pursuant
to <U>Section 10.1(b)(i)</U> or <U>Section 10.1(e)</U> or (y) prior to the Company Stockholder Meeting in the case of a termination pursuant
to <U>Section 10.1(b)(iii)</U>, an Acquisition Proposal shall have been publicly announced or otherwise been communicated to the Company
or the Company&rsquo;s stockholders (in either case, whether or not withdrawn), and (C) within twelve (12) months following the date
of such termination, (x) the Company shall have entered into an agreement, arrangement or understanding with respect to an Acquisition
Proposal which is subsequently consummated or (y) an Acquisition Proposal shall have been consummated (<I>provided</I> that, for purposes
of this clause &lrm;(C), each reference to &ldquo;20%&rdquo; in the definition of Acquisition Proposal shall be deemed to be a reference
to &ldquo;50%&rdquo;), then the Company shall pay to Parent the Termination Fee, in immediately available funds to an account designated
in writing by Parent, immediately prior to the consummation of such Acquisition Proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) &ldquo;<B>Termination
Fee</B>&rdquo; means $9,660,336.00.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) The
parties agree and acknowledge that in no event shall the Company be required to pay the Termination Fee on more than one occasion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <I>Parent
Termination Fee</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) If
this Agreement is validly terminated by the Company pursuant to &lrm;<U>Section 10.1(g)</U>, then Parent shall pay to the Company the
Parent Termination Fee within two (2) Business Days after such termination, by wire transfer of immediately available funds to an account
designated in writing by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) &ldquo;<B>Parent
Termination Fee</B>&rdquo; means $22,540,785.00.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Each
party acknowledges that the agreements contained in this <U>Section 11.4</U> are an integral part of the Transactions and that, without
these agreements, the other parties would not enter into this Agreement. Accordingly, if the Company fails promptly to pay any amount
due pursuant to &lrm;<U>Section 11.4(b)</U> and Parent commences a legal Proceeding against the Company to enforce this Agreement that
results in a judgment against the Company for such amount, or if Parent commences a legal Proceeding against the Company as contemplated
by <U>Section 11.4(f)</U> that results in a judgment for monetary damages against the Company, the Company shall also pay any costs and
expenses incurred by Parent in connection with such legal Proceeding, together with interest on the amount of any unpaid fee, judgment,
cost or expense at the publicly announced prime rate as published by the Eastern Edition of The Wall Street Journal (the &ldquo;<B>Prime
Rate</B>&rdquo;) from the date such fee, judgment, cost or expense was required to be paid to (but excluding) the payment date (collectively,
the &ldquo;<B>Parent Enforcement Expenses</B>&rdquo;). If Parent fails promptly to pay any amount due pursuant to <U>Section 11.4(c)</U>
and the Company commences a legal Proceeding against Parent to enforce this Agreement that results in a judgment against Parent for such
amount, or if the Company commences a legal Proceeding against Parent or Merger Subsidiary as contemplated by <U>Section 11.4(e)</U>
that results in a judgment for monetary damages against Parent or Merger Subsidiary, Parent shall also pay any costs and expenses incurred
by the Company in connection with such Proceeding, together with interest on the amount of any unpaid fee, judgment, cost or expense
at the Prime Rate from the date such fee, judgment, cost or expense was required to be paid to (but excluding) the payment date (collectively,
the &ldquo;<B>Company Enforcement Expenses</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 75; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Notwithstanding
anything to the contrary in this Agreement, in the event that Parent and Merger Subsidiary fail to effect the Closing as and when required
pursuant to <U>Section 2.1(b)</U> or otherwise breach this Agreement or fail to perform hereunder (whether willfully, intentionally,
unintentionally or otherwise), then, except for an order of specific performance prior to the termination of this Agreement as permitted
by <U>Section 11.12</U>, (i) the Company&rsquo;s sole and exclusive remedy (whether at law, in equity, in contract, in tort or otherwise)
against (A) Parent and Merger Subsidiary, (B) the former, current and future holders of any equity, partnership or limited liability
company interest, controlling persons, directors, officers, employees, agents, attorneys, Affiliates, members, managers, general or limited
partners, stockholders or assignees of Parent or Merger Subsidiary or (C) any future holders of any equity, partnership or limited liability
company interest, controlling persons, directors, officers, employees, agents, attorneys, Affiliates, members, managers, general or limited
partners, stockholders or assignees of any of the foregoing (collectively, the &ldquo;<B>Parent Group</B>&rdquo;) in respect of this
Agreement, any agreement executed in connection herewith, and the transactions contemplated hereby and thereby shall be (I) to terminate
this Agreement in accordance with <U>Article 10</U> and collect, if due, the Parent Termination Fee pursuant to <U>Section 11.4(c)</U>
(including any Company Enforcement Expenses) from Parent, and (II) following the termination of this Agreement by either party, the Company&rsquo;s
right to seek monetary damages (including any Company Enforcement Expenses) from Parent in the event of Parent&rsquo;s or Merger Subsidiary&rsquo;s
Willful Breach or fraud prior to the termination of this Agreement and (ii) upon payment of such amounts, no member of the Parent Group
shall have any further liability or obligation relating to or arising out of this Agreement, any agreement executed in connection herewith,
or the transactions contemplated hereby or thereby; <I>provided</I>, that, if the Company accepts the Parent Termination Fee pursuant
to <U>Section 11.4(c)</U> (plus any Company Enforcement Expenses that may be owing Company) from Parent, the acceptance thereof by the
Company shall be deemed to be liquidated damages for any and all losses or damages suffered or incurred by the Company in connection
with this Agreement and the Transactions (including as a result of Parent&rsquo;s or Merger Subsidiary&rsquo;s Willful Breach or fraud),
and the Company shall not thereafter be entitled to bring or maintain any Proceeding or make any claim against Parent, Merger Subsidiary
or any other member of the Parent Group for monetary damages); and <I>provided</I>, <I>further</I>, that in no event will the Company
be entitled to (x) payment of both monetary damages and the Parent Termination Fee or (y) both (1) payment of any monetary damages and/or
the Parent Termination Fee and (2) a grant of specific performance of this Agreement or any other equitable remedy against Parent or
Merger Subsidiary that results in the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Notwithstanding
anything to the contrary in this Agreement, in the event that the Company fails to effect the Closing as and when required pursuant to
<U>Section 2.1(b)</U> or otherwise breaches this Agreement or fails to perform hereunder (whether willfully, intentionally, unintentionally
or otherwise), then, except for an order of specific performance prior to the termination of this Agreement as permitted by <U>Section
11.12</U>, (i) Parent&rsquo;s and Merger Subsidiary&rsquo;s sole and exclusive remedy (whether at law, in equity, in contract, in tort
or otherwise) against (A) the Company and its Subsidiaries, (B) the former, current and future holders of any equity, partnership or
limited liability company interest, controlling persons, directors, officers, employees, agents, attorneys, Affiliates, members, managers,
general or limited partners, stockholders or assignees of the Company or its Subsidiaries or (C) any future holders of any equity, partnership
or limited liability company interest, controlling persons, directors, officers, employees, agents, attorneys, Affiliates, members, managers,
general or limited partners, stockholders or assignees of any of the foregoing (collectively, the &ldquo;<B>Company Group</B>&rdquo;)
in respect of this Agreement, any agreement executed in connection herewith and the transactions contemplated hereby and thereby shall
be (I) to terminate this Agreement in accordance with <U>Article 10</U> and collect, if due, the Termination Fee pursuant to <U>Section
11.4(b)</U> (including any Parent Enforcement Expenses) from the Company, and (II) following the termination of this Agreement by either
party, Parent&rsquo;s right to seek monetary damages from the Company in the event of the Company&rsquo;s Willful Breach or fraud prior
to the termination of this Agreement and (ii) upon payment of such amounts, no member of the Company Group shall have any further liability
or obligation relating to or arising out of this Agreement, any agreement executed in connection herewith or the transactions contemplated
hereby or thereby; <I>provided</I>, that, if Parent accepts the Termination Fee pursuant to <U>Section 11.4(b)</U> (plus any Parent Enforcement
Expenses that may be owing Parent) from the Company, the acceptance thereof by Parent shall be deemed to be liquidated damages for any
and all losses or damages suffered or incurred by Parent in connection with this Agreement and the Transactions (including as a result
of the Company&rsquo;s Willful Breach or fraud), and Parent shall not thereafter be entitled to bring or maintain any Proceeding or make
any claim against the Company, any of its Subsidiaries or any other member of the Company Group for monetary damages); and <I>provided</I>,
<I>further</I>, that in no event will Parent and Merger Subsidiary be entitled to (1) payment of both monetary damages and the Termination
Fee, or (2) both (x) payment of any monetary damages and/or the Termination Fee and (y) a grant of specific performance of this Agreement
or any other equitable remedy against the Company that results in the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 76; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.5 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Binding Effect; Benefit; Assignment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Except
as set forth in <U>Section 7.4</U> and <U>Section 10.2(b)</U>, the parties agree that their respective representations, warranties and
covenants set forth in this Agreement are solely for the benefit of the other parties in accordance with and subject to the terms of
this Agreement. This Agreement is not intended to, and will not, confer upon any other Person any rights or remedies hereunder, except
(i) as set forth in or contemplated by <U>Section 7.4</U>; and (ii) from and after the Effective Time, the rights of the holders of shares
of Company Restricted Stock and Company Options to receive the Restricted Stock Consideration or Option Consideration as set forth in
<U>Article 2, as applicable</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) No
party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of each other
party hereto, except that Parent or Merger Subsidiary may transfer or assign its rights and obligations under this Agreement without
the consent of the Company, in whole or from time to time in part, (i) to one or more of their Affiliates at any time; (ii) as security
for any financing, including, without limitation, the Debt Financing, at any time; and (iii) after the Effective Time, to any Person;
<I>provided</I> that such transfer or assignment shall not relieve Parent or Merger Subsidiary of its obligations hereunder or enlarge,
alter or change any obligation of any other party hereto or due to Parent or Merger Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.6 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing Law</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
This Agreement, and all Proceedings (whether in contract, in tort or otherwise) that may be based upon, arise out of or relate to this
Agreement, or the negotiation, execution or performance of this Agreement or the Transactions, shall be governed by and construed in
accordance with the laws of the State of Texas, without regard to the conflicts of law rules of such state.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.7 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction. <FONT STYLE="font-style: normal">All
Proceedings (whether at law, in contract, in tort or otherwise) arising out of or relating to this Agreement, the negotiation, validity
or performance of this Agreement or the Transactions shall be heard and determined exclusively in Texas State court located in Dallas,
Texas or, to the extent such court does not have jurisdiction, the U.S. District Court for the Northern District of Texas (Dallas Division),
and the parties irrevocably submit to the exclusive jurisdiction of such court (and, in the case of appeals, the appropriate appellate
court therefrom), in any such Proceeding and irrevocably waive the defense of an inconvenient forum to the maintenance of any such Proceeding.
The consents to jurisdiction set forth in this paragraph shall not constitute general consents to service of process in the State of
Texas and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed to confer rights on any Person
other than the parties hereto. The parties agree that service of any court paper may be made in any manner as may be provided under Applicable
Law or court rules governing service of process in such court. The parties hereto agree that a final judgment in any such Proceeding
shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Applicable
Law.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 77; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.8 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WAIVER OF JURY TRIAL. <FONT STYLE="font-style: normal">EACH
OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING ARISING OUT OF OR RELATED TO THIS
AGREEMENT, THE GUARANTEE OR THE TRANSACTIONS.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.9 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts; Effectiveness. <FONT STYLE="font-style: normal">This
Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument. Any such counterpart, to the extent delivered by .pdf, .tif, .gif, .jpeg or similar
attachment to electronic mail (any such delivery, an &ldquo;<B>Electronic Delivery</B>&rdquo;) shall be treated in all manner and respects
as an original counterpart and shall be considered to have the same binding legal effect as if it were the original signed version thereof
delivered in person. No party hereto shall raise the use of Electronic Delivery to deliver a signature or the fact that any signature
or agreement or instrument was transmitted or communicated through the use of Electronic Delivery as a defense to the formation of a
contract, and each such party forever waives any such defense, except to the extent such defense relates to lack of authenticity. This
Agreement shall become effective when each party hereto shall have received a counterpart hereof signed by all of the other parties hereto.
Until and unless each party has received a counterpart hereof signed by the other party hereto, this Agreement shall have no effect and
no party shall have any right or obligation hereunder (whether by virtue of any other oral or written agreement or other communication).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.10 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire Agreement. <FONT STYLE="font-style: normal">This
Agreement and the Confidentiality Agreement constitute the entire agreement between the parties with respect to the subject matter of
this Agreement and supersede all prior agreements and understandings, both oral and written, between the parties with respect to the
subject matter of this Agreement.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.11 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability. <FONT STYLE="font-style: normal">If
any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction or other Governmental Authority
to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain
in full force and effect and shall in no way be affected, impaired or invalidated so long as the economic or legal substance of the Transactions
is not affected in any manner materially adverse to any party. Upon such a determination, the parties shall negotiate in good faith to
modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner in order that
the Transactions be consummated as originally contemplated to the fullest extent possible.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 78; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.12 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific Performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
parties hereto agree that irreparable damage would occur in the event any provision of this Agreement were not performed in accordance
with the terms hereof and that any breach of this Agreement would not be adequately compensated by monetary damages, and that the parties
shall be entitled to an injunction or injunctions to prevent breaches of this Agreement or to enforce specifically the performance of
the terms and provisions hereof, without proof of actual damages or inadequacy of legal remedy and without bond or other security being
required, in addition to any other remedy to which they are entitled at law or in equity. The pursuit of specific enforcement by any
party hereto will not be deemed an election of remedies or waiver of the right to pursue any other right or remedy (whether at law or
in equity) to which such party may be entitled at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Notwithstanding
anything herein to the contrary, it is acknowledged and agreed that the Company shall be entitled to seek specific performance of Parent&rsquo;s
obligations to consummate the Merger if and only if (i) all of the conditions set forth in <U>Section 9.1</U> and <U>Section 9.2</U>
(other than conditions that by their nature are to be satisfied at the Closing, so long as such conditions are capable of being satisfied
at such time as if such time were the Closing) have been satisfied as of the time when the Closing is required to have occurred pursuant
to <U>Section 2.1(b)</U>, (ii) the proceeds of the Debt Financing have been funded (or will be funded in accordance with the terms thereof
at the Closing) in accordance with the terms of the Debt Commitment Letter, (iii) Parent fails to consummate the Merger by the date that
is three (3) Business Days after the date on which Parent is required to consummate the Closing pursuant to <U>Section 2.1(b)</U>, and
(iv) the Company has irrevocably confirmed to Parent in writing (that has not been withdrawn or revoked) that (A) all of the conditions
set forth in <U>Section 9.1</U> and <U>Section 9.3</U> (other than conditions that by their nature are to be satisfied at the Closing,
so long as such conditions are capable of being satisfied at such time as if such time were the Closing) have been satisfied or, or the
extent legally permitted, waived by the Company, (B) the Company is prepared, willing and able to consummate the Closing, and (C) the
Closing will occur pursuant to <U>Article 2</U> if specific performance is granted and the Debt Financing is funded in accordance with
the Debt Commitment Letter. For the avoidance of doubt, while the Company shall have the right to seek (i) an injunction, specific performance
or other equitable remedies in accordance with this <U>Section 11.12</U> and (ii) payment of the Parent Termination Fee pursuant to <U>Section
11.4(c)</U>, under no circumstances shall the Company, directly or indirectly, be permitted or entitled to receive both (A) a grant of
specific performance or other equitable relief to cause the Closing to be consummated and the aggregate Per Share Merger Consideration
to be paid, on the one hand, and (B) payment of the Parent Termination Fee and any Company Enforcement Expenses (if any), on the other
hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.13 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Recourse. <FONT STYLE="font-style: normal">This
Agreement may only be enforced against, and any claims or causes of action that may be based upon, arise out of or relate to this Agreement,
or the negotiation, execution or performance of this Agreement may only be made against the entities that are expressly identified as
parties hereto and no member of the Company Group and no member of the Parent Group shall have any liability for any obligations or liabilities
of the parties to this Agreement or for any claim (whether in tort, contract or otherwise) based on, in respect of, or by reason of,
the Transactions or in respect of any oral representations made or alleged to be made in connection herewith. In no event shall the Company
or any of its Affiliates or other member of the Company Group, on the one hand, and Parent, Merger Subsidiary or any of their respective
Affiliates or other member of the Parent Group on the other hand, and each member of the Company Group and each member of the Parent
Group agrees not to and to use commercially reasonable efforts to cause its respective controlled Affiliates and other members of the
Company Group or other members of the Parent Group, as applicable, not to, seek to enforce this Agreement against, make any claims for
breach of this Agreement against, or seek to recover monetary damages from, any member of the Parent Group or any member of the Company
Group, as applicable, that is not a party to this Agreement.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 79; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Section
11.14 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt Financing Sources. <FONT STYLE="font-style: normal">Notwithstanding
anything herein to the contrary, the parties hereby agree that (a) no Debt Financing Source shall have any liability (whether in contract
or in tort, in law or in equity, or granted by statute) for any claims, causes of action, obligations or losses arising under, out of,
in connection with or related in any manner to this Agreement or based on, in respect of or by reason of this Agreement or its negotiation,
execution, performance or breach (provided that nothing in this <U>Section 11.14</U> shall limit the liability or obligations of such
Debt Financing Source under any Debt Commitment Letter, the fee letter related thereto, any credit agreement or any other documents governing
or evidencing the Debt Financing or any other financing provided by any Debt Financing Source); (b) except as may be set forth in any
Debt Commitment Letter, the fee letter related thereto, any credit agreement or any other documents governing or evidencing the Debt
Financing, any credit facilities or other financing provided by any Debt Financing Source, any action of any kind or description (whether
at law, in equity, in contract, in tort or otherwise) involving any Debt Financing Source arising out of, in connection with, or relating
to the Debt Financing, or the performance of services thereunder shall be subject to the exclusive jurisdiction of a state or federal
court sitting in the City of New York (Borough of Manhattan), State of New York (and any appellate court thereof); (c) any interpretation
of any agreements related to the Debt Financing will be governed by, and construed and interpreted in accordance with, the laws of the
State of New York, without regard to principles of conflict of laws; (d) no party hereto will bring, permit any of their respective controlled
Affiliates to bring, or support anyone else in bringing, any such Action in any other court; (e) the waiver of rights to trial by jury
set forth in <U>Section 11.8</U> applies to any such legal proceeding; (f) only Parent (including their permitted successors and assigns)
and the other parties to any Debt Commitment Letter, the fee letter related thereto, any credit agreement or any other agreements governing
the Debt Financing at their own direction shall be permitted to bring any claim against a Debt Financing Source for failing to satisfy
any obligation to fund the Debt Financing pursuant to the terms of any such agreement; (g) no amendment or waiver of this <U>Section
11.14</U>, <U>Section 11.5</U>, <U>Section 11.8</U> or any of the defined terms used herein or therein, including, but not limited to,
the definitions of &ldquo;Debt Financing&rdquo; or &ldquo;Debt Financing Sources&rdquo; that is materially adverse to the Debt Financing
Sources in their capacity as such shall be effective without the prior written consent of the lenders party to the agreements governing
the Debt Financing to which such amendment is materially adverse; and (h) the Debt Financing Sources are express and intended third party
beneficiaries of this <U>Section 11.14</U>, <U>Section 11.5</U>, <U>Section 11.8</U> and any of the provisions in this Agreement reflecting
the foregoing.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The
remainder of this page has been intentionally left blank;<BR>
the next page is the signature page.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the
date set forth on the cover page of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SANARA MEDTECH INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Seth D. Yon</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth
D. Yon</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MIMEDX GROUP, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Joseph H. Capper</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    H. Capper</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MUSTANG MERGER SUB, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    William &ldquo;Butch&rdquo; Hulse</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    &ldquo;Butch&rdquo; Hulse</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page to Merger Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<!-- Field: Page; Sequence: 81; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VOTING
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
VOTING AGREEMENT, dated as of July 29, 2026 (this &ldquo;<U>Agreement</U>&rdquo;), is entered into by and among MiMedx Group, Inc. (&ldquo;<U>Parent</U>&rdquo;),
Sanara MedTech Inc. (the &ldquo;<U>Company</U>&rdquo;) and each Person identified on <U>Exhibit A</U> (each a &ldquo;<U>Stockholder</U>&rdquo;
and, collectively, the &ldquo;<U>Stockholders</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
concurrently with the execution of this Agreement, Parent, Mustang Merger Sub, Inc. (&ldquo;<U>Merger Sub</U>&rdquo;); and the Company
have entered into an Agreement and Plan of Merger (the &ldquo;<U>Merger Agreement</U>&rdquo;), pursuant to which, among other things,
first, Merger Sub will merge with and into the Company, with the Company continuing as the surviving corporation of such merger (the
&ldquo;<U>Merger</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
as of the date hereof, each Stockholder either directly or through one of its affiliates is the record and beneficial owner of, and has
the right to vote and dispose of, the number of Company Common Shares set forth opposite such Stockholder&rsquo;s name on <U>Exhibit
A</U> (the &ldquo;<U>Existing Shares</U>&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
as a material inducement to Parent to enter into the Merger Agreement, Parent has requested each Stockholder to agree, and each Stockholder
has agreed, to enter into this Agreement and abide by the covenants and obligations set forth herein with respect to the Covered Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
THEREFORE</B>, in consideration of the foregoing and the mutual representations, warranties, covenants and agreements herein contained,
and intending to be legally bound hereby, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">ARTICLE
1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.1 <FONT STYLE="background-color: white"><U>Defined Terms</U></FONT>. The following capitalized terms, as used in this Agreement, shall
have the meanings set forth below. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in
the Merger Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Board</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Contemplated
Transactions</U>&rdquo; means (i) all actions and transactions contemplated by the Merger Agreement, including the Merger, and (ii) all
actions and transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Covered
Shares</U>&rdquo; means the Existing Shares, together with any Company Shares that any Stockholder acquires, either beneficially or of
record, on or after the date of this Agreement, including any Company Shares received as distributions, as a result of a split, reverse
split, combination, merger, consolidation, reorganization, reclassification, recapitalization or similar transaction or upon exercise
of any option, benefit award, warrant or other security or instrument exercisable, convertible or exchangeable into Company Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
Transfer</U>&rdquo; means a Transfer of Covered Shares by any Stockholder: (a) if such Stockholder is an individual, (i) to any member
of such Stockholder&rsquo;s immediate family, (ii) to any trust or other estate planning vehicle for the direct or indirect benefit of
such Stockholder or the immediate family of such Stockholder for bona fide estate planning purposes, (iii) by virtue of laws of descent
and distribution following the death of such Stockholder, (iv) by operation of law or pursuant to an order of a court or other regulatory
agency (including, for the avoidance of doubt, a domestic relations order, divorce settlement, divorce decree or separation agreement)
or (v) to a partnership, limited liability company or other entity of which such Stockholder and/or the immediate family of such Stockholder
are the legal and beneficial owners of all the outstanding equity securities or similar interests; (b) if such Stockholder is a corporation,
partnership, limited liability company or other entity, (I) to another corporation, partnership, limited liability company or other entity
that is an affiliate controlled by such Stockholder, (II) to one or more partners or members of such Stockholder or to an affiliate under
common control with such Stockholder or (III) to any investment fund or other entity controlling, controlled by, managing or managed
by or under common control with such Stockholder or affiliates of such Stockholder (including, for the avoidance of doubt, where such
Stockholder is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership);
or (c) if such Stockholder is a trust or other estate planning vehicle, to any beneficiary of such Stockholder that receives Shares in
a distribution from it for no consideration; <U>provided</U>, <U>however</U>, that a Transfer referred to in in <U>clauses (a)</U> &ndash;
<U>(c)</U> shall be deemed a Permitted Transfer only if, as a precondition to such Transfer, the transferee agrees in a written document,
reasonably satisfactory in form and substance to Parent, to be bound by all of the terms of this Agreement (without modification or condition
other than the consummation of the Permitted Transfer).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Support
Period</U>&rdquo; means that period from the date of this Agreement until the Expiration Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer</U>&rdquo;
means, directly or indirectly, to sell (including short sell), transfer, assign or otherwise dispose of (whether by merger or consolidation
(including by conversion into securities or other consideration as a result of such merger or consolidation), by tendering into any tender
or exchange offer, by testamentary disposition, by operation of law, by gift, or otherwise), either voluntarily or involuntarily, or
to enter into any option or other Contract with respect to the voting of or sale, transfer, conversion, assignment or other disposition
of (whether by merger or consolidation (including by conversion into securities or other consideration as a result of such merger or
consolidation), by tendering into any tender or exchange offer, by testamentary disposition, by operation of law or otherwise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">ARTICLE
2</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VOTING</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.1 <FONT STYLE="background-color: white"><U>Agreement to Vote</U></FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
During the Support Period, each Stockholder hereby irrevocably and unconditionally agrees that, at the Company Stockholder Meeting or
any other meeting of the Company&rsquo;s stockholders (whether annual or special and whether or not an adjourned or postponed meeting,
however called, and including any adjournment or postponement thereof), and in any action by written consent of the Company&rsquo;s stockholders,
in each case at which any of the matters set forth in <U>clauses (ii)</U> or <U>(iii)</U> below is put to the vote of stockholders of
the Company, such Stockholder shall, and shall cause any nominee and other holder of record of any of such Stockholder&rsquo;s Covered
Shares to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
when any such meeting is held, appear at such meeting or otherwise cause all of such Stockholder&rsquo;s Covered Shares to be counted
as present thereat for the purpose of establishing a quorum, and when action by written consent of the Company&rsquo;s stockholders is
proposed, respond affirmatively to any such request for written consent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
vote (or act by written consent), or cause to be voted at such meeting (or validly execute and return and cause such written consent
to be granted with respect to), all of such Stockholder&rsquo;s Covered Shares in favor of (A) the adoption of the Merger Agreement and
approval of the transactions contemplated thereby, including the Merger, (B) each of the other actions expressly contemplated by the
Merger Agreement and (C) any proposal (to the extent permitted by Section 6.2 of the Merger Agreement) to adjourn, recess or postpone
the applicable meeting to a later date that is prior to the End Date if there are not sufficient votes at the applicable meeting to approve
the Merger; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
vote (or act by written consent), or cause to be voted at such meeting (or validly execute and return and cause such written consent
to be granted with respect to), all of such Stockholder&rsquo;s Covered Shares against the following actions (other than the Merger and
the Contemplated Transactions): (A) any action or proposal to amend or waive any provision of the Company Charter or Company Bylaws for
which the Stockholders have received at least 10 days&rsquo; prior written notice from either Parent or the Company that it reasonably
expects that such action or proposal would (1) result in a breach of any covenant, representation or warranty or any other obligation
or agreement of the Company contained in the Merger Agreement, or of any Stockholder contained in this Agreement, or (2) prevent, impede,
interfere with, delay, postpone, or adversely affect the consummation of the transactions contemplated by the Merger Agreement, including
the Merger; (B) any Acquisition Proposal or any agreement related thereto; and (C) any other action which is intended, or would reasonably
be expected, to result in any of the conditions to the consummation of the Merger under the Merger Agreement not being fulfilled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<FONT STYLE="background-color: white">[Reserved.]</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Section
2.2 <U>No Inconsistent Agreements</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Each Stockholder
hereby represents, covenants and agrees that, except for this Agreement, such Stockholder has not (a) entered into, and shall not, until
this Agreement is terminated pursuant to <U>Section 5.1</U>, enter into any voting agreement or voting trust that is inconsistent with
this Agreement or (b) granted, and shall not, until this Agreement is terminated pursuant to <U>Section 5.1</U>, grant a proxy, consent
or power of attorney in any manner that would have the <FONT STYLE="background-color: white">effect of preventing, materially delaying
or disabling such Stockholder from performing any of its obligations under this Agreement. Each Stockholder hereby further covenants
and agrees that, until this Agreement is terminated pursuant to <U>Section 5.1</U>, such Stockholder shall not take any other action
in its capacity as the record holder or beneficial owner of Covered Shares, that would reasonably be expected to prevent or materially
delay the consummation of the Contemplated Transactions or the performance by the Company of its obligations under the Merger Agreement.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.3 <FONT STYLE="background-color: white"><U>No Obligation to Exercise Options or Other Securities</U>. </FONT>Nothing in this Agreement
shall require any Stockholder to (a) convert, exercise or exchange any options, warrants or convertible securities in order to obtain
any underlying Company Shares or (b) vote, or execute any consent with respect to, any Company Shares underlying such options, warrants
or convertible securities that have not yet been issued as of the applicable record date for that vote or consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.4 <FONT STYLE="background-color: white"><U>Proxy Card</U>. </FONT>Prior to the Expiration Time, each Stockholder shall promptly (but
in any event no later than ten (10) Business Days prior to the Company Stockholder Meeting) execute and deliver to the Company or the
Company&rsquo;s proxy solicitor (or cause the holders of record of such Stockholder&rsquo;s Covered Shares to execute and deliver to
the Company or the Company&rsquo;s proxy solicitor), any proxy card or voting instructions such Stockholder receives that is sent by
the Company to its stockholders soliciting proxies with respect to any matter described in <U>Section 2.1</U> which shall be voted in
the manner described in <U>Section 2.1</U>, and such vote during the Support Period shall not be amended, withdrawn or rescinded<FONT STYLE="background-color: white">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">ARTICLE
3</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.1 <FONT STYLE="background-color: white"><U>Representations and Warranties of </U></FONT><U>Stockholders</U>. Each Stockholder, severally
as to himself, herself or itself, and not jointly or jointly and severally, hereby represents and warrants to Parent as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authorization; Validity of Agreement; Necessary Action</U>. If such Stockholder is an entity, such Stockholder is duly
organized and validly existing and in good standing under the Laws of its jurisdiction of organization. Such Stockholder has the requisite
power and authority and/or capacity to execute and deliver this Agreement and to carry out its obligations hereunder. The execution and
delivery by such Stockholder of this Agreement and the performance by such Stockholder of its obligations hereunder have been duly and
validly authorized by such Stockholder and no other actions or proceedings are required on the part of such Stockholder to authorize
the execution and delivery of this Agreement or the performance by such Stockholder of its obligations hereunder. This Agreement has
been duly executed and delivered by such Stockholder and, assuming the due authorization, execution and delivery of this Agreement by
Parent, constitutes a legal, valid and binding agreement of such Stockholder, enforceable against such Stockholder in accordance with
its terms, subject to the Bankruptcy and Equity Exception.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Ownership</U>. As of the date hereof, such Stockholder is the record and beneficial owner of, and has good and valid title to, the
Existing Shares set forth opposite such Stockholder&rsquo;s name on <U>Exhibit A</U> free and clear of any Liens (other than pursuant
to this Agreement or transfer restrictions under applicable securities Laws). The Covered Shares owned by such Stockholder will be beneficially
and legally owned by such Stockholder, except in the case of a Permitted Transfer of any Covered Shares. Except as provided for in this
Agreement, such Stockholder, directly or indirectly, has sole or shared voting power, sole or shared power of disposition, sole or shared
power to issue instructions with respect to the matters set forth in <U>ARTICLE 2</U>, and sole or shared power to agree to all of the
matters set forth in this Agreement, in each case, with respect to all of the Covered Shares owned by such Stockholder, except in the
case of a Permitted Transfer of Covered Shares. As of the date hereof, except for the Existing Shares, such Stockholder does not, directly
or indirectly, legally or beneficially own or have any option, warrant or other right to acquire any Company Common Shares or other securities
of the Company that are or may by their terms become entitled to vote or any securities that are convertible or exchangeable into or
exercisable for any securities of the Company that are or may by their terms become entitled to vote, nor is such Stockholder subject
to any Contract, other than this Agreement and the other Transaction Documents, that obligates such Stockholder to vote, acquire or dispose
of any securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>No Violation</U>. Neither the execution and delivery of this Agreement by such Stockholder nor its performance of its obligations
under this Agreement will (i) result in a violation or breach of, or conflict with any provisions of, or constitute a default (or an
event which, with notice or lapse of time or both, would constitute a default) under, or result in the termination or cancellation of,
any material Contract to which such Stockholder is a party, or give rise to a right of purchase under, or result in the creation of any
Lien (other than pursuant to this Agreement or transfer restrictions under applicable securities Laws) upon, the Existing Shares owned
by such Stockholder, (ii) violate any Law applicable to such Stockholder, or (iii) with respect to any Stockholder that is an entity,
result in a violation or breach of or conflict with its certificate of incorporation, certificate of formation, bylaws, operating agreement,
or other governing or constitutional documents, as applicable, except, in the case of clauses (i) and (ii), as would not, individually
or in the aggregate, reasonably be expected to prevent or materially delay the ability of such Stockholder to perform its obligations
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Consents and Approvals</U>. No consent, approval, order or authorization of, or registration, declaration or filing with, any Governmental
Entity is necessary to be obtained or made by such Stockholder in connection with its execution, delivery and performance of this Agreement,
except (i) as required by the rules and regulations promulgated under the Exchange Act, the Securities Act, or state securities, takeover
and &ldquo;blue sky&rdquo; Laws, (ii) compliance with any applicable requirements of the HSR Act and any other applicable Competition
Laws, (iii) the applicable rules and regulations of the SEC or any applicable stock exchange or (iv) as would not, individually or in
the aggregate, reasonably be expected to restrict in any material respect, prohibit, impair in any material respect or materially delay
the performance by such Stockholder of its obligations under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Reliance by Parent</U>. Such Stockholder understands and acknowledges that Parent is entering into the Merger Agreement in reliance
upon such Stockholder&rsquo;s execution and delivery of this Agreement and the representations, warranties, covenants and obligations
of such Stockholder contained herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Adequate Information</U>. Such Stockholder acknowledges that it is a sophisticated party with respect to the Covered Shares and has
adequate information concerning the business and financial condition of the Company to make an informed decision regarding the transactions
contemplated by this Agreement and has, independently and without reliance upon Parent and based on such information as such Stockholder
has deemed appropriate, made its own analysis and decision to enter into this Agreement. Such Stockholder acknowledges that Parent has
not made and is not making any representation or warranty, whether express or implied, of any kind or character except as expressly set
forth in this Agreement or in the Merger Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Except for the representations and warranties expressly set forth in <U>Section 2.2</U> or this <U>Section 3.1</U> no Stockholder (nor
any other Person on behalf of any Stockholder) makes any express or implied representation or warranty in connection with the transactions
contemplated hereby, and each Stockholder hereby disclaims any other representations or warranties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.2 <FONT STYLE="background-color: white"><U>Representations and Warranties of Parent</U></FONT>. Parent hereby represents and warrants
to other parties hereto as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Parent is duly organized and validly existing and in good standing under the Laws of its jurisdiction of organization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Parent has the requisite power and authority to execute and deliver this Agreement and to carry out Parent&rsquo;s obligations hereunder.
The execution and delivery of this Agreement by Parent and the consummation of the transactions contemplated hereby have been duly authorized
and approved by all requisite corporate action on the part of Parent and no other actions or proceedings are required on the part of
Parent to authorize the execution and delivery of this Agreement or the performance by Parent of its obligations hereunder. This Agreement
has been duly executed and delivered by Parent and, assuming the due authorization, execution and delivery of this Agreement by the other
parties hereto, constitutes a legal, valid and binding agreement of Parent, enforceable against Parent in accordance with its terms,
subject to the Bankruptcy and Equity Exception.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Parent acknowledges and agrees that no Stockholder has made, and no Stockholder is making, any representation or warranty of any kind
(express or implied) (and Parent acknowledges and agrees that it has not relied, and disclaims reliance, on any such representation or
warranty), except as expressly set forth in <U>Section 2.2</U> or <U>Section 3.1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">ARTICLE
4</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
COVENANTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.1 <FONT STYLE="background-color: white"><U>Prohibition on Transfers, Other Actions</U></FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
During the Support Period, except for any Permitted Transfer, each Stockholder shall not Transfer any of such Stockholder&rsquo;s Covered
Shares. Any purported Transfer not in compliance with this <U>Section 4.1(a)</U> shall be null and void <I>ab initio</I>. Notwithstanding
the foregoing, (i) direct or indirect transfers of equity or other interests in any Stockholder by its equityholders is not prohibited
by this <U>Section 4.1(a)</U> and (ii) each Stockholder may make such Transfers of such Stockholder&rsquo;s Covered Shares as Parent
may agree to in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If during the Support Period any Stockholder attempts to Transfer (other than a Permitted Transfer) any of such Stockholder&rsquo;s Covered
Shares in violation of <U>Section 4.1(a)</U>, such Stockholder hereby unconditionally and irrevocably (during the Support Period) instructs
the Company to not, (i) permit any such Transfer on its books and records, (ii) issue a book-entry interest or a new certificate representing
any of the Covered Shares or (iii) record such vote (including by written consent). In furtherance of the foregoing, each Stockholder
hereby authorizes the Company to notify the Company&rsquo;s transfer agent, and the Company agrees to notify its transfer agent, that
there is a stop transfer order with respect to all of such Stockholder&rsquo;s Covered Shares (and that this Agreement places limits
on the voting and transfer of such Stockholder&rsquo;s Covered Shares), subject to the provisions hereof and provided that any such stop
transfer order and notice will immediately be withdrawn and terminated by the Company following the Expiration Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
During the Support Period, each Stockholder will not (solely in such Stockholder&rsquo;s capacity as a stockholder of the Company) bring,
commence, institute, maintain, prosecute or voluntarily aid any legal action or proceeding which challenges the validity of or seeks
to enjoin the operation of any provision of the Merger Agreement or this Agreement; provided that such Stockholder shall not be prohibited
from enforcing any of its rights under this Agreement or bringing any claim against Parent and/or Company for a breach hereof. In addition,
each Stockholder agrees not to demand or commence an appraisal proceeding under Section 262 of the DGCL with respect to its Covered Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
During the Support Period, each Stockholder shall not, and shall cause its Affiliates and its and their respective Representatives (on
behalf of such Stockholder) not to, directly or indirectly, (i) solicit, initiate or induce, or knowingly take any action to facilitate,
assist in or encourage the submission or announcement of, any Acquisition Proposal or (ii) enter into or participate in any discussions
or negotiations with, furnish any non-public information relating to the Company or any of its Subsidiaries to, or afford access to the
business, properties, assets, personnel, books or records of the Company or any of its Subsidiaries to any Third Party or its Representatives
in connection with or in furtherance of any Acquisition Proposal. Notwithstanding the foregoing, to the extent that the Company is permitted
to engage in any of the foregoing activities pursuant to Section 6.3 of the Merger Agreement, any Stockholder may participate in such
activities and therefore shall not be subject to the restrictions in this <U>Section 4.1(c)</U> so long as such actions by such Stockholder
would otherwise be permitted to be taken by the Company pursuant to Section 6.3 of the Merger Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Each Stockholder shall, and shall cause its Affiliates, and shall direct its and their respective Representatives to, (i) cease immediately
and cause to be terminated any and all existing activities, discussions or negotiations, if any, with any Third Party and its Representatives
with respect to any Acquisition Proposal and (ii) cease providing any information to any Third Party or its Representatives with respect
to the Company or any of its Subsidiaries, or their respective businesses, properties, assets, personnel, books or records, in connection
with any Acquisition Proposal. Notwithstanding the foregoing, the restrictions in this <U>Section 4.1(d)</U> shall not apply with respect
to any discussions or negotiations with respect to the Transfer of Covered Shares permitted by <U>Section 4.1(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
For the avoidance of doubt, for the purposes of this Agreement, the Company shall not be deemed an Affiliate of any Stockholder, and
any officer, director, employee, agent or advisor of the Company (in each case, in their capacities as such), shall not be deemed a Representative
of any Stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.2 <FONT STYLE="background-color: white"><U>Further Assurances</U></FONT>. Each of the parties hereto agrees that it will use its reasonable
best efforts to do all things reasonably necessary to effectuate this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">ARTICLE
5</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.1 <FONT STYLE="background-color: white"><U>Termination</U></FONT>. This Agreement shall remain in effect until the earliest to occur
of (a) the termination of the Merger Agreement in accordance with its terms, (b) the Effective Time, (c) the termination of this Agreement
by written agreement of the parties hereto, (d) the Company Board effecting an Adverse Recommendation Change in accordance with the terms
of the Merger Agreement or (e) such date and time as the Merger Agreement shall have been, without the prior written consent of the Stockholders,
amended or supplemented, or any provision thereof waived, in a manner that changes the form of the consideration or reduces the amount
of the Merger Consideration payable (or issuable) in respect of any Covered Shares (other than, for the avoidance of doubt, adjustments
in accordance with the terms of the Merger Agreement or any increase in the Merger Consideration), in which case this Agreement shall
automatically terminate and be of no further force and effect with respect to all parties hereto (the time of such termination, the &ldquo;<U>Expiration
Time</U>&rdquo;). The representations, warranties and covenants of the Stockholders contained in this Agreement shall expire at the Expiration
Time. Nothing in this <U>Section 5.1</U> and no termination of this Agreement shall relieve or otherwise limit any party of liability
for any breach of this Agreement occurring prior to such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.2 <U>No Ownership Interest</U>. Nothing contained in this Agreement shall be deemed to vest in Parent any direct or indirect ownership
or incidence of ownership of or with respect to any Covered Shares. All rights, ownership and economic benefit relating to the Covered
Shares shall remain vested in and belong to each Stockholder, and Parent shall have no authority to direct any Stockholder in the voting
or disposition of any of the Covered Shares except as otherwise provided herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.3 <FONT STYLE="background-color: white"><U>Publicity</U></FONT>. Each Stockholder hereby authorizes the Company and Parent to include
and disclose in any press release, the Registration Statement, the Proxy Statement, and in such other schedules, certificates, applications,
agreements or documents as Parent and the Company reasonably determine to be necessary or appropriate (as required by applicable Law)
in connection with the consummation of the Merger and the Contemplated Transactions, such Stockholder&rsquo;s identity and ownership
of the Covered Shares, and the nature of such Stockholder&rsquo;s commitments, arrangements and understandings pursuant to this Agreement.
Each Stockholder acknowledges that each of the Company and Parent may, in its sole discretion, file a form of this Agreement with the
SEC or any other Governmental Authority or securities exchange. Parent and the Company hereby authorize each Stockholder to disclose
this Agreement and the Contemplated Transactions in any reports required to be filed by such Stockholder or any of its affiliates under
the Exchange Act or otherwise as required by Law. Each party hereto agrees to promptly provide to the other parties any information it
may reasonably require for the preparation of any such disclosure documents, and each party agrees to promptly notify the other parties
of any required corrections with respect to any information supplied by such party specifically for use in any such disclosure document,
if and to the extent that any such information shall have become false or misleading in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.4 <FONT STYLE="background-color: white"><U>Notices</U></FONT>. All notices, requests and other communications to any party hereunder
shall be in writing (including electronic mail (&ldquo;<FONT STYLE="font-weight: normal"><U>e-mail</U></FONT>&rdquo;) transmission, so
long as a receipt of such e-mail is requested and received) and shall be given,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Parent, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MIMEDX
GROUP, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1775
West Oak Common Ct. NE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marietta,
GA 30062</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
William &ldquo;Butch&rdquo; Hulse</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
BHulse@mimedx.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
copies to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greenberg
Traurig, P.A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">401
East Las Olas Blvd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite
2000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Flora Perez and Matthew Miller</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
perezf@gtlaw.com; millerma@gtlaw.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company (prior to the Closing), to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SANARA
MEDTECH INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1200
Summit Avenue, Suite 414</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forth
Worth, Texas 76102</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Seth Yon</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
syon@sanaramedtech.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
copies to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alston
&amp; Bird LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
Atlantic Center</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1201
West Peachtree Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Atlanta,
GA 30309</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
J. Mark Ray; Kyle G. Healy; Tyler w. Pate</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
mark.ray@alston.com; kyle.healy@alston.com; tyler.pate@alston.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to any Stockholder, to the address set forth next to such Stockholder&rsquo;s name on <U>Exhibit A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.5 <FONT STYLE="background-color: white"><U>Mutual Drafting; Interpretation</U></FONT>. Each party to this Agreement has participated
in the drafting of this Agreement, which each such party acknowledges is the result of extensive negotiations between the parties. If
an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties,
and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision. For
purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine
gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter
gender shall include masculine and feminine genders. As used in this Agreement, the words &ldquo;include&rdquo; and &ldquo;including&rdquo;
and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &ldquo;without
limitation.&rdquo; Except as otherwise indicated, all references in this Agreement to &ldquo;Sections,&rdquo; &ldquo;Exhibits&rdquo;
and &ldquo;Annexes&rdquo; are intended to refer to Sections of this Agreement and Exhibits and Annexes to this Agreement. The words &ldquo;hereof,&rdquo;
&ldquo;hereto,&rdquo; &ldquo;hereby,&rdquo; &ldquo;herein,&rdquo; &ldquo;hereunder&rdquo; and words of similar import, when used in this
Agreement, shall refer to this Agreement as a whole and not to any particular Section or Article in which such words appear. Unless otherwise
specifically provided for herein, the term &ldquo;or&rdquo; shall not be deemed to be exclusive. If the last day of a period of time
before which, within which or following which any act is to be done or step taken pursuant to this Agreement is not a Business Day, the
period shall end on the immediately following Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.6 <FONT STYLE="background-color: white"><U>Counterparts</U></FONT>. This Agreement may be signed in any number of counterparts, each
of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. Any such counterpart,
to the extent delivered by .pdf, .tif, .gif, .jpeg or similar attachment to electronic mail (any such delivery, an &ldquo;<FONT STYLE="font-weight: normal"><U>Electronic
Delivery</U></FONT>&rdquo;) shall be treated in all manner and respects as an original counterpart and shall be considered to have the
same binding legal effect as if it were the original signed version thereof delivered in person. No party hereto shall raise the use
of Electronic Delivery to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated
through the use of Electronic Delivery as a defense to the formation of a contract, and each such party forever waives any such defense,
except to the extent such defense relates to lack of authenticity. This Agreement shall become effective when each party hereto shall
have received a counterpart hereof signed by all of the other parties hereto. Until and unless each party has received a counterpart
hereof signed by the other party hereto, this Agreement shall have no effect and no party shall have any right or obligation hereunder
(whether by virtue of any other oral or written agreement or other communication).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.7 <FONT STYLE="background-color: white"><U>Entire Agreement</U></FONT>. This Agreement and the Confidentiality Agreement constitute
the entire agreement between the parties with respect to the subject matter of this Agreement and supersede all prior agreements and
understandings, both oral and written, between the parties with respect to the subject matter of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.8 <FONT STYLE="background-color: white"><U>Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury</U></FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
This Agreement, and all Proceedings (whether in contract, in tort or otherwise) that may be based upon, arise out of or relate to this
Agreement, or the negotiation, execution or performance of this Agreement or the Transactions, shall be governed by and construed in
accordance with the laws of the State of Texas, without regard to the conflicts of law rules of such state.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All Proceedings (whether at law, in contract, in tort or otherwise) arising out of or relating to this Agreement, the negotiation, validity
or performance of this Agreement or the Transactions shall be heard and determined exclusively in Texas State court located in Dallas,
Texas or, to the extent such court does not have jurisdiction, the U.S. District Court for the Northern District of Texas (Dallas Division),
and the parties irrevocably submit to the exclusive jurisdiction of such court (and, in the case of appeals, the appropriate appellate
court therefrom), in any such Proceeding and irrevocably waive the defense of an inconvenient forum to the maintenance of any such Proceeding.
The consents to jurisdiction set forth in this paragraph shall not constitute general consents to service of process in the State of
Texas and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed to confer rights on any Person
other than the parties hereto. The parties agree that service of any court paper may be made in any manner as may be provided under Applicable
Law or court rules governing service of process in such court. The parties hereto agree that a final judgment in any such Proceeding
shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Applicable
Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING ARISING OUT OF OR RELATED TO
THIS AGREEMENT, THE GUARANTEE OR THE TRANSACTIONS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.9 <U>Amendment</U>. Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing
and is signed, in the case of an amendment, by each party to this Agreement or, in the case of a waiver, by each party against whom the
waiver is to be effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.10 <FONT STYLE="background-color: white"><U>Waiver</U></FONT>. Parent may extend the time for the performance of any of the obligations
or other acts of the other parties hereto, waive any breach of the representations and warranties of the other contained herein or in
any document delivered pursuant hereto, and waive compliance by the other parties hereto with any of the agreements or covenants contained
herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by Parent, but such extension
or waiver or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate as a waiver
of, or estoppel with respect to, any subsequent or other failure. Any delay in exercising any right under this Agreement shall not constitute
a waiver of such right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.11 <FONT STYLE="background-color: white"><U>Specific Performance</U></FONT>. The parties hereto agree that irreparable damage would
occur in the event any provision of this Agreement were not performed in accordance with the terms hereof and that any breach of this
Agreement would not be adequately compensated by monetary damages, and that the parties shall be entitled to an injunction or injunctions
to prevent breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof, without proof of
actual damages or inadequacy of legal remedy and without bond or other security being required, in addition to any other remedy to which
they are entitled at law or in equity. The pursuit of specific enforcement by any party hereto will not be deemed an election of remedies
or waiver of the right to pursue any other right or remedy (whether at law or in equity) to which such party may be entitled at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.12 <U>Stockholder <FONT STYLE="background-color: white">Capacity</FONT></U>. Notwithstanding anything contained in this Agreement to
the contrary, the representations, warranties, covenants and agreements made herein by each Stockholder are made solely with respect
to such Stockholder and its Covered Shares. Each Stockholder is entering into this Agreement solely in its capacity as the owner (or
as a trust whose beneficiaries are the beneficial owners), directly or indirectly, of its Covered Shares and nothing herein shall limit
or affect any actions or omissions by such Stockholder (or any designee or affiliate serving in his or her capacity as a director on
the Company Board or an officer of the Company) in any other capacity (including as a director or officer of the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.13 <FONT STYLE="background-color: white"><U>Severability</U></FONT>. If any term or other provision of this Agreement is invalid, illegal
or incapable of being enforced by any rule of Law or public policy, all other conditions and provisions of this Agreement shall nevertheless
remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in
any manner materially adverse to any party. Upon such determination that any such term or other provision is invalid, illegal or incapable
of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the
parties as closely as possible in a mutually acceptable manner that will achieve, to the maximum extent possible, the economic, business
and other purposes of such void or unenforceable provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.14 <FONT STYLE="background-color: white"><U>Expenses</U></FONT>. Except as otherwise expressly provided herein or in the Merger Agreement,
all fees and expenses incurred in connection with this Agreement and the actions contemplated hereby shall be paid by the party incurring
such fees or expenses, whether or not the Merger are consummated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.15 <U>Non-Recourse</U>. This Agreement may only be enforced against, and any claim, action, suit or other Proceeding based upon, arising
out of, or related to this Agreement, or the negotiation, execution or performance of this Agreement, may only be brought against the
Persons that are expressly named as parties hereto and then only with respect to the specific obligations set forth herein with respect
to such party. No past, present or future director, officer, employee, incorporator, member, partner, stockholder, trustee, beneficiary,
settlor, agent, attorney, representative or affiliate of any Stockholder shall (unless itself a Stockholder) have any liability (whether
in contract or in tort) for any obligations or liabilities arising under, in connection with or related to this Agreement or for any
claim or proceeding (whether in tort, contract or otherwise) based on, in respect of, or by reason of, the transactions contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.16 <FONT STYLE="background-color: white"><U>Successors and Assigns; Third Party Beneficiaries</U></FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except in connection with a Permitted Transfer, in each case, effected pursuant to this Agreement, neither this Agreement nor any of
the rights, interests or obligations under this Agreement may be assigned or delegated, in whole or in part, by operation of law or otherwise,
by any party hereto without the prior written consent of the other parties hereto, and any such assignment without such prior written
consent shall be null and void. Any assignment in violation of the foregoing shall be null and void. Subject to the preceding two sentences,
this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties hereto and their respective successors
and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
This Agreement shall be binding upon and inure solely to the benefit of each party hereto and their respective successors and assigns,
and nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person any right, benefit or remedy
of any nature whatsoever under or by reason of this Agreement. The representations and warranties in this Agreement are the product of
negotiations among the parties hereto and are for the sole benefit of the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
pages follow.</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PARENT</U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>mimedx group,
    inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Joseph H. Capper</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    H. Capper</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Voting Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>COMPANY</U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Sanara medtech
    inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Seth D. Yon</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Seth
    D. Yon</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Voting Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ronald T. Nixon</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronald
    T. Nixon</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Voting Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brad Gurasich</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brad
    Gurasich</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Voting Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CGI
    CELLERATE RX, LLC</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Catalyst
    Rochal, LLC, its sole member</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ronald T. Nixon</I></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronald
    T. Nixon</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manager</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brad Gurasich</I></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brad
    Gurasich</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manager</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">[Signature Page
to Voting Agreement]</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FA
    SANARA, LLC</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Family
    Alignment, LLC, its manager</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Catalyst Group, Inc., its </FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">manager</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ronald T. Nixon</I></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronald
    T. Nixon</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Voting Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CATALYST ROCHAL, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Ronald T. Nixon</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ronald
    T. Nixon</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Manager</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Brad Gurasich</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Brad
    Gurasich</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Manager</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Voting Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
    CATALYST GROUP, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ronald T. Nixon</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronald
    T. Nixon</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Voting Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAMILY
    ALIGNMENT, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Catalyst Group, Inc., its manager</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ronald T. Nixon</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronald
    T. Nixon</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Voting Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROCHAL
    INDUSTRIES, LLC</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Catalyst
    Rochal, LLC, its member</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ronald T. Nixon</I></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronald
    T. Nixon</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manager</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brad Gurasich</I></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brad
    Gurasich</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manager</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Voting Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MIMEDX
to Acquire Sanara MedTech</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transformational
Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Accelerates
MIMEDX&rsquo;s Strategic Priority to Expand Surgical Footprint, Nearly Doubling Surgical Revenue</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Immediately
Accretive to Revenue Growth, Gross Margin and Adjusted EBITDA Margin</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Anticipates
Over $20 Million in Run-Rate Cost Synergies</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Conference
Call to Discuss Transaction Alongside MIMEDX&rsquo;s Second Quarter 2026 Operating and Financial Results Today at 4:30pm EDT</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARIETTA,
Ga. and FORT WORTH, Tx., July 29, 2026 &mdash; MiMedx Group, Inc. (Nasdaq: MDXG) (&ldquo;MIMEDX&rdquo; or the &ldquo;Company&rdquo;)
and Sanara MedTech Inc. (&ldquo;Sanara,&rdquo; &ldquo;Sanara MedTech&rdquo;) (Nasdaq: SMTI) today announced that they have entered into
a definitive merger agreement under which MIMEDX will acquire all of the outstanding shares of Sanara in a cash and stock transaction
valued at $35 per Sanara share with a total enterprise value of approximately $350 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
is solely focused on developing and commercializing regenerative products for surgical markets. With technologies targeting multiple,
large addressable markets and a compelling financial profile, Sanara has a track record of delivering double-digit revenue growth as
it has built its surgical commercial presence. This transaction would combine MIMEDX&rsquo;s high-growth, best-in-class surgical portfolio
with Sanara&rsquo;s innovative surgical technologies across collagen particulate, wound irrigation and bone fixation. In addition to
Sanara&rsquo;s industry-leading CellerateRX&reg; Surgical Powder, BIASURGE&reg; Advanced Surgical Solution and additional soft tissue
and musculoskeletal products, it is working towards a 2027 commercial launch of OsStic&trade; BioAdhesive Advanced Bone Fixation, a Breakthrough
Device as designated by the U.S. Food &amp; Drug Administration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
are thrilled to announce the planned combination with Sanara MedTech and look forward to welcoming their team to the MIMEDX family in
the near future,&rdquo; stated Joseph H. Capper, MIMEDX Chief Executive Officer. &ldquo;Over the last several years, MIMEDX has demonstrated
the ability to drive strong, double-digit growth in surgical end markets. With Sanara, we will accelerate this effort and meaningfully
expand our reach across several subspecialties. On a combined basis, 2027 total revenue is expected to be well in excess of $400 million
with an adjusted EBITDA margin expected to be over 20%.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;This
exciting transaction brings together two highly focused organizations with deep benches of talent and strong momentum in the surgical
space,&rdquo; said Seth Yon, Sanara&rsquo;s President and Chief Executive Officer. &ldquo;By combining Sanara with MIMEDX&rsquo;s broad
portfolio, robust commercial capabilities and commitment to innovation, we will be positioned to deepen our existing distributor relationships
while expanding our presence in the operating room. The Sanara Board of Directors conducted a robust process and determined that the
resulting transaction delivers a compelling and certain cash premium to shareholders while providing the opportunity to participate in
the future value creation of the combined company. I am grateful to the outstanding Sanara team for their focus, hard work and dedication,
and I look forward to bringing our teams together to build a stronger business with even greater opportunity in surgical care.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Strategic
and Financial Benefits of the Transaction</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
merger of MIMEDX and Sanara is expected to result in a stronger long-term growth profile with significantly expanded addressable markets
and positions the combined company as a leader in regenerative medicine solutions for the operating room.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expands
                                            Product Offering with Differentiated, Innovative Technologies</B>: The combination creates
                                            a larger, more diversified surgical technology platform, combining Sanara&rsquo;s portfolio
                                            of proprietary, evidence-based surgical solutions, including CellerateRX Surgical Powder,
                                            BIASURGE Advanced Surgical Solution, a no-rinse irrigation solution, and exclusive distribution
                                            rights to OsStic BioAdhesive Advanced Bone Fixation, a synthetic injectable bio-adhesive,
                                            with MIMEDX&rsquo;s growing surgical business, further diversifying the combined company
                                            beyond soft tissue into adjacent and complementary areas such as musculoskeletal applications.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Adds
                                            Significant Commercial Scale Through Distribution Network</B>: Sanara&rsquo;s well-established
                                            U.S. hospital and surgical call-point relationships are positioned to meaningfully extend
                                            MIMEDX&rsquo;s commercial footprint and accelerate adoption of both companies&rsquo; products
                                            across a larger, more diversified surgical customer base.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Immediately
                                            Accretive to Financial Profile</B>: The transaction meaningfully shifts the combined business
                                            mix, nearly doubling MIMEDX&rsquo;s surgical revenue. On a combined basis, 2027 total revenue
                                            is expected to be well in excess of $400 million with an Adjusted EBITDA margin expected
                                            to be over 20%, inclusive of over $20 million of anticipated run-rate cost synergies, driving
                                            strong profitability post-close. The transaction is expected to be immediately accretive
                                            to MIMEDX&rsquo;s revenue growth rate, building on MIMEDX&rsquo;s recent surgical segment
                                            momentum.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Strong
                                            Cultural Fit and Deep Expertise Expands Ability to Support Customers</B>: MIMEDX and Sanara
                                            share a common, patient-first mission grounded in evidence-based healing and improved clinical
                                            outcomes. Sanara&rsquo;s and MIMEDX&rsquo;s teams are expected to integrate seamlessly, bringing
                                            deep, long-standing relationships with surgeons and hospital customers that will strengthen
                                            the combined organization&rsquo;s ability to support physicians every day.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transaction
Details</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the agreement, Sanara shareholders will receive $33.00 in cash and 0.4735 shares of MIMEDX common stock for each share of
Sanara common stock they own, which represents a value of $2.00 per share, calculated based on the average closing price of MIMEDX common
stock of $4.22 for the last five consecutive trading days through and including July 28, 2026. The merger consideration represents a
premium of 46% to Sanara&rsquo;s 30-day volume weighted average share price as of July 28, 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MIMEDX
expects to finance the cash portion of the transaction through a combination of cash on hand and a new, committed debt financing in the
form of a $300 million term loan, which has been secured with Hayfin Capital Management, LLC. In connection with the execution and delivery
of definitive documentation with respect to the debt financing by Hayfin, MIMEDX&rsquo;s existing credit agreement will be terminated
and all amounts outstanding will be repaid in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction has been unanimously approved by the board of directors of both companies and is expected to close by the end of the year,
subject to approval by Sanara shareholders, the receipt of required regulatory approvals and other customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MIMEDX
Second Quarter 2026 Operating and Financial Results</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alongside
today&rsquo;s announcement, the Company has also issued a press release announcing its second quarter 2026 operating and financial results.
Please refer to that release, which can be found in the Investor Relations section of the Company&rsquo;s website at <U>investors.mimedx.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conference
Call</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MIMEDX
will host a conference call on Wednesday, July 29, 2026, at 4:30pm Eastern Time, during which the Company will discuss the transaction
as well as its second quarter operating and financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
live webcast and presentation will be accessible through the Investor Relations section of the Company&rsquo;s website at <U>investors.mimedx.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conference call can be accessed using the following information:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Webcast:
<U>Click here</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Investors: 877-407-6184</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">International
Investors: 201-389-0877</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conference
ID: 13761338</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
replay of the webcast will be available for approximately 30 days on the Company&rsquo;s website at <U>investors.mimedx.com</U> following
the conclusion of the event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Advisors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Centerview
Partners LLC is serving as exclusive financial advisor for MIMEDX; Greenberg Traurig LLP is serving as legal advisor for MIMEDX.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Truist
Securities, Inc. is serving as exclusive financial advisor for Sanara; Alston &amp; Bird LLP is serving as legal advisor for Sanara.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
MIMEDX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">MIMEDX
is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other
hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of
healthcare. The Company&rsquo;s vision is to be the leading global provider of healing solutions through relentless innovation to restore
quality of life. For additional information, please visit <U>www.mimedx.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Sanara MedTech Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical
outcomes and reduce healthcare expenditures in the surgical market. Sanara develops, markets and distributes surgical products for use
by physicians and clinicians in hospitals. Each of Sanara&rsquo;s products and technologies are designed to achieve the goal of providing
better clinical outcomes at a lower overall cost for healthcare systems. Sanara&rsquo;s products are primarily sold in the United States
surgical tissue repair market. Sanara markets and distributes CellerateRX&reg; Surgical Collagen Powder, BIASURGE&reg; Advanced Surgical
Solution, FORTIFY TRG&reg; Tissue Repair Graft and FORTIFY FLOWABLE&reg; Extracellular Matrix, as well as a portfolio of advanced biologic
products including: ACTIGEN&reg; Verified Inductive Bone Matrix, ALLOCYTE&reg; Plus Advanced Viable Bone Matrix, BiFORM&reg; Bioactive
Moldable Matrix and TEXAGEN&reg; Amniotic Membrane Allograft to the surgical market. Sanara believes it can drive its pipeline from concept
to preclinical and clinical development while meeting quality and regulatory requirements. Sanara strives to be one of the most innovative
and comprehensive providers of effective surgical solutions and is continually seeking to expand its offerings for patients requiring
treatments in the United States. For more information, please visit SanaraMedTech.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Important
Cautionary Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">This
press release includes forward-looking statements, including statements regarding (i) our expectations for future financial results,
including revenue and Adjusted EBITDA margin; (ii) the expected strategic and financial benefits of the proposed combination with Sanara,
including anticipated cost synergies and the impact to our financial profile; (iii) the expected expansion of our surgical business following
the proposed transaction; (iv) the anticipated timing, completion and financing of the proposed transaction; (v) our plans and expectations
for the combined company following the closing of the proposed transaction; (vi) anticipated product launches of Sanara; and (vii) the
total addressable market. Additional forward-looking statements may be identified by words such as &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;goal,&rdquo; &ldquo;outlook,&rdquo; &ldquo;potential,&rdquo; &ldquo;will,&rdquo; &ldquo;preliminary,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;positioned,&rdquo; &ldquo;strategy,&rdquo; and similar expressions, and are based on management&rsquo;s
current beliefs and expectations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Forward-looking
statements are subject to risks and uncertainties, the Company cautions investors against placing undue reliance on such statements.
Actual results may differ materially from those set forth in the forward-looking statements. Factors that could cause actual results
to differ from expectations include: (i) future sales are uncertain and are affected by competition, access to customers, patient access
to healthcare providers, the new reimbursement environment, and many other factors; (ii) the Company may change its plans due to unforeseen
or evolving circumstances or market conditions; (iii) the results of scientific research are uncertain and may have little or no value;
(iv) changes in the size of the addressable market for our products; (v) the inability of the Company to successfully or timely consummate
the acquisition of Sanara, including as a result of the failure to obtain required Sanara shareholder approval, required regulatory approvals,
or the satisfaction of other customary closing conditions; (vi) if the acquisition is consummated, the failure to realize the anticipated
benefits or synergies of the acquisition in the timeframe expected or at all; and (vii) difficulties in integrating the operations, personnel
and commercial capabilities of the Company following the closing of the transaction. The Company describes additional risks and uncertainties
in the Risk Factors section of its most recent annual report and quarterly reports filed with the Securities and Exchange Commission.
Any forward-looking statements speak only as of the date of this press release and the Company assumes no obligation to update any forward-looking
statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Information and Where to Find It</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the proposed transaction, MIMEDX intends to file with the SEC a registration statement on Form S-4 that will include
a proxy statement of Sanara and that also constitutes a prospectus of MIMEDX. Each of MIMEDX and Sanara may also file other relevant
documents with the SEC regarding the proposed transaction. This communication is not a substitute for the proxy statement/prospectus
or registration statement or any other document that MIMEDX or Sanara may file with the SEC. The definitive proxy statement/prospectus
(if and when available) will be mailed to stockholders of Sanara. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT,
PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS
TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT
INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain free copies of the registration statement
and proxy statement/prospectus (if and when available) and other documents containing important information about MIMEDX, Sanara and
the proposed transaction, once such documents are filed with the SEC through the website maintained by the SEC at <U>http://www.sec.gov</U>.
Copies of the documents filed with the SEC by MIMEDX will be available free of charge on MIMEDX &lsquo;s website at <U>https://investors.mimedx.com/</U>.
Copies will also be available at no charge at the Investor Relations section of Sanara&rsquo;s website at <U>https://ir.sanaramedtech.com/</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Participants
in the Solicitation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara,
MIMEDX and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies
in respect of the proposed transaction. Information about the directors and executive officers of Sanara, including a description of
their direct or indirect interests, by security holdings or otherwise, is set forth in Sanara&rsquo;s proxy statement for its 2026 Annual
Meeting of Stockholders, which was filed with the SEC on April 17, 2026. Information about the directors and executive officers of MIMEDX,
including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in MIMEDX &lsquo;s proxy
statement for its 2026 Annual Meeting of Stockholders, which was filed with the SEC on April 29, 2026. Other information regarding the
participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise,
will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed transaction
when such materials become available. Investors should read the proxy statement/prospectus carefully when it becomes available before
making any voting or investment decisions. You may obtain free copies of these documents from Sanara and MIMEDX using the sources indicated
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Offer or Solicitation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
communication does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy any securities or a solicitation
of any vote or approval with respect to the proposed transactions or otherwise, nor shall there be any sale, issuance or transfer of
securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MIMEDX
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matt
Notarianni</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">470-304-7291</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>mnotarianni@mimedx.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sanara
MedTech Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Walter
Frank/John Nesbett</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMS
Investor Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>wfrank@imsinvestorrelations.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  X (P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **YOQ;XQ\*^ ]"O?$_C+7]*\-:#IZ;KK5-7O(K.V5R&,5O"9&#W5[<LI
MBL["U2:]O9REO:6\\[I&WPMK'[:/CCXAW=QH_P"RU\$_$WQ&$=P]G_PGGB73
M;_3?!T=RCL%VP+/IL2P7$8WH?$?B?P?J$++()=+959A48RELM.[=HKU;T^6K
M\A-I'Z&U%-/#;QM+<3101(,M+-(D4:CU9W*J!]2*_,F7X'_MW_%ADNOB'\;=
M/^&NF7&_=H/A75KNROK"*0DM:S67@.UT:RU* +(R#^T/&VK2N%,<LS1A&)9?
M\$SO#-]/]K\=?&'QAXGO7.9;RPT72]+N),G)S-KUWXRGR?5YI.><<U7+!;U%
M_P!NIR_'1?U]RN^D7\VD?HTWB[PHK^6WB?P\LF<;&UK30^?3:;D-GVQ6S;7=
MI>QB:SNK>[A/26VFCGC/T>)G4_G7YXC_ ()E? @#!\7?%DG Y_M7P&.>Y 'P
M[P,GG'-8]]_P3*^&\#BX\*_$OQ_HEZF3!=:A;>&=3>)^H8-I.D^&)^" 3Y=Q
M&QQ]\'FCEI_\_)?.G_E)A>7\J^__ (!^EU%?F?%^R[^U_P##9DF^%7[3LGB&
M&WC(CTKQJ^MP6(B4,QMK32-?/Q+T2-W)*(RIIREF$AGMF^==ZR_::_:3^$8\
MO]HSX :IJ?A^W#-<^/\ X81PZC!:64(V->ZK8V>I:SH:F=\2-+?:YX.6-#M3
M2V=EC"Y+_#*,O*_*_NE:_P F._=-?E]Z/T2HKS3X7_&'X<?&70CX@^'/BBP\
M0V</DIJ%M$9+;5M'GG$OE6^LZ1=I#J.FRS>1.;9KFW2"^CA>XL)KJUVSMZ74
M--.S336Z>C0PHHHH **** "BBOY;O^#G'7-0OO W[&7PITV&6]O/''Q,^)GB
M&RTR'E]0U/PMH7@[PKI\$:%E1YI)OB:UM"'XW7)&Y03G[CPWX+GXA<:Y%P?#
M,(Y4LXK8N-7,I8=8N."P^"R['YEB,0\.\1A554*6":<98BC%*<IRFE3:?R/'
MG%<.".$\XXHG@I9E_95+#RIX"%9X>6+K8K&X3 T:$:ZHXATW.KBXVDJ%5MQ4
M5%N::_J1JI?2W<-I<26%K%>WRQ-]DM9[K[%;S7#?+"MU>""[>UM!(5:ZN(;.
M]N(;=9)+>QO9UCM9OQD_X(7_ +7FH_M(_L?V_P ,/'UY=M\:?V4M1LO@YXXL
M]66:'7[KP?;6URGPK\1:O:S6\5Q;W3Z%I.I^ =2;4II];U'Q-\-_$FLZOY<V
MI)O_ !@_X.)/VJ=?^,WQKM/V3_AX-1U7X<_LJ>'].^*/QPGTN.XFTR#XC^.+
MGPYX6T&[UYT66U33/ >C_$/PCX;TW5HYHXE\7_&+6/#.H1?VE96:Q_9<,^"6
M?Y]XK9CX7XG&4LLJ9+B,PEG&>RP[KX/#93A?8_4LUHT98C#1Q$,[_M'(H951
M>+@J]7-X4HUJDL//VORO$'BUDV2^'&"\0L/A:N8T\TP^#_LS)X5O8XK$YCB%
M4>+RZI4C0KRH3RI8+-Y9A5^K3]A3RV<YTZ:JKV?]7C_LZ^&?&'B&W\:?&J\;
MXM^([)Y3HNC:S ;;X:>#XIB1+9^%_A_]HNM.E,\:P#4=6\67'BC7-1GMHI3?
MVEI#9:=8_05M;6UE;P6=I!!:6MM%'!;6MM%'!;V\$2B.*&"")4CBBC0*D<<:
MJB* J@  5^"WCWQ,GB__ (-UK/5U=I7B_8%^'>@74KNSO+?>$?"OACPGJ$LC
ML68RR7VB7#RY)/F,P-7?^"$_B6W\$_\ !*"U\8W04VOA+Q3^T'XGN0Y.PP:!
MK^KZI*'(*G;Y=H0V&!V]".M>/C_#2O@N$.)>)GFDJN)X=\3%X;QRGZCR?7*T
MEFBAF2Q+Q;^KN<\OI16"^KU?][BWBKTWS^KA>/J.)XFR/(/J"A0SG@*7',LR
M^N<T<-1@\#SX'ZO]77ME&.+JS^M>VIZ8=_[.N?W/WCHK_/U_X(?_ +5GB/\
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00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>smti-20260729.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa+DObP9z5Z8iekhvWB3bblqryMvT/fDxCwZzVUmMf0H -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:SMTI="http://sanaramedtech.com/20260729" elementFormDefault="qualified" targetNamespace="http://sanaramedtech.com/20260729">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sanaramedtech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="smti-20260729_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="smti-20260729_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>smti-20260729_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>smti-20260729_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="smti-20260729.xsd#Cover" roleURI="http://sanaramedtech.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sanaramedtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 29, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 29,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANARA
MEDTECH INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000714256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2219994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200
    Summit Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort
    Worth<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">76102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(817)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">529-2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.001 Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SMTI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sanaramedtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>smti-20260729.xsd</File>
    <File>smti-20260729_lab.xml</File>
    <File>smti-20260729_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "SMTI",
   "nsuri": "http://sanaramedtech.com/20260729",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "smti-20260729.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "smti-20260729_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "smti-20260729_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://sanaramedtech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-07-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-07-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001493152-26-035196-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-26-035196-xbrl.zip
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M9(DI:6?I369W4PEL^.%&9O*N-\ZX&SO8=C-%[N=(QWPPN3>B-'RJCLDY1$D
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MATZK'@:*!HTE#"4JM*,X1!MRX(MZ.%J_7-2QCKB?-$$1.("8=5_P"@&>GUV
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MBF=YAU_U^RWWIM8\IWH#G</S3H_3TY5!:^!.<][.M3X>Y^U<1Y>-]G8>G'Z
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M4.*Z<;[5,WW_)Z^L:@:4=W8)G&^IAJ >_'T10ED]X_1Q4L 0<R_>\,-XG$3
MIDS]T65RJ6])-NO&5%;/J-RL=K).94R>]'4"OX#R5L]<_2V2>9XT?/LOU[C4
MP$%?56!)507ZL@)]68$[>-<ZE!7X;D;FG[^)D=EFCB\_B/#)=X1X:YVY-:@.
ML9FFZ.55A.@1X;Y,M/UY!6W4I_JB3A5HX!+0VL!8XL2M(_ACR2E_WY./K3K-
MK)YQ^6.1?[;QSZKBY%"D%""FI*PX#,/]M$2Z>=HC("Q"0JMG(/Y8C](D$I:3
M9;#.T=+SBI_N]TQF'H6LGF7X=5U@I+R02"GU1=;#WO?TH!>*%J>]U;,TO\]A
MR;7SG![!'J@D"TZNELRBUIH$UXWGK9Z=N3' O:??P,?QM(]H78145B_^V8N.
MES#ZI)*(CP="+NO&3E8/@^Z;5NQ[VL>_+D(E*PA&ARG,/)*3S]$E(CP!,RDQ
M@.=%<*Q3_I/T^V-=>!K^ R&FE><SFVFV?MB&ZN_G WN^#!]8%B=L+ZYR\GQQ
MJ&G/(%;F)*[HL'H&L9YRS/,5]&0Y+L3#$5;D1<*C*>=$19?HIU]J7&G/G>83
MSNJYLQ8C'"^VXULF4CSM(]L7H:K5\W M1E7?)DSHZ=.UYT?+;^6?+7$[LG C
M=0L+K'Z/RL6Y+B9)MFR#PSTZ7KY]K']_Y+[WD5OMZW%O=P7%]6]SKA_ S;<\
MHE@]4?QD/-9>POS:\?Z?'Z )H;\&5A4SQY80N4=QZUU21CI-5:;S>JGNP@=5
MEK<_(VM]%>ZMH'PD,6CK<>_U$,%?0FRK)W=9J.JZN$JN5-I1PR?T"OB0%?3P
MHM!+C]E>:QI=.RZX>E;40R"PF(B,A\.%I)*KY49%/NO+?"]$+ZN7-6" @AVU
M>#ID\%KKM>!5SW9[7G47[:U>UL"K)(LMZA5;,EX$KW2FQPG\<5@B)/J2\^'N
MD03[%)8OH<;5RR7X#2-_,TN/;]7U,B_,/BY\/FVL7O+ O^HB*>,D6K)A]5M2
MQ3HSC]7+'/CS\,U_3DYY*!]>!__ZX_1_@_/3-X=OU^/NZB%#[Z2YU<M#.(+U
M!)*9JJ(J7_A"%&A[F2Z7JN\][FN@?Q^SZ^[*D>%)5B6%8$Q:$U?/]AX(V]M;
M/4/_F8;%7C[6[;,^/V\Q"ED]Z_S95$?)V,"E?-0%5?#+HC4Q9CWIV=*=1+=Z
MEG?C$CK545X794]K#Y'7K9X!_UB/)/[+@BX'9T" RW6%/VN'"5KX90?ZNCCE
MW(5T[.)[&@->8D(;8\[>#MO\N(=M7A9L<X_;_#UQFYO8S7R,1WD:?\%9IJ5T
M_[LE.N^['.P',[O#WTY/3MZ=O#\?#@[?'P<?WQZ^1_OCNY/3WTY.'^JD%]K2
M?SHQ&?U?=5DEXQOY,LEBC8W?.S+PK?L8;%6721G\F,9_U_F+EZ]^]<PLKW[]
ML:"OMX-853H.%*7)_:M.;P)X<O]YB,\$^[O[3P,UR4$X@&_/5*8*%;S3\;F.
M+H,W6;2#3X6!"L[U9V@ARHMISJ EP\$6YMRYSFWVG>LZQ$;?)=#>Y^ W$/:F
M8:--^/$UB'Y)K&@L7N/!EFO7%'OSF\5X!&P:-D&A8\XEDH:WCYK>5,'U)3#C
MFT?Y=08K4]KT4R\]U1M 1Y:J&\O.@R*WA\T4_QP.W@3GP?O@)#B#_S^!OW__
MY:%.]@$RPS]_/SD].3P+AX-Z"D<9V0\LVH2C*.$4_P5:F4D/CAR42JDK:*NH
M+H,$7P*.:?ED.)N"#M)9F@8C'4SPEQ@^PHO809))T\+H8!CTF_<5]EHE64TP
M3R7]PH&@^,61XT+,P#0B*"1E62-WAL]Y72$[P]"7H,1";X28*2T3N%203"8:
M1EEIX.+3(LD+F.YP@/U8#P\M8K"5(^8KC$!EW!8ARL"L(C1WI1JG$Z@(.&.,
M7_ L7_YA%-M@'V-K__B5P:I@C#HC["JN/[=MUPCFBS*JYM7AD9"DB;T5.M(X
M((=C0PCH22SUQ1\6<3[H\^;3^*M<%7%P"?1=9RI+)GE= C5N)2!HZ(IB!#56
M[5!5ZZS9:AX>XB)TGF116A/-.SJ!\P'4K^*KI%2C5(?!6"4%C"*7@TB/CG19
M(=EIH,BJC0' #\+7)9X;N.V!Z,H7,$H8III.B_Q*\V#T9QW5?"9CG6(\++\[
M=<;A8'3C-ST<4%>=4X/S4-:3"8L:,J+*FRXQ"#V9IB22P0G5HYON)0A:TI6_
M:+[\\0+DL"2AQ8]26+78+=LBZQ]\%1_%@2<9+N?5-A[S?(+1Q3I&0J%]MXOU
M8U'B,)O[$%SEE<8.9"=8*(OS:9MD7M O6]!)3.4-YQ 6,"(8]22IZ(&\0:[=
M Q@CY[S422%#4*D;0\^95G]*3<[$' F.FRF"Z>/,(*.R)QXW^>L.RIQ3*H\.
M!WB/$[-P/0,%3JA\ ]W<&1ZE3*Y7*SAP,P]K<S:4WF8ER:62WL-:X =-,W#V
MR1B,5UZ"E>RU81'P!2E^1KF8H85(U:6>O;5%EC?2AHY#T" 96K]QSS6%HN$
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M;MHMN5T/FQV)"GMW98:Q(DTC$MF ;TM6VU]Y0KVX[. 0\U;CI)$P[*+Z!?H
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M*6HE$;-2O*0F5XT%F$7WS^',MY>8T+"^8(U#A\'(H%>T1(7&-0G-&.W802/
M;!WK91L..-".AA+G.))%5!9/QZ#<#=:)K,8A9A;*)D* LE(B.&#'I+QD U@)
MGO:"$?U2@*98HAG"G'S53GLS&IJENAF[+- CC';Z+5DN7AND-5H"S\FK)(;1
ME57C!(3FM]LN C+)_$IC;S75<#K50+D?_>!$TT-'^"2T3CD:E><@(B*9F9;-
M J-\@?_F&<<X9#0+]E&-ZB2-F6;B1LI BG^B-ZD!:<-T2OE;5B0^],!PN(;E
M O;2A$\T]OP7L+=2W+D!/DMS;BZ)49#])&JF08^B>-&H\J0/WN:<*4AJ4L2N
MY@A2-N?)9C2Z#"6#%#.(1/VXTE83PE?\S$ W4A+R-=>_O.-DNT15 6<5W,LQ
MA3<9ODI<JZ:TL+(&3GC3.5S1^\T5)B!+JB( J;O.J*SDO1_5!DY28[B]C6#5
MI^1+4&7>$1^/E.E(*[39BQ3?9<*%,,8;PV_04ZZX(B0AV)DO77IW9,/[@'%&
MB<E7(SPQAG;EHT5.<U@#3R<GAL:I\\4%7.&FT%LSF;5WVZSGE%J$B-%F;UQ6
MX'ST;3]UD#AI! 0[TLBW...?4^%N0D(9KG1H##@(=M:B;1L/>'VI340@JA0D
M1(HW6D9''%::9D0-+_W2PGO/#LZ+DY IVQ8IK]),LOVCW[X]H.8ASFN$^3*T
MI?^P:2]O5W&7"%)7 A.N\68,7W]F5GU*[LQP5?7;4$_;@(($47 -)+Q0C78O
M:-2$B:%&H9-I%4K$9B164E0AS!D.WK02>REH):&JF0X-L;*XAY[1=C[*?3/+
MMCTO1A$GH3VZ&>DB*F 1J>^.HNJAK;/UQ,@R!@"4TX"/;#U7!*0+@R,$4\RA
M?84(H5R@7A;?(-;M[^[][ '6N1@W]ZIYXY0MU?;%_5T#BD[[T%4%_BW5:_0>
MLKO26@CS$-VR*>*<RG-9317,O+WEQT_^"'Z3Z_P8&_[H'CBUN@'.[NE/3Y\]
MI^?-/'!U3U!$+D#WB&C1ZLRF[A]3PB2*U?N[N_L_/?GYIY.CD&5W6Z99XB\<
MPF:*V?S2)Z?^UPX3MJN&LP4);04B>Z"K#3Q."1L%^:*NN!Q]U!RVE$_5;EX<
MU8<M>0 :^M%$):G[#3/E4^T>)0D=V  <Q;(D_-T>S'+EI^0Q5N!K&C=Z3A12
M1*&8J+!' NZ *9T8=00=Q0(3H1D56DH%B,A;(Q(97-A<2QH-?@9$3-6$4H:B
M<HI(#2Z_U,-:$8TOJEQL_14"0PM@DH5.B- ;AZ7J$WP3A9Q&X02*GTI,7H#7
MQI7>%M\9NP5ZX7J-I^33,Z5!=):ORDLO3T+@1P@#FHR,#;SQF$'$\5\/UIO(
M?9++P\@!Z<$\C9W%B>*-D=7"U9P(.!S?D!2I-3\1PP?(QI&:J028I@P4BB(Z
M0Q28F)V]G7U,]]]@U^M^[WI=INOUY][UNI:NU]4[QP_E?CGU(+J&@S/CI.N.
MLVS@>5F''G+QUZ T!F>/'OO(WPSY-!4= 6'F,<.E0NT.8RGAW["1IL,N(\ZQ
MH?12"7+SPX%)WQ34/-04,E%XR.#C9=T27MK(C)@PQNPC9R='O0"TZE/R"52J
MB-U9RHRJDHD:';JJ9:ZX&896UFF5F&\:%<R,+<XK6^:JD+GP,B0C\F3Y#_JN
MLM!1FGL+R%NBS%S<G8O>:T+IN>XD6B\ *D==M*#Z&!S3[-6707^X5U>&_#\4
M#H X+>29G&!6)AHL-2$BBLC(H#2@_K"5AE!7&0*2/%'-\.@\<!OA%(DV6@TE
MG9DJ562<.>YKGZ_\E+K/FA#J B@02E*^:C13-X^" ?PT-!^E6A42/-H1QCJ#
M*?D350YLG@9Q7W?2HV)$T=L/3- ^+W13F=,"38NF@N> )M"8TW#@4+LI<$%F
MQS#?H)FS#>FGO U"3B69L+G;FN]/RZI/R9Z6,\6I:\CVCC"-L^BZEX*(?V+B
MSAG9%I$!$B)=%GH2EJ\,.A<5"J2W'I'!WW^#O[%P#Z6R^7.NG!E5A!)[Z[ST
M[J-ZI,+@38%3?D_*^+]!H8&OSFZ*1''"P1&:XI4,'!OYXU.ADDRWZP<=8XVH
M\E/P4><@[9G@&@PM,%4U[:NVRI1[^VU]"2O5?COH>+D_'*L^I<[#,1.IX,EL
M@GI'OE;R$$^G<$.4)GY0&GR;<)#5&<+D4B#,,2'P4H[7>Y'F.$KJ%4B!G^!;
M08.W/:)=5K%W6/P[C2)UT* I0NM -;0JZ^+&4B15EJ;#]%K*E!TR2([4GO,!
MF3^\/CSR@8SXR/RQ\^^=P"Q-B:&OI6!DGNS\L4,>*K30T+1>V]#),\R')8<(
M/X_6MM*O=H#X0FAOKLP%=M;!%:A25W#R64<U^78H53?8>[R[_W@X<(#>AW"'
MI<'>DQ#=6WOAG+<.GC[=]U# WQ$&,GK#]G?W'KOZ;['Q)'%VONP9W>+RLE,
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M070.-M<-^%:KTBBCIWK]4H<V5R=]IX"=)@W=1JV+8_!@@[=-%Q?K$HFTP<Y
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M@^<O?_KCUY"/IM&/Q[<0G"C1/HD)657J$UJV583&!<4$YE7$TE(4AO1&@Z_
M' )62&$=01*<2[03ECD0/OP[S5GO#\F:+Q9^C6#N</T$*2)8H@4$B1:--UL'
M3?4;VAI78CQ'W9MYTSP6U+DTGA&EA,-5BM$R#!HV)38?FK%>*V!8UIB AC<R
MD) %#N:'Q2[1U&)W:*0S/4[(LD4&)V^ 6VR!ICEZ7Y/5A]M/BD!63XRN(^V-
M5-BH[!HO8Y,CP^FGIY5Q2=T]M8))! WTWIB:76V'.&55\8QX%D0<8>M+,O%B
MU#2:K=S79"H!"O"L/3ZCGBCX7XT6+#3&D.4.=O":'0%,L]0"-$KF/']HP.+E
MQ3R*ZJ)DZI\A\>& BTUYO/1!\8J'R/ZB[>"P:EC[P@;9,*="PU^@X$Z&\S@&
M7;@BIC1A?N=L?CI"MRQ<X? CY?$:SF@_G.O/JA2W)C _;)NI%WJ ON%F%3N>
M909XBR*EPKG)6&YV'8J8.WMACW243\QUC;*0'#7VDB!'ZYP)7.-Q#51.=DY/
MZD%SZK2B,85?-M-<S/S,>/F(XL$D-U))AQ*X#QU'M@,Z#IB0 SF>D37F#;YU
M[33EP T_E ]1=5Q" ,P1!FD4)M"#LZAV@CMC7 P#:9+<+QMCCE[O*:$2>O(9
M&=QPH'S' HG!,;,=$/*$] *@/!":2=(#[M;XX0F+QA@5B(RX(/9D;A).@06Y
M"-V6%"I05V4%?Z" D4PH J#2Z"!L.+F:1!5L:1HJQ10U6V9!+D(]-+4^UN:@
MJ5M7/5TH?!L:5>2_]$4:.@KD7Z>G.L1W]L/R4TXQ)A,O!QY$&H>-GL3_.3C8
MV=VE:TR5T).)^:!8)EU6;>9M88(Z,9[<2$)V39%S;G?G\;.#)[SNI+B(( BK
M-($5X$6:VT]G@K+M2/3P_(+#4>P%[,$9S0ZT+27*#3UW,CO!86FNT;85 ]>;
M_>5V>LW=IRT9#E#'R3/L!G;')S 78:;J*D>G;T0"K4\R[$*M2/IPSY,A C>4
MS!:A]PN%3["^5!B?*L6S,3N<H01/1VPL@I#N5"5QESVE<<0.^(BU"6@#[_3U
MFA)RGQ/@,F3 ZF*,ESJ=\:8#.ZZ PLH:K6+T%'"]'$%/\4EZUYG-Y.1X\07"
M %"K;#\Z',B/'N,-;N.[CN7):0DE7A3(]J89P4?Q&42Y$HS#!Z7*[X](5R_D
M^@Z7]-/>);U4E_1^[Y)>2Y?TZAWD-;]FHIEK)F+Y3^Z/+H?+'$%\P?N@*0+C
MI2#6ESS3MPR#C"5=OAA?],(PQX3B(_%Q2A7P!^N$00EQG],\2*>N_0T4E1ZB
M^>/@_LT?0"^%)K412? CRS4;2"[K-26T7WQD&)E.5A4:.5C4O^DT!TX5O"IR
M%1=)?*$M\]'!&[1. &_,TYI<-&'P]NW1C&75^.4.+P@,RC,,C&D4:,"MH<F2
M&)^X\9!?C?-BOA)89YY=-YZKZ+;=V0)UU%"C*W(/W<*^6VL2:QAL4CF]OCE%
M^DI=7!0:P]?)H*$F>9U5S'E![P<=@$)[07LU,K\).K>&%+&VB&&F95!2V] J
MV93PZ#4U7K$VL<)!I@X7'<N9:[?:/$+COB/ZF-,TFJ5H!G-'Q\/;P?2_R;1"
M'YIUE+9-5.0R$+, :/Y3XWBTRXJ)3SA,SMQP2MN/14DQ_P''ER$CHN<P70.V
MR8]71[4PSV#(-T&F,=@;+W(T4F0TC:Y-S$T^ *5N*7*XP 4]$U/27"+>E:V7
M;WXU]L"7/[WY5?(\FJ[&[NN<2:RF$&T9,SIPRPJ' QV7E$N3CRJ5B#_3GZ>;
M$OTDP\:OR15)X=>^5_LZ#[;VY_NTFUNU'=XB)\C M_@N\$Y+I' R\R=<Y=M!
M"?<(^7/=P[/;P0_A#-%@"I0<$U$/!PLQ@LYXGT"!Z%]5XG!&*L(<'4ED35PB
M91ELL9?795UBZA6NNT=:PP%[OI0D$C1L$TCD4Z2)V2P RWF,:YLX'RZ$V6(3
MV]#?KBL^);1;O<\QR<R$.P O<L;]+ANS(RFQ]6.*,9!PG1(GHQ3>6]VY;[(@
M371MQ'CBS1PMQCEW1$%= S*I2$+)< KLH0IF[J'KO$YCS]V!21P29]*Z'N%V
ML]=HBX,#RY&K<*YM/X3KM2+<)CXH$UB'9)K>D +3F(F<(A-5!*>(0^1N7V^*
M WE/)1@#B;1+,;L&3C\I23&,OJG5P7U!O_@1'L=TLQ=Y31F0,MM,*_).H.K-
MYGD39N1=/U,:OF2Z>=%#,FEE-HF$B(;8$&+J,B;?^ 9P3&BC32L[=RUQM(&D
M8-8.5;]+SHSE52\QO:M;'.A@QI(>1B$)-D^)-H='7'9MJRS2;:-M!"X9-P!'
M+,'\>^:WXE-RUA3'1^9=QR00N="W13R#<U4!RT$-_7AO80K8E 1 %BUA("20
M9S:;[8)2-D62G*!H>*%-SEI+$!7RWS)A*AR+HU',RS#PS)Q/(TR02%JR8-]J
M T-9/*Z 83QP2D#",D$KBM6AEIK#!R6T*88*W<Y374 3F'H.P@P\U"W2;*&2
MH\;C)%97264Y0R4)SJ""X;U!*]Z2^L<DU,Z.K7-D<W?)*3N2^:Q;)&&=@N*O
MX28QC[%*@%]A2KH8'#BKTBQQ0=Z5T@V-PX2,8QTWBIVV!MI#NO'9;TLL1/F+
MKC+62TNVI752);7?.>$9KS4O]29:U-9K2EOQ=O!&A"?$@?!NY&[*+ELWLC)X
M %YPK?C_&24 %7$@U$Q)?)U'RD*K"0H-%QCXC^0-M[/G,50N*M8B-1BW(O%5
MY' S=#_2CE?X_5DS@3="84=6YI+633I!AX07& '/-4[>5UJ <_59EX$-56Q)
MN,WQSU\]MQZ-"\;-$_JS&>1F?,W8XW&WN<8$#,,XX4XJ^4JBS<PIRA&U9K'9
M;+!3]EGOE%VJ4_:@=\KV3MG^^OUU2V\'ARB9=87)ABQ%N3LMRQ%>@VX*OB *
MIT++153>HHCLP$T?SK5XAB+6,D*;$T_E<NDV:(K7HGG+M &O&E%TQKP7W^[R
M(*2XCNQ!N-8C'=<XO4[SM,DWVB>3_(.BE8=(_F,G??JI"TUGD>K0OF90>=(<
M#2]EE:>:R#+&,COY#>I+-LUTHCY)3AX:YZQZ*-A4PP$!IXD>+')9E*ID8F5#
M?XPL!L_M%HF=M.1VUDKG06)=$E&%R-<P$DNF$0YQ#48Y-2A6<L]A(I8ST0J[
MSRFJB3&,(JI(?<0-G61)A>E>"FW_),S27%E$A.=A%!*P9YXQ;D ;NR?R^)%;
ME4X3&@)*L<67QF^3%\<V!6;N(GH+'C*+7"!*MNEGG&N6:>G@[0VFA2(PH<DT
M59790,0F!#Y#^8T]LUFG*6U=;"/@Y'"PB)[;1!*;HP'Z=B23\.H;DQ1[2.E$
M,0 7^KCIF*%B)PS!LQ+/M2!>ZQ3S!?;VMX,)S.MRON/27;N%KNHBXQM\#M-!
MSC@< "\@9F40-.DDB-8)RCNIB:@6NJM[WCCON-([\ #XUJ;%\R-X:-V\* 7T
M:+K)>='U:9Y_$HO5G%G2H(S*?:MIP^<<H/Y[.07&O,6P!BT35_ ^K_ !&WN&
M/:!2<I%3SF3#82288&EBR J;O,6$/!RXE27?*CL=//,+PZC!*\"V$I4VB%(Y
M($LU@M'E2 Y3J>\8!KJ,+K6B,/ 2;CF$,VQ"7Y8[P;DD-OL)S)5PP^;#86.
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M+DT$,8.'X:0H>W@Y44[ [98KH7__6W"#[_<G2PB2: "J;J"U;KVF9&,CO,B
MV^IG&(1/XO[[N^'N+OUO;FT(E'CV.YZ:VDNS9""[J9)B[L/!_^SMP+-3-/[@
M\Z9$R<M7O_X+?7C[ST)TMD#O^T]#3E4(KO$_63X'2+C569='[7FX]_P@W'VZ
MYS=!F(Y=TX(A84K"0JC%S7A_$XX1VNAE>9.<7))E2WB"\6Q%U,Z*(X+%2N6E
M,O/JG*KW8M:CDL#HO>?50ZMB*SK$17%S@V$PKE.,2R"L-:[QDN&=5[*/C[^I
M_&  ^+.,BL26()FBT#REOME3W_.&%9\2^= Y.L>=/3QZH3M['F6C(%SJ MVW
M\/B>.?1T5N>Q!W0O(H41F=Y>8(?+ I2SW* U(N0&K5HT6Y^WYP.BMG.6'N_M
MAC\_>S9OR&QYW;IQ+1H8U79#T,[^WL_SVMD)/CBQTI_M(J#4H #@V1I)Q3,*
MTJ),;=0G;(9'E[IL$LPPXRE>W&+-ZZJ$R;*R0IBY37;IDCKN+(XD7NRN;>P9
MPXI/"9W(\S)\&[BJ7GZ=14+'(\]Z)KR9(*UVT8#H:7AZ+=BKH-S?652L"_;>
M8IDW7-0^D\"\1$KS$_?)!:;@N? (R9'$2PXTU,MDE/@5O'Q7=N.LF.O3LL8&
MQ\,#X?.I9'N^(&%T]*N<%L'SZN140"2_SD!/NTRF+G3(,@<;ZT>J8_/5EG!'
M%F.\TJG (ZTF[Q;=\SCZ+Q\A72'=0^RH0<:6%Y,#&5+,%A96F%I/5:, G"L.
MUU%XTC[L3!@T&+]+ ^ LA2G\.85=JUWXGQ9:L9EUXE8I<73.3GCF"G,;F H3
MW HZ577$Y>IE*<*&]1)+W'.R&?:%M,OU*<VS$M8TA:%6^<1"E=DQ&D-@<^IF
MT2D-&,%:@$5<<02P.*<-HIJMEB#VH9(K8X82E&1,#^93:$)$1 F@EKAF9L?&
M",TW=Z=ME.3X3CBG$R(S8SXAYK3EF5#D"UCMD<;F/'L>1@2G*8O,Z8U!L>L(
M][6+Y,6!!13EZU^</KNQ!-FU]W-M9A08!X(24!@"?L,H-<+%-R[6R)D:6RV[
M838S_C@6#56&HI;PR#HC4=]4,"EGXP*H_4X5J"GC>8CS;=EF<XO\[1_TCMZE
M.GJ?]X[>WM';R^I<Y*_AD?H"Q2](R=1' C/I>]VRMZ>H=C]JU-:&SC<<-"UY
MK?+H1OYVGJ$.G=)/RC$A;HS@6MC"'P%>8)7++F>4E&9&$0F%MQ<9DA)_,PK%
M#)Z+7\"(!^_<8KPR:)^0Z9FX>1HX#8R',N<N;=C7T"OD5^JZ<X-FAA^RD.DB
M<S.OWI)#?;B[(7]*@6@X*.MM2>M>?)K1XDI#8W>M/,F",^.^ZJY[WDZ4D^%Q
M0#RJ%4)D;NOO[)]K/2B0>1(JHF&#_@[00$9 A8DI[>972Z[-2=A >\9#=)8]
MO7]GF2_;;R"5K->4T%5V0D$W'@+3C'_'R^(T,33(").R&Q=GB^%+''_<7@0J
M)T';3@-+A?1A/X?2P.:TXGB6 IV#.4M?C)TSB^MR+] Y='U^(7;./PI9)II@
M;M] 4?TB$!V*@Y'<OON%S^F *%H$/R=8"GP.YF/>&?K]$'C%0V1_Z U,4VL^
M]47/+MO<?&MU.-\6+%7DYC)88J3X:FSKDME?YMD5QX5F?UB4:E7XH5UH579.
MN&9D5QF:TWB7:WPX(-]XT.T:-_Y**V-[%73_B9N@;3EVTOHM07!M:W789:X.
MO\X'T=Q5=#WXVTHJS/Q=W;HODW]S]NUPU YWP!=87V_S%-RQ-J3#S"-Y4S)Z
MOE=ASC[=ZRANW2'GE[E'A\1PL(!'(EBZ0P+1@>_V2 1W.22^FN,U%W[&/?5E
M3@S<HADO1K"@$\/M?J<_8WN'BEW=HS\C^"IWAF-UG2/N)8D5GQ*&#S1-DD_A
MJT5-DJ5&*%T*-S#6OC!HZT(S^0Z^&D1 29[&%8KX3;F=$YO4T<Z"9[[@\PAD
M;VB$1L.W.]TF8GLN,VWZWN)<ES8?!%HA)DT%92EBCV+PO0L/7Q'X&L=BPB[F
M$B+G S[W"/DT:Q$64L2R*??=EK.D&O=TK$?5MF%?'D-KW$0NX$+0/J ]NIUH
MH=#:QWDCAM5)6D,CJ/ZV>V<X(.& (B?I&Y>, ,LRH2HFF ILNPH\CSMEBR2C
MFO6BS,N8_:)A;+"?\G'OIURFGW)_M_=3]G[*W@:_H W^V1)L\"='0!H,?6"N
M_C-5C%2FRT<?/J?Z!A$7>J%RQ:=D$UE\4SQ7E#'9H>.ZR)+RTL5TPM:3DJ<"
M<>V!0IB@X2?%JF@@/J(09?R4\">*AZ3OFC(L)&*1QZ\FNW6A+Q)0CR7.T'_.
MY>/:\D92I\4FUOHV]!%&PX.@$\&@>!*-\;=-7TYT:\?0[ST_.!@.$#*D 2!B
M\CAG"3V4H%S\U<N)/4;3U9:O1T*#^04[4RU\B?Y,@;$\/[MP+!-B,)V;ME_L
MQ2\?P,\F<Z'7&EA0/2+C&DW)RR:A8B@,1&2BK1OX8"8*(:DHKL#1_1;J%<G8
ME<F=A<)CMSO^CB2R+0;E+O+!V$Y,ZM9<G3BGXTU* AS_B?%2B$??PRNZ&Z/G
M()@]</.OEI""Z&W"+^> ]>2\XE-"(\:*D3-?%%TWP!?18Q G[.Z32E?$V6O0
MHVOMKCZ#[2RG!(MXT;PG"0<',PH5OME\IG7)T6.6Z5/HEP5MIL_D^18U'X?K
M[E0.R['7A?@:4\8L$#MAE!2P.&BCA$;;P5@WG#6*S80TWTE2IEP'KC]]*SXE
MC&IL2'LV]E#.HZU'RL"2/G['%W%XBT;A2A3-Z@9D%H<&,] L.R"V212U=\WM
MW9^BB7/O0#W:>X*G8>])C'^Y"!"+ "? X%CCEC@'HNI.X+1*;3KTAD O%:WK
M7(DN](N:D:TL3UEX@WE'(+T5;*/7&9<]XQQE&;@OPA4:@440&3UOH-O[HBEN
M"\9OH,6'3GW3-T>UTS!E&:=#W9>EY"+02?^4Y=?9K+1NV-S,ZC=IPQG^7) "
M):Q.,9_=).IP(J6>*F,X[L9#-4AY#@[QY&@G.)N[RH3I*(A#5[96;A>58!@&
M,T?+\5J:@V6@YG*8;9>IY<P4I3O8W4=2>K[[U/J6.IA^.WRQD3:RX0"LZS6E
M_Y^]=VUNVTJZA;^SBO\!=>HY4V05Y+%\2QRG4J4XGAF_DYGXV,F9\Q4D00DQ
M"/ !",EZ?OW;J[OW#1>2<B1'IE@U4Y%) MA[HW?OOJQ>/4FG(HNR$SM;OD!C
MU78"?I@V)S;2\$_:@"2<Y]V+^_9(T@@[/PD_!-M@L,6398B<P&JOH*#IAI,S
M(:2$0F-QIXV,9A;S+"WFFNNUJN<J33X"1)7:^D'1A''$*A#-+14VL4Z--\Y9
M(;J^,&F!,H^ ?J/=C)^+*H;/SQ +YWF^-1>]5OWH>YT!TBP10!-2K$)ZW+,N
M9.O/2'MLK@W%>>6T'7HIK$B.Z%VRSI+A>.,CM9EP)OY'62MNIM !SIM5BB-M
MD'H)3O4ZT)! F?,U!B0/'%BI29;@'=",TU:1IGW'G:6)^G6HFX$SWQYP2N7Y
M,:5RIRF5TV-*Y9A2.1H"/TR6Y"2I/3Y\>._J)M%K,(0FH6G79*J3&&))IOIY
MB;,4/ZW2RRR]$OR9!QK"5](48]/!2?8,)(!,XMJL@#&LUH$@  P(R0/[N5\)
ML^)X%/"EOP'X ]^N4X4R[6?S@#HP+;C;]GE2V;Y0'4-H/B\;AKS1L0B&QSFJ
MK[<9:#)-U[D+^%!STH:3O '2:NL@R2KI&27R&9=I 80>&2ID$H1DD=XE>"[L
M/7;S@)"LQ;-LV(43/E,1 4E>\-NBGR<;^V_I+6*P>#Z3Z466+KM>3JQ?.-O"
M?F%Z/F%X9([YV$%NC^5^Z:^=-&F1%>30,(.!.X+//WN /M A9I._O?UL\M^L
M.'YPINZ>[2=X"Z6+,$C29SLK04/O[UE39*O^ZWJ([]I1F1 R[7JR\);U\G3<
MM7Y)BDI#:L.'PR3LF\>AHI0CS&DK43B-D,6%XG.Y&>^ RBJ?P ZC%3Z?'=$\
M^G]QXH7T/+VU+7_C&E5U8N859S7%13MO\E 78_)A,$6RGW&$#)C3ZN(C;0L(
M!B1^XQ'?].]G9^\,!R.-.M>6$72;15.9)2:G-RL7M7']%M%$:X"2VE(,TE$W
M;\?>]37*F]%A\VGH$=+:&)*3OSY1XV2YBK>NU+RI>(37:5*=I-R="VK 2;0;
MW=J68FBF&XM*1\+?D*$[?7SR?^+QB/_^]N2?<?3>OH3HP\G_LW#Z9@ZGFK&?
M49Y]3"6_YT*I;Q3%B%<[E6*\^93[L:&8 Y48Q6;PY<C9$6X<MPX^C_"N#1<>
MTZ$U9@D:C>C1%@BN%98LH8 RH8Y:>SLE]46TS,NKVH4V52ZP(R)..443KZ)\
MQ]O"V^Z\LXVKO&-/ORPW(CZFS:DA,98DDA&9;5IJ>N08_HIFMO.0?7G[AZP'
M"S^&I;^6*5F UKHJ/UV'F61?1TIBV$-N&?W/6;RB\.D6\%5_']YW_!!K@X4Q
MVRS/Z0!AOEQ^3BS9N>O;QH&PU4".K=+QT_KP'ZVQN5Y.-L_/+DM#]Y<5,D=Q
MAM1352/$:])$DA/WVF#VG#B)]_RV&^\N'8^TAV/<-T@VP]R0Q""TN 5@&.QJ
MQ*[%Q<T1!&1>K*27P!= $/C@ 1\X$ 6X 4-KNA=P@$L[R+(3\\%#^VEQHU;W
M:9;6\&5^_]L/7+_E^#)?TG;ABABSEB0E:XBH61F5-89<U)*@OI&MWGJ_4@LG
M'17\Q"Z_\DSN\8[,56:XU"WGETO8P$/'3G_O+0;2$/B"DPNHF85EHHTKPI*=
M8,CZGHXJ_IY/"0X.J_@A"?)5SU+>>=[46IN#+]][ %I/.,TFB -=MN4"]MWV
M5JGMHR;^7.A3O]XBS^!/45P=P!.=>;>LN'R%-9LZQ;]+5T%$;J"L!M[R_CHK
M&E)9QITEG74?%=7]2XGLR&V^..8V[S2W^>28VSSF-H^QASUC#Z>/;S_X<.:B
M7:]).F$EO!8Z^SWB_%[:SR:4DIS12A\NR/V2.AO#Z; M%PIW&M];/JF!4&,0
M7;3T9):&RU+$ET@.XER<EPU8F8;\WU<<QC8I2JE<YULR]:7!/9&9AB\O$C[?
M!1ZU@ST*(_EL%JY7-GY;I-G&$#R:M2BVY$4QS V96(77#ADOB&8@P^:(O;7=
MQ)ZPR5W3PL\'W7M]#UYP7^A)-HWMG_[?E^YO_\^,/3]:$+J3_4P_C-QGG[J?
M]/R('M+Y[%+)%JK@0[F8WYG$MB^!HP.)CFOP8*Q5DW1PR.)A<3Z&<[^BF>U6
MJ:=WT1,V^JU0)#H)E=WC/V<"ELSVTJV_0C;)ZQ-X2.ZN9<_#T=,XP*3RW?N<
M1#&R&67>:!G/QK#0W(#2AE0'.5JL.V:>YB!'@9-WXOV1SY"+_BLKQ_J5G--Q
M4F\$Y1XD>F:ZK6K>5OOH^@F":6Y1^W)[4Y__[#LF(!E>MLC=2PL$P*JD3&7%
M%AV <?0]_96P?FUY(BF7IJK<X-MG%"V#/?Y<3E1<^752;QR41135SH/7;_7I
MCTO9I3)I&:,$=Y+(CK03@FDO6_E=9X4YI=6ME;U.V\M4)<F_" UHIPYV)?Z[
M'J?Q/N?I;"]*2Q>>:,']^\0I-H<D6"NO+LH\-<S56]Y?NZ: T3>QE_1+%I=9
M759"\V(P.F"M23E,@.A*JIEVS*\0P+<3BKY\@-]W6:IDF.-ZRS"]PYX#K7?*
M%OKOF]DG3"2:H#LB0\;Y]3.U*W?K 49)PEEXZ?3O-/@M?J0ID7*Y;.D0#NL(
M'MQ0K6$-=3*K-"FTU]+;3;H:CYX^?HI_!+GV?^)=K9K\/'%$[3Z$XGCR?T4S
MVWWR/[F#;K&MMMH_@^!8&MXUU2;Z!1&$8VKWOD^IP[W1KL8,(66JEH=Y)HR;
M&K<J-X5G@KS2L%F[H[,6>9%4F7[?.MN&-6U 2*UTR+60)W)NV#_9VV?&P%G,
M)^MM,$Q;]-:6?HZG3S1E:!@\W"*-1[RL0ZYQKT]<I?,T8YN4?G55 8U5[(>,
MIK'/&'V[6C6%X:0&3ZMD9 +L]9G0ZH+Z.B?K0%C1,:JB\]KIX]9KCZ-_I$F^
MN9C#Y)</]/6*'$2#8L! ]$$Y$ [?$&JMT/&AT3MT=5+(5#1#/M_0*W=1E,#,
MXX%P#6<XL?:\>%H\):2K/A.EWNI\Z "!+,2H4+U;FO2#4GB'J,-G04_/+\*=
M;X&E[*PM@1:8/)\RY!!UHS<,Y<%CVF=/,.DF5QDP2Z6I!4C.-4ML^P;=@%@;
M&I/9>%N1Q&%6<N\ $1 G1UP]!:$*A_6#D%76%GO[VZ,/CP"&Y=X!K\NJ:DAN
MWEEG]TQJ<$Y??O.-@'G.BDUV\L]L_G&&1)K]^EOMX?S;HW\^BGY$/^'JVGS[
MY/'I8ZM/M> #=YG)ST!:@W_.Y>$\U5)_LB+']3K*$W8(H*K:ZHW]_J;6PV79
MH+U@*Z3!^=8B3ZZ63<CB2:_Y/%L"@,MI$L3?!41EZU+L9=9E]-@)HG4))W .
MYQ/X%%+>L2.W/B<1+%@FTDII"%99K:K<,L#S0.FGZA_)=&6EX#^=\VMBTNC8
M1 ?<L1'] H'C\EP+RVVJ=5G;*NBL6.;(ZIG31(($BW3./!2V[K_GEBQC*QKT
M.JW07RM#D)_)J(<NH.$AJXW< AQ+(>;*):<(PFN#8\8T)+:OLMT>4C)P,I*<
MH%JYG.%%Z8S,$+U>&(O+A&ETY5V\]B_@2(OYA[GB 6?8OSEFV.\TP_[TF&$_
M9MB/!F&[R?L#,0AK:Q'6:A+6ODT(.R7,(FQ[_(1YRS7EGD0?R)O%:8HT,AMT
MF@'!3]+B/#F7H':0=T(PEX[JM=;VB9%5<Z9CP3;/,IDCK,W?NXD$+/4+\B;U
M)-VXX+B6Y>(6:H=H7PQI<-$W6FLG8<1VC..1&*WIPG>XS>7'Z-U]GQ*XU#0K
M$8KV-MA$UN&K%>Y;V,V<)"I\1OZYWM&E"-ZZ+\WCK%OR[+%08CI:Q*UUEWX.
M@E.+_)0'*'8'F71X>OM)!\UA(>](YQ");*V/>/2 A.7KFA(R#(J=^_^2H@$&
MX#2.GCQ^\C2VB8:=B(A,=(<]D;5B5OHK[DT0B:]<?'8\0N#Y 2J;KVM*B&X.
MR8]60P$/67OU^8OT,LU)1.C\V:0U=RRE)S4HY6@X.%23!N'_EDTUYV@1^= P
MXF*.;3$#BH2M\(\\F:6YB2F5&^X[1NOS,=W(/?*%(X5GRX]Y<2I$::3K8-"S
MJ)T9VRVR[1B<)66@HS:0Z.@HT%_!E%K>62<O:.MR3I]RNZV__O;#[MY:)G/8
MV2*[':\6;4@G@PA72+.(['.$^3B+I[5.&GZ4<"T1=W4W71[_]M-9&)/NCSJR
M3$LZD>/L>T+WW,E0:1M>%X[78K#V#O.I*[=M,?HZW&*]A*NJ<Y3M*JVE'->I
M'?XG] Z'2JU^X>B[Z!7^4_2*_#C)):CJJY/$,F+ZNB_VJ25E==LSPL^#%*82
MF]?1'&T)V9.<D_.?(TM)L[6\G<5"["W$E,'M01[L)2<AI?QO/.(W_*\4I"15
M&NM?V:*5@9#:.KBLZ8(IGBYX32->5%J \RI9J5-M4M8J0<S^*36IC"LK9X!<
MRCPFWHN2#LF&B!B[B:O!(7?/OGT*_G4:PRS/ZHN5T(.8>RI;9XQZ.0Y5YRE,
MR]@;@/*# O^VX)<CBW3-B#AL/G698^FGG=:"1:#!D#3[-_)>064 7F"TV:"0
M49Y;*Z;+HT%#??HBT\2'0<RU!-">@[OR]5XP0.YNUGOAD<*AI^V.Q+G=IQR
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M.&7;C^G:!8,Q)G'<*ZXRJAH8(@.>JJ"2Q09(Z,R<B^G$WW.@7L9RM*;O^92
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M)/3<6!9W$\T0?NDGPE]^^_C'P$!AFL\$'1Q>\-_?,-2=6]*\]2QPHZ0J#VW
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M=Y)A5(W;&_R4$D&<&OK$6IP0F*II76OK6OQ/*Q'H!3U]+,@57!)=I>E'DFZ
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MC-_XV-=AUGU!/"K.FU.4+"2@<95[O3'"C92S8(U-*T:NDSVB^BXL)'<O,LS
M'JV2)MOZQZ_?'Z'_C3P;]SE2MEK4074,J$X*\_56J9#B%P+L]74GIGY4\V+9
M>(7:7-;1N5],>:R'GI/_4>+7)'S)<_@2"NWG?)^1/C7TX1NJ9TCA14J17428
M"&4"O9ZT"6$DI2X;Y[&XN1*&W#N96W%_P_6X891H%)L[5M+8S]V1"6WUC0*N
ME/II"#^H5@G:LNFNQ2("O*:=QA)^66.FL,:5<L4@=J'6<$73L:?P<B^U-7DF
MN")&V'Y?C8\UL55@D)PLI7HC[S]:;(S@*J-CS8VKX<4O"6W( 7V^M1(Y?U/_
M[DK=T(CDR/)!&.'O+K$"97JJD_;W3%?[GJ6?.1R\H;0Q[?%T8<0_UDGSY1XJ
M-'B:3MJ6XZ,X'R/N/UU!98;(GCLMS+S$ ?*Z5,WX'B^(=+%O!UR!2,S/:L4L
M);3/S;^UK^6]$6A(JE2H3BNP88CI6?X&N]Q\QJ^.$2QD'Z'"QZ:@^^Z?WA S
M68*,U&>^QM)OB=D(HM^ ,[MB'%Y%63.PH0@W,%BS3\+\21^ 9YGV:3H9[G.&
M. W;M(]+?)@NX")M'V7;%J7KD06.> F2@LDPL/LD[*!-^+B.O)P-2[VTP#ID
MO?4C^.\+;9BFX1A?)Q^Q%%BVA:B!BK.B:3Z%("NYS>122/T<(FRX.D>[,^;_
MH$557S\1I$H9X>?I48 ].UT5*E\&P-5]2%8+ =BG!GS*0L,LN";_3C^<P3E(
MJ^#>D@OK1XCSB9_*8%3N#"NY-7)D5B.FPW?;TG>=K.?O9Y7L,*7^R?V2BU;#
M:AX02L#V34 B38,0>9#.R%V9053V N*KE&8CDEE4(&8()=9!?B:FD&)6')>D
MX@F!M')]9[4 N13$3M)+7C,"WH>0QD;,&Z^.O)ES$:(:8LI'Z=UBIZC<;UAN
MZG2T%E1DUJTMX>2@33N#WZT:;6X 3BC7UXJ[-N.J:OP;#8 #L;Y%(B5P<&Z>
M/V8-8 XU 9E.VKE9OC5/ JE8. =>HIH I.DEEI1\@5R!Y':6#-(T=LII@?GA
MZ"SI/A55DX-A44WY?[/CHL5^4LVDP$PYYAQRV"CPML?RPW!534EC!M0E_*YR
M?EHU]1R7#7DQ$&'*<+ U57MKP!R\Z%BQ=JZB'+3\& JF87B^W0;TH"J#A:$Z
M0%G94#"=!V!I_]*-.1Z'<+-;6V*W(?/^=)=YO]+,^\-=YOU&9MZOWT&^"\&W
M)Y<??/M0MC#!0@S6C2&)(VDKI(D71>H[ R(5K/(X;BTPH?N6RTMZ[+B>3_KT
M99=G*DR/U.BGP=0<9=VH6!2C:JFU'/2[QLQ>K)+2!?@\B#(5]*,/.[H'"]4K
MEIVL^TOP$X.>1G<-LWL;3^/3RS^-[XMS$/;L9VK,W3[/?J[@C'W@?EOPH_$N
ML]=_+,HY_/:OS:K<KJ3VY</_"V:@[3G_*>6X?5@K=UAJ2E>VB"7)#IX-P'4^
M;\/W8:9Y5"V8U5M>GKV"'W,?"!PGV'DPS.,)QQ<LC=PF'IOZ@<OI'(8RT^0I
M*,DWL*!#^!,%"H**VC",_-0U1@Z5_BL?EOLX.BG'*P5P8<2'@D6F\Z+C6J?$
M]P]8C?/KRY?W'GDG3CK4286B_VJ8OC5QT#HK,?:(IB<.JX5/MQ,Y:)S?X)9W
M4G^&QY(??KPJ* 10NKIBCV$+0@KK(]0QR&U7YW/-IX1]WC\9(^3"A[E[^'*/
M-L'X;DFP-4M'U29U"A]K1.>?UA32<HE-4 ]CK.7M.8\9'L?AML>Q<T8F*ZR*
M*\YG&L&TAX;DF4G7S)55RI5E+*N.870K+[';:/T\NWSKYP>%GH @NE#S3A5>
M\RFAS6.86_NLG7Z&@DS:EE6-595#="M%7W9).>-B=4]6@/U#''D<QCCK\[)4
ME$(GFKW%J^/\KK>/1EY**9/(D%AK8HA[' 1XTX7CV2LPH#)_ FBY6O>RRK;W
MQKSFL&Z:^@S-+^35U*\YO9IN[N+>\Y*06Z2ZV=>@RX<'Z!%R];14G6V2SNP_
MURNXK"IXB"3$*!/=MXBPAM]1\@E3S6*8$H5?8;\Q7VG.4G#6A#[1#:O%XAJO
ML&0?))QN(H_Z:$LA\.];T8_UJ@E3/O62(_:NW*]QZQ?OQM(.=$DGA H>(^".
M4!L)\ V3 &.!#JH(@7E8<5&$'RA7^'OPT+"8?P[2!+-R5L,].BYR,!"H.*^[
M+EK&Z',:KB9_>XD3$Y\A.FJA(-LW<1F".>"%WQXFSKL6*Q"+IOHW_T*]AA0C
MA8>7H_"B 4\S8(SL*#Q"SJRHV5 /D?T$7K2P5EI><]2B]:5,H^M4Z ^.R8(G
M!HQUW':M<N8GT#WM\/!SLB?*[O:((P,4I -6,4TB/\F-F!.3;9B@5[+YC8I6
M>Y?"4,>H2SS!!27]10<B^D%:&U"BRVTV:AR_5IIX(R6C<B=;$R]46+\ 6C+
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MAP&!A8O-\)'-FVXB,]\>/I1 J9?_#@>3IU#KYQ#RH9YG_#2GV,:H^#2-Q0*
MKV &;U:R3EJZ:)$^-X+[E#,ZN33P%JK+9;_,-$Y/P9],TUJ:"G%)][D5\34;
M$5EH8^[>U8B+AN] K&$#WN79#N]RI7B71SN\RP[OL@L:4OYD:U)I[+7#<-/
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M'\$C;+^97[A6<&?-WJ"9;3PF5\ R_TIA8RA@[X11ZF?-1][!2.;-FA)6F?^
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MOKT4DMV3D)TH?2GDV3'IM29 S>+OYFXK4P.5M"EF6DJ0N$JYIJ@SO53V3<%
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M93Q^)BP[<+@@CWWWX*BH,".W%>R-T#:%Q! ]F'8J'CZAE0GJU(=L["R;%<<
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M6((#"592A,E:=_"&8 F#CF)CY1@SP9."[49P9?!TT!LRR62Z'TSPT<>6A^7
M[L67K$EX-__I,X![Y,9LA@:2V%:V7V0E[J.FK4(D@;8V2KCI/?*S5I[OH*4Q
MK.'JNJ1Y:2 RG-;E0JGHV=SEJFYFWV6KQ0+\9G!$__;]$4;SD)OLFTN'4_WC
MQ8?OL8A*4^W=WAUBPMRJU;Z5QNHG+LMC12\*29+9H&_N($77[4-4?G/XX/(1
ME1_*8R0,J>%J/EJ!6]!4_RX\+NXE0RU:>>WA'9*?FS4EA%M^-+QFO7'Z1&$!
M^J367<5O!+[MUAC-K?&6\/DM()>)AHL!\I)S_U'5$%>5&CS&_IY-H5ML)#AY
MH#&50!\=0&Y*[GQY^C<1V'&B7>MB?T0&USFN'MAV<FR6Y]XQM&4=.)UQ#:XX
MNY-XD!%KP@@$0BXY6"F/H,W%T81_:-$K(K&P-$OP74UY7+5++JQHB=!N5K6N
MAH;S]@+OD6"67WH>H8ZHS=$0UP7Q-0TF!G:$(*\&Q!B7MS6]3ZS,>$%9DPS)
MTZ(5?@/%)I2L48U;C[L9D_[G2<'++E'N"( 9"QXA<0S($AYL(;;TT@6ZPL6T
MS16NUMTVQI?AJG05KP88YI-*MI*Z;?@F[-3[6\+P+O!P$;GTN:/UAVS#>;K-
M9/XW="[Q+-9!3Q[MH"=7"CWY=@<]N9'0D]NDC*Z%?2HXE,FJP9N(DA+2;!<O
M4\]-[^)<(.S'->7V.,G0%YK0!KT4F)WSQ;MH,)2O%AV1P;VMEP[TS!5)'TH,
MK2$OQ:P3CO[IXX?L:,3O\L7 8I^%#;9-)A$<-,UU1QC,5U4[FM;(S)9]')V4
MXY58DQTB;WNUKC-%!7/I,SY"F8,XT(,']P?9"\2U(B+D5<R<(_W[J+T!AB"%
MFQ\6I?]UVB2:$:9<-J$=I,'4,!:GE%.)O=L8 ,HF*X7M,[".:2<Q $J+KHL1
ML@:X(HKRCT5E*HR[V%UCR<;='#QVV.ZWLW?W]]#@Q:5H:YQ8L"2' 0I(>Q.+
MQ&&;X4U/)VOZ$(X0TR5S0@8?QE8R"3W^N+_G)AL63YN4%9XB#,KSTJ'YS@*Y
M%4@<3+VR::D+L,"BT_!D8GLGHU;S83T;F8)GA2CF[J0YJS[N*;?6\HHE(5"D
M4+V[OB;K,CQW&1PUT9M2/;RYNEI]YY[R+:36I=HPZ#7.![?HFS[Z& INYXW9
MOD  SR;U\6;R<*H^FJV8O-OG,\Z-*A3</.N9.QCHOUE30D@!]D_G4.UYEZQB
M#9J@=D?&A'CE)-8-)Y1]B93)3&.RB=+BF,I.:N']/2^^%G&#KYUQ@V3O+Q(0
M1@I!X?7A_8>7GWJV_:,F=-!I!<N&=QBW4&=L07H"$5QJ5HRI@2US"]-"'DAI
M892Y'^C-M>;.<8UZ=;2=.#KW??%P0ZJCU)XV:,_GSC1PKG9R(JW+1<)G9AT0
M0C3XG HO:%ASN+:)HTX-DO1\<H7H\ACX*UUU'(;_3%&O-9Z"=D'R6%!+G._&
MRAFE9,->2& 2S5O.CUI;((9%AI??FL)@VEG[)+X)=>\#2#)R4@B9$=:$PTTF
M=2GU?'H^0**,;/UA<S5_IM>0@\^6)=-\-;Z3+Y;"CL&@6U'(;6-4L$LYPIA2
M#?95<^(2.W9&#&]>-<=@#Q8X(; W[NCDKW.,4#FK),>S3K?-5''2O8<P.'KC
M_A=T[$X^W5+/1G/IT27<[K1=HP=.;)-GVB'4-B3CXV [5"9D/X)6&7P!!D2"
M%BHJ<;\>V48)JN:$*9QF8-NLO"UYF0(OMN0%)3[[ H'GHM)>-B0$")'^JK$;
MB[(L^Q#K9#55.B[VNT08=2D(7!^/U:M1]^>BQ85@Z4I( -/6P.BPS-_(FM:P
M]<"DG5>H#E!;EI]=_=XZ5R *:D?&Y,YPNN930IY$I1/Q3A*+<J%)!.,14:]
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MG9XJM4,F=I3[7> 0SC5.6=?*K]B[-#PNJAR:^.?T!JRV>UHN^!XL-+#X.K>
MVCH>II[R:?J+*7M$#8.47-$65T4(."-(2T78;:GI$)9FGM:<;4.M"/3S >LK
M8LES51[(<3;-,)LC&9?>1PR8%%) S?PX\I#Z7\IAR)G2RYHHKKQ]:,Z8Y;ES
M?&UD$8J\A"\B)TRV2P\+;HUKP<%0$T<+&(%'Y95"\ZQ_M/V-LJW:&^WO27^C
MYZ:1Z4E]A@FR7! ]D; X/A")5&+F5,LFM/#'^Z3\@3_IDN8,OVPT8!)-&,':
MYP1I7QO+B./;'F5^W@UBL&L5XJUR\<X5$Y<KQ5YANJ6)!%%5!:HP@ZYKNOG
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MB(QL>.!V+?-ME)SA0$D\*0.78F1E#K.M!*N?QG*CI*!FNE5+>QNE921ZQG
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M#7^4H&]O\0HSV+*=3$%%O:;681H[K$"L>!QM3OI-ND7CX/)+4K@F$EEKJ.A
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M94&W]R;C(?O3MD-L/%!(O,]Z\)2U(@5*]0[_:<Y=PRDT 7K,+MHG^H!L%"X
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MNK,0X,*(5H*WG*]]) B@Y(6SQ]RLIX/3P:,NEKY6YS*?F'9'IP[)'&@'9Z3
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M,SVK?S6#"ZZ"G88+;[60H(\YS; EN#S19H@:=L/%:U>Q&]&.W$$5<"L+H:Z
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MS^$7([!&D4GW%JWJUQ>3RX_"CR@*S];:_EZTK;M@_+67R8L&XR\4ZCFVX<R
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M\ SP#_!:=X20$P.P&%I):[BHBI( </C9>>@W#6BN9*BPFO_J=D'/5%&X(\Y
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M.CH]>#=R$)U%N2V7_)LF)W3M_7T-:SGFM_>UD0'7J!_#QM'+_!XM>C3XO5_
MT8\3;;!MUK&*QW PE>A'L ;"D$O?O>TLC56$)(K)#!3\Y&L1,+-AKN?P&]ZA
MDIJ8O-AJGM%MK_-4%31;'B#XASN8G.Q+[<%CQ1?B>.'/A[](NW2IF/A!0<98
M7JFOE-=($#_.;Q[C&2AOBN'D861=J9JIQ+H[>TA9H213-9FHH'ZG3*FXN)13
M6!< "-#A 5'*W;/B6E@*;FK*C>Z8A[BR6NM 9R\_]J^C-:P\7JSID'YYNX[#
M:W?,&G6<]=5OUMKR^X"907U.D&=([-AP((F0,#V8MAGW?ZT5AONZ;=S_MIXX
MR@Q=6=_ZOXOW )!AX[?25KLTED^1><'[^/ '_:.[!@*3UF79BM;=<+"4_-4!
M"[48TG<.674+*R-P%V: *;B&P^7%V^+^WGIZV;C1@1D;4AI[^R4_-5"J;5OJ
MW5I8PYEA\Y2YY&1[7/'2/64$:A-68J$^[(F?+75<;$9*"Z@K"7<X]!6/7(4S
MTW@+4<>U32S*6\KZE"8BZD->\=;A54C6-;TL-Y$*=58W)BZ3@.AG5Q;PD;D
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MTD)S:__T\!W>LKOU9G1\]/+_ %!+ P04    " "UHOU<+ HRU"DU  !QD0$
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M^^%TN/VN]^TQ*IF _/R\:\<HCZJ\GD[D][^4V+\JY4JERBYYP#YR=V[:P;S
MTZ<1,/=4$6!'(8"B:I*@S<DX&;S>>1_RRK!J?_OI9T+',Y."6';6;:T.]WL/
M][@[DM0R?]3-W%W7VLO\BFJ#^+/;W/W'Z?;N=]_S ?5(M(MBZ6L'1;3 7!<2
M_]#F7^?%W#7XQ(FXR\YX\$5$M\4[_V#%JS $8CFTL4<'K>79J(H+JS=E?0S:
MP 5\ 98OJ.A +J+""1G,"[H\KG'(AH%_'8U0HY]@E 4/F2T&CB>+FTD':&6W
MH 1O6GEWFZWCYNZ_("=H9=>BAQTJBS;!LF@8A2;- K7>9NV.Y7SUH-)&D+YH
MC%M>RM-\*HB*7SXD7$V%<58.X_*D=R^30Z+?>DLO->0[Q13XX^3#6?WD]<<W
M@_NE:]W1&%B07E*XN#O; 5=(^RQ :PVL^?02 _,E\659XNO,1+*-@+0*5_0C
M(*V>3Y:S.!3T% "@XN6P1:U#UC39G@^1D^9RIWAUKAV8&B^-!\N'7P)QY83P
M'A!L[O71Y<S[U/055XK]@6T>V*&,E+/GF>VVUWEBMC,I<9DEB+R$Q_KT,/91
M.L(95HU"J\?.Y%<.2?XQ>)4Y5(3X!;S]-4:/"KQ%X),.,GN0<RU4MT&^1P>8
M&JM-XW3>>)V=<M;JG+-.SRI3J=FH(.&Q4*B8,?A)5,[[3K42HAI-SFQ2(/B7
MS9X &@F+F=#&FANS5XP2LY5I<J[;269"$V>+T/4GY<@]Z"UY8-VZ%8FQ52U7
MJJR)534Q'MQGG.DH,':"&H9#J:+U82#(KUB>R<=99I*P+*"A(<4Y3@X1)"6;
M7;J<(OG/0&+"HDK.$TF66YWL?4"[\*Q,BQ)XDGL\@%LL[*[HCUC+ZY?9.@J-
MF+9:J[Q0^@]]JK[88&2U(SL"WGXOO>IL%DLR ZFODN?UB&C?P%?YV ?Q%E]H
M:"G\S(%EW3!0Q.))B996 H+SQO4#Q\9LV:30()H5:))+[-N2#$WCGL4H,@_U
MDCIQ+QV*RE.8 Q&J<W8] BXYW?2OT6(2QKW0L1T>4+:*G"&9,!U5/:/G+K,/
M$U@8P@,;-@YI+:"PVHZ,K@A%A&H 2/Z.?"J_/R5K9FQ@V:[+>H*AV@(K4XJ#
M.@QCZPHV7J^K)-\R'P[CX,JY<M3NJUEA7[+[8!7M0UG;'P''; 5HC+I++XY(
M'Z(*F=>@SB0&*/@L .1PQ &6$;^2RM(8]'-8 4P:]@.G)[.,X(=Q=GLLD[,L
MX?U<8M*#1OG7/FBNB#TG3@"*JA^$6D4M0EQZ.KG+,2C#SECFFZT[&X!/B&Z$
M4M&(1X5WB"X'74%4P3FIQJ%%9B-0OCDJ[;UI\>TS<O/3WTN8I\^X#?HYBK E
M-N!.P(@0VAI1>]CGRB$J&48S\-&#\'6(GCVX72"<AR5KW0& *!_O2MC*>$!E
M-WS85UNX(%,%\MV)",BRA2F^:NEZ:#73W#T L,-X/.9F3M[\?<%[*WK3>?L
M*Z8SZ+L<N4&R)7<_!E8X'6S%U0;#YO3NE20"@"@4J&8<L\&3L+!"9C/9E1\)
M.A*YG9*WV/[DFS%$+:V(*S*)T&V]1-K;#/=9!VAL0O:%> HT'<CK&/.7-.6S
M%D*)%B1X"+!/PHE&(@THK*',X+JQXNNF.)AYGS*HEU^<I;>H:VR1@1>E#-M0
MSSHAFJ0DDJH)8>H^N;8E)"70[0)VA?YL[> &Y$:^$ B3T1J[+K^RI(-<.L?U
M9B\ER5QB;@#ZA>+H#< F!W":R_+9SG+J% "O/LTEA=#L]UG,49$VQ+-",1"^
MST"=%-DS961;),*@E!IA#$E Q6" AFX4'AW9S,F8$DF&I4A&,WD0EY\*P10J
MF- :DZ+<1I<RTDJ.'61($M% D)L11C^.R'!/J?3 *FS,N@?".PD</]"09]?*
MUGWEZ(4#0H&'5A""_.R2U,*9Y 4HI*/[%XL"1ZYD'[88$S= @2'P8?GNU)+?
MA43K.3!K%X$)8[T-F-]/?H; )KI-6D)#^F3AA$NHAB@7+7NG]T'J3Z_C$,2P
M,&07P1!XRC]<GAX6#)(\T$E6;^G59_0\S2 "ELHQ#OI!L"<7;4BB>Z!C>1T/
M#]%)\X7F#;(B #TY!YQ,GP.I/%)OZB-HKJL.!3 -39O"T)\H?D5)'0(G_M?V
M-J" @0&P2WT>CJ0:!<>:B'I93H5Z&SW?@(=9AL:9\H%5*>_L;^_J(TC9GHF1
M<T:6OV6&+JFQ)1OVAS)4(%'X%JVJ9,WJZH7+EJ+%PF5@@U< !^! )5)>)0#M
M7[7,5I9@(]U^K,1PCEHC*.!4F0*.!6VR?=</94T(IR_F;8Z2A-@ CPME7%VO
M+I*Q5<SFT[#XTF5,(656C[+7T,)KJ$A%,8I)Q,**,2A6 S@PGHEF= Y =F$9
ML1..E,J.6(-#]#-[-N&.= S2G<S/9]%\*Z7WF8&&2N_BNPUHV!.*51!Q\3U/
M^7"3>ZNNHZ9B+D;[XF6A'V5XF!I-1H&566MF("LCE<]9#!#SHJN?4&A:P<!Q
M1;JV#^5.V8SZ08Q/_,UI5XH,#>LT&XGUCR?>=%HJ59XEE0@^4!&:SN9.YN6V
M^7A'/VZ8MR@FFE8J512IDP(?O)F:PV<XN847+Z>7L[$0Y'(/!- H4H#]&3UH
M=2.?&6@@B'<#P2/2; $)FE]C)YJR^C7&5"RM<+Y2/TIWE;M+#"-GLOH!RG<@
M@T0F_Y>ZPA"C@'(Q.$7&F[8@TF.#J%'=81=CS^G%(3OUO>%F%S0A]$B@  ]K
M0!=*J=#,!5+*75[5?:G0ZEZR=+SHE9!,(V"Q)_^M227H#J9ZPHE5W55)07*?
M#&-H<GK'2!- L0YIYD :B+9@-*"W ^%$,>QOD5VMG6YX1J<J+92XE,"5RO79
MYU#*MPJE_$'@C[,J"2=U!)C&>!*A@6P0Z8S7'+( ^O(Q!F>1CJ:T [;NHCX$
MJI8+<Y-9E-\0ST36@GZ.#4M\C4$'4[NZ2#)/=2BN"L>2YI:7*DS;&ILS>(&L
M;F5Y:W;;BS4 J5Y@6NB=KQ1=)VF:E%900T/ ZY*<".\#/0Y$_IH] *9JK3&/
M:A<3$S:+_%(E5%&OG""*\[8%PG=#AI=B@);%)CS(2Q:F=HM?*]E"Z][9592R
M&&O-Z!*+4+M8@7T(U+86H;4(-[+H5B1!LO4");1(<]1ZH#0%F?J?I?9U,>*K
M-UVL?FHH@%G,:*AQ3P!K-AC!I'PN01]=E5+?G/ IP>AXVA(!DUH%IY:A8.JK
M8M5Y*3GOTQ,69V(N\^%YM55XWO,.SUO=F"<*&B@:;<W:I1VX9/W! Y22M76@
MX5\)#SZOM*WG"R':M6:<V.@UYPYZ]F%"&":8IF*>P@5VG<6%OL:%C#]9AH*1
M$A/J]DB:_ !-'@8@E-A(-/W@"$7#2*P=)R-9>7--7HU"!U,L4]+0XM/3WHN>
MB*Z%D/*#C;D?MP54"!ZXCI3E9L6GQ&LNHU0R41<SNJE.YM3OY)=L%%,&H$@(
M]$#W2BQ469&S,&+ DB^24$+S4)Q$XH[3@0,RBD"'%,Q9[TJ.>6:@U6WI4D5=
M03IZM 0+*E4/;Y/T*.I+I%.90ED"$R\GO ]W@JP+7SPJU0VZ0\2_"%,-@E<&
M(..X3D3W)V @;ODQ^7*DPV,\D0A+:I[,B;+00^F'W W+[)U_+:XHS$IJ5^3<
ME;*&4FB<;(RHU"&43E77:+MNY+O*,N$EG;HE0V*2V#'R>@Y]W[8&'!24DM*&
M*%3*E41+FKJ14ACY6!CNA.$TVK<+MPK$K"'\A(E:H7!+4LV%\X./<A>%7;P!
M3&\ '(8%>W;MQZX-X/(0#JPG[1OB9J)"B'R8A]/?G'5BRB<+V*4>01.0)'2.
MZ # YJ*E!5X2WA!/0\[1$^8TKO,%=>C(1[43^W@#L0@C:?9/=@ H)T6 VC'2
M<+)3>2R'4!/<6QW)I":$;;:=$!B#+.T.:_;$T$><HL^)=AB-'#@?U*,!40U[
M4A^$7$Z:&-D'QF0YN#6&MLQ:@^]$INQUP70_I5G;^<.=.0UC=R3:C4$1'<LK
MP^HV(#KHFMG8,=7$0UO)^EPE$VI[(O$TQ5"*8^U*[+MWS8SY&S@!:-(RU1!S
M%1-'$&9+)FQ^S".L0X.VAY"<3UP1G,+5&!$>B*_FXA9,G:C[>E;+G+64VV89
M('+[1J_K0.7%N[JAK0#H7Y8!GUKA;Z'_'\@F[D[S*G5%K9CD,P,-I/9&@IE6
M@:]O::7Y7T-?R<3/Y@*YM&N=AU\DVR+I."\;WZ80S)&;]<^DT%BWQD 3O[J/
M:"\C<M1DP'^1G!EDEVO!!49+2&_)0L*7]=F0=95C)Q=MU09AA&/L.5N_QK49
MG+TW-<W +K^F9/.$PBL#:TKI#<+^4RI(+C05SB9^4HIG:IIZ B4B'[Y5Z0\N
MH'RXMW_XO9,5-E2ZXPI0BKJ7EJO#%/D )!%TM8!F+\G"P/#D$"F!Z\H_^UBZ
M2?]H^JE2CX4J[28='V; IDQ:P#N6<R<L$DT3?YQ1XVF%)@^!)KU0J"@IW'N@
M;B46Q"[9IASO<^PEY)$NK/9H8E22@Z1.>)]]^D= A:1!R72E<FBZYE&R'3D]
M1WI B[)SE(5M=;P/?+R@3#O*W8@F"F7%R]GI,#O1X'# !XD=RP(NH5$"^QWH
MJIN=/K">S;8/T_FLCA<[@(6QUICR:J3>5>^K&'A2("<4?:09I@SU-N;3Q F@
M[H/"'Z 7F-3F=/%$4>:OBR>K /R5FA:JOK!K*B$)4!D#02@0BAZ!X>0Z/L>!
M$]HJ>N-QT2_GDI*=OIY(B^<[%C5\F*47ZEKJMCP$,-]S:9:E]Z$4P-D]_J0F
MCH4BK;QP_7X<\/XTJ41-5JQ$8L^Y0NZU#(HZR7I."F:@BE).FKV!K"5QBTB1
M1\LVH7;6"/M>"YEC,6+K!68>C EQ!DD[ 1[BC[J+$HA*&Z89X>%+%F>YW/,A
M*,M)01X,I$C5=KT]:KR4"<J4$62W!Q!1B+P*^UD0B]\3N@*ZT3\A>:C3;-!]
M2_*CTWPUI53 $Z74;F#(F[B,B9(KPSB<"*5#Q$FA[SS,)4N3B-NANT>V 4&8
M9@9C@#PF'I!-PE-9!QG,TK=W):0^M Z2UEC2QFSI:V8AM?J^S6%=-B4X70'X
M#B:/)V"9613$M;T*XEH%<:T\(8^4(Y-JPTOK%/@UW!XSLCJZ1WMI7)(TYH_C
M"$.XKV4+Y511**I?HTL_9?R\PB'3 6DD-$7&H3J["F?PI/P CTH6?K;OX#$T
MJN=H3EF9AIZ!8J<H!4;:H".SAR&9B7%<YH;X@8[C,3/X]S..DR80*LSO2#/'
MDGK99*Y7]"HIGA5H?0EH%ZU#EN^6D9UJ+*H9P+T8[4%JT@-M$A$8^I%6>**@
MEM")3#ML8M.59>\2Z/R>M,1HW5!/]T(>Z8]1L9Z:->,Y65X>=JT_X3H6 ?#8
M%O^G<GA/@5.L6,-"D+AJ3QL'4>)"94,?T,Q#69)30O!(^M_)MA6JH!>W!%36
MVP3"*[A+0I@TK&$<"_?@57>:^&W)NRL]MV3C*G+5:IO?'(<M2QRV*Y+]Q"_.
MBF0_8T1;D>RGA8L+I/F%>1HJ5C&1?^\;^,C65<DX;G\&YN"-59[]Q ^CB>^E
MG<UE9-6 \E6\HD)WA3'?+V"L%2E_\A=J1<J?,:*M2/G3PL4"D)Q!(O/ZAHT7
M?4C]$46C3'4N[:)T7VIYEF3[XFAR!)6+)E.=Y@>0(Z>0ZR 7MHQ3=["*D?9\
MJ^$44\%8'"GP4^Z?^E@R?E8.>V6_B6 3='NVV_/*5LU5GS=H+<]*71>%$4VS
M7A*L[Y2O7)N4E9$RS)T2"F56)*:94D$J+E-59>.DU.]"8HFN.U.<[9E-KLL%
M?ZE\%!U/2L;/4$>-%D%,">L3/C6]/H87D+T1PBC(3&FUI;0T55KF'2Z;F7#Y
M#3MDI:E\,FXFO#6/;Y5L]\Q :PVLPFL'Y-FX<C*:.6$*3M"/QYA6T5>IQVG^
MELYG5I429%8%8+/&2IZ)[QX(59"X5MK=J93V#W;+E4I:Y<IP(ZC7<Q<A5PNY
M\)ET3:J05*:N11X89W!$!*;85QKFO+5JQH'ONI2*7Y#SO?"ZO)"7UMS!9(+0
MH YINYTLT6+?3K10J5+=0[++G\1P='W*$@?F'P<J_8)Q%V;%;;T25F'6?'[2
M#(&^ Y)A9)N1(2_IU.U$"DA?20L0U1J#HXU&H:H?0-%Z!L)ED97V,5RXD0,4
M6_S <'QA(H"Z!_-VQ,PL++,W<8"(-O:QTK99O[<G=,IU<DERW:.*+\MA:6^O
M4MK>WL,JWDZV?&XA]F3ZFTCYCJ+9]&:G,8JJ-HF$U!SA&A/HS=7:6)1B7M.>
MLM7R0+I3OC@"-A.64  Y2JUF/;L\W![##614A-_WX(L^D ALL+*45/G79#B&
M=[DT>^^32X-]F*B&:E)240;!ZA9HJOBV"OPUPH+3G)RT3K9E]F3&FU ]W-XI
M4=>UL>P:G7%F&P^OB@D^4]#J5M^?S&_3!8C(HPA5:MDC#YE#R)HWY'ABM7)5
M]@X+J32+;%B8=M/KH1]K /\&:4(*)1@>,?2I_"4)[3J#O?@6V+Z0>O$DQJ$C
MI6634B$BH:=6*1TR=AQ))^:PPE*GF05H=C*(X>+@IL[5.<I6MV@U&/M!D1%8
M:EZ2:AF[ =-2]S-=;$AFL&$A'@ 6I!]JKQ))[HZ%2"*M[F.3#MF+/1V+[!:4
M$83Y[AC]9H[.>UCB-2-+2&9%?'FV-:,-%UM+,M**D"DY.M];:&;O6[,U!>@M
M&#\<D3@I@T:P)#V> I7OPF)'J=!TSW67V3FQM4)C>ZYD0I!NF5&G!VT[:G$!
MU@]211/N7/EM;DZ1FL] W]#2AGSLVCGB 9P;[+5N.*. 4(<91BHD'D]7F9\2
M8U)QC=[B+2KE&]-8\QK3X',#P%FLE*6J,N2V(9_)E61AS=T%'B3]"W35.K-R
MDI6V3=6'$6GJ8;;,TS^..?9#\*7F'OHNGICNH-(3'LBB.(4NV"RS4FF[$&)Y
M]>T4.AZ&:&S&=8AQS[<=#8@?W@HZ F;8+_+98O"PZXR=Y&7<$+J^2O8SSD##
MAOUTJ#^C&_HY4C5&HH:90%2AN4>]5P9 !& I@"K&]0F1_L:N"'7;Q5OS9(QB
M4P4';N6@1K,217\1?:/3T-M/I%?)R* 8X4Y("V@4*)0.G/!+IDQA<N22R!CI
M?8X'P@>GYG]8>1Y4JW"$T0OP&$P!=(A4$![*VR'109F\C$.A$@;8& '',5+W
M,B)S0N!HG92,G& B8)_M#+#NNQ*:$,#T9<NDX2N!YHDDUNRL$FM6B36K&_,8
M&2<]3#KYZ%,@6<(X9/I);SE34);X-!N^!^I\0&&$5B(6))V;YU;[11$YTWHN
ML<^195#W(^18%8AR<-,T>\,F(+$H'3;I8#'3WYW$;64[7%0$+=.B*Q'W#.-G
MF-J]+[/];EA^-25+2I!RAN+12,^3@EW6-HXVU6%8TH61I"54EL(DM12_Q%?<
MI':3RGJ6$BR6:$5%A+K6]Z;2&ENXA"S(-$;:O1/43W[E)^6=[U0%C@^Q I!J
M#7*+X1KK1T@YN\]#<4NES)5P],Q JX>Z8<FBU.S2HNN!THY4<0";J7$J99#<
M.&/9[6;[H'SX[Z23NX\F2$4Q)OYU4I=<=HY4"EO^FDI=*2G<GNO:-.=6CE2W
M]$%:^[R3[4T['Z@5'C\ST#"%= 9KR"2>)G@F5>1E+:V0K!3818U0Y?;Z]T41
MF8D9KT2=IA"19_JT]>?.,+-B0,JYN:TYPPD,;&\8-]<S:H>0C]7"&LZWQR00
MVUH7&Y+_T%ADDL&H"#['3T;=IU(#0=IE6)J T*"HP+"HU>U,@FYAG&PI<2I0
M>UE0OVDVY*'*M)6$AR2ALE3XTR8>A=4-/4_7N9.>"+E^-)=J,I?M9NMC^V8[
M[JL'58NT[/EG.S_I=DL8TZN+L"1EEV7S)8/4K.C(,P,-Z4CJD]!6[7G7]8[^
MB%1DDA:L1?Z)4N*3L!#4I ,;3WDQ-D"0'IJDW]P"ETRU<@^?S%*>Z8]#UP=6
MPEN1&%O[Y4H5*/<0.Y!3S,X).TD,P>49A7QU:D\?M O/RBG6IGZKREYQAA9Z
M%'9=P=$<[7G G/K:=PB4(# :*LY:^>O,].-FQS(HAF60BL/#%:E86J1#SF9Z
MCN$\D;XPHB^$)7#J#6DH GI#[$R7J3O8?&^6D33QA4+591&V01QX3CA2/4"E
MC*@<P39BI:U-&.0O5Q8,*^=7(G-/1SFQJ@>).)6V;O_ND)1L[V'-G74K!=?A
M/6P-A%/ID!B0)T.YI"1@3=[9Q]A0JVCG5$4\\U)F8AD20H!^7=!_\T:SHN >
M8P.WS0W$_:'X"W/SL+FM;-%,WD!5V()<R;HQ*^D.VO--!80QV('ZEJH2U4,!
M\CE%,&@X<.-<F"-6W7=(UI$PE%G*_V[?3JGL93<-PS+ML4/-?%1A3URGZ2%4
M"\N=8\%<ECD788039L+T<%K)ET7BLNY-LYQ[132?&6@@A,&A7P,:;Y[Z_A?T
MAW1T0<MP:9TA +4^TR6%L L7W$)C2.RI6 Y&_1AED )7QF\DLKKM(CS<T]8;
M(X(YB7,X<\Z$?</>!GX\*6&S^S);5SQ(_I18[)$T=KC' PY2F]T5_9&5>5S^
M9L;N4_"GN=:TA:6RP \4DKH225E2=34TD\?&@GM&SO)EX%PAR3;"/4_A+]7!
ML8T4?ISRB,/=4L*7:_OU L8\EYT0Q/K5:O,6GFX5\/2DM3JQ3$$^%0-&&<'A
M$_F7YZ@I,)PF;%_D!^A<)P>-HNHJH$3JUJ$Y6!*C1SPP<L;&EB5X8:) 4A\7
MM/B^,Y',608IA8M>)%MW*!8='@]DATX5W)OQOHR1<6&L#8 !BH'$A"1P#>'#
MB$.Y;Q@S(UU3@SC" "**/0\5W](,$?9+AL'0!JGPX=D%6L8"I6&.;.X8OD3A
M?I%4%S1XM$1:4W:5ZBQ+#%O\8$ 4GAX%4Q%#/<H#E?!O>236@IU]83Q7THT,
MY#FAK5;WJ#?"[&@O-3?/U&PA$R'Q<#^8&L6QE-NB$".D!5(%&Z)Y<2%^F!WT
MS%@IWH-U*I-U,91R:R7&VUJ S?9&2JR>&ECTVZFTU;D8O9XM&3^;=N+!EH:A
M;)T[NS>6$NG-UC4I59NQ^V[HJ$)S@]#^/ C@^A.*H0?(E:=*T66J:^54:\7)
MU<WTU"T^''DN9+SFRC"N\_?49H]EA/P$B(8H6#M&7R8D/87F!<I_02R]KTGP
MO5Z"V5 +)O@B]7B9MH&7SNG'KKK6#A'WE/50]\Z),D!C?)V0 F4X<B:AJ48$
M0N<NXBLCAT)]OX@IAOJ&&!KHOB":YO<E%4Q[QQ Y*"FC>5J\*)/]96+U$-T;
M@1,F<74%SHVQ:BM6T*^1<MB*TN74'<1U*Q:I$F!F<GURR$])-^GV4QR@!SJ%
M#CF@8\)P0B\Y'BM_K)XT^B;[GNQYR.PX@;3X)H8@J5!<*,8:9) MC$(#<6%A
M;LIC9?],R[Q#RJMI@#5_TJ'K]P ?!-QN?^STC5O^(D%MQ[-!? JF*G22$-M\
MCNX=*;Q3)" 2A8S-D]A'V)!BD:;I8>CW'5IG$LUA RJY_B1Y%5:.I(+"1]/<
MV@*J04]XXMI2(<3*A4OU#4FNT*'%MAA34MLXS6.1_2\0V?I],2%44F_+ N08
M7CJ[227=Z%;FON%U)WZ1X3O6HP#)LD"J \@EF)$ESHO$$/5],S9#!<+*4U$2
M (J$,"E<:BT!9-FGC0?K2I=##O''@*/$) D:CT)XL_IUM0)*+\8M8QPY!6!&
MZI%0)3^D/052H0X7D0AVV%-,:>*9:)9F(Y5T_Q@YKE!&&.F=G2,[6"IX69DF
M015/ZRND_7L7#* $GW08)V&S-]-4 ),D3V=624A!IY?[9V7Z*,R)OB[D0(DT
MIYV1PLX$9%\)+ @G95.Y$X$)EDICZ GC?8NG7B>CS81L$#7Q(Q5"/F<[RNR#
MI[/&E-R($J-:48:XZ7H$R-5[,%/?30.[ P$:FTQS0.ELOEQ;)J>JBN3-1&TG
M FB?)$3TJ@)?).D/X>-&_PJ*T38D!G6$"X15R;L2N;,H:B0A_BDS*668+QQH
MSQ7H[T_[;(,XI1!0]D_3)D25L>H$MF4$_\-V@M+*DYNK<C:DH&X*)^FF9.44
M+::H S=8[CSU!)LT9R\]^>4Q(EKF%B>@I)TWDZU'"37AA("S< 0@N 12T*)V
M&T"8X*OIRKKU1"+C=U>1\:O(^-6->9R"/"X6M$H">@W.F+=N%!M/#"Y8TCI.
M'[78",5IU+*G?IPFQ,U_V])^BJQID&0+:H:D9!S9[PW#DY'WX.!&CJ:T=:F5
MFG8G+$V;S1&3;98I0VR:"D$E"XT8LE.CCR%</JJR*@\36T;[4R%R29E2CY P
MJAV@5?/^R '!FMS;/IFY0!*2+'/B C^C("\8)<WQHR ULA*4K,1,4&9U;[K(
MJ%:\<6B!ZO%0IZMFDFRO0'36661JQ8H'IU&S^0'+5L=H;IUI0IT<?!(_1.XY
M+/M(^BZ5&'&GL! Y/%J@KE#9QIU9(%4MY95;8FJ"(3XZY=.JIX)U*\6]I?7
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M)=X.:81E2OYR7#46OP+[%2+'IT4P?P?'NCVB"XK.-[5 RTW5]/(W4$L#!!0
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MH*(6V^^7-S==BT]BL]HD_EKAC(@M_P502P,$%     @ M:+]7#:P+2!>!P
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M3'UTUB2DQ]%=4+:)>FA>V?83Y\. DVDYS@,3(,\.!M!2-5A$/U =*S9W7"K
M[ED"^791^99HJQGSYMQYH%/F_'6NN LO=0?#XX*G"!#\*>9($52+%($K(3+"
M'^A<J@KP^Y9 WG]@\B[3AH3Y[XPH0Q5?04@?&0-AGV'"]BA$XOVHB-#,\8$
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M-D   *". @ *              "  0    !E>#$P+3$N:'1M4$L! A0#%
M  @ M:+]7 ,0HE#@8@$ NZ(*  D              ( !7D   &5X,BTQ+FAT
M;5!+ 0(4 Q0    ( +6B_5P%Q49ZLQX  /.U   *              "  66C
M 0!E>#DY+3$N:'1M4$L! A0#%     @ M:+]7"P*,M0I-0  <9$!  L
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2      < !P"E 0  KPT"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="smti-20260729.xsd" xlink:type="simple"/>
    <context id="AsOf2026-07-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000714256</identifier>
        </entity>
        <period>
            <startDate>2026-07-29</startDate>
            <endDate>2026-07-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-07-29" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-07-29" id="Fact000004">0000714256</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-07-29" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-07-29" id="Fact000010">2026-07-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-07-29" id="Fact000011">SANARA MEDTECH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-07-29" id="Fact000012">TX</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-07-29" id="Fact000013">001-39678</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-07-29" id="Fact000014">59-2219994</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-07-29" id="Fact000015">1200     Summit Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2026-07-29" id="Fact000016">Suite 414</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-07-29" id="Fact000017">Fort     Worth</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-07-29" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-07-29" id="Fact000019">76102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-07-29" id="Fact000020">(817)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-07-29" id="Fact000021">529-2300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-07-29" id="Fact000022">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-07-29" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-07-29" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-07-29" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2026-07-29" id="Fact000026">Common     Stock, $0.001 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-07-29" id="Fact000027">SMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-07-29" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-07-29" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
